Sentence,class,file
http://dx.doi.org/10.1093/nar/gks1091 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gkt1250 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gkp940 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gku968 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gks1137 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi .org/10.1093/nar/gks1145 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
BMC Genomics 14:213. http://dx.doi.org/10.1186/1471-2164-14-213 .,OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gkt1190 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gkr1020 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093 /nar/gkt1123 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1093/nar/gks1195 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
http://dx.doi.org/10.1128/JB.00031-15 .Minireview August 2015 Volume 197 Number 15 jb.asm.org 2467 Journal of Bacteriology,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/zjb2458.PMC4505447.pdf
"Editor: M. S. Diamond Address correspondence to Saravanan Thangamani, sathanga@utmb.edu.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JVI.01056-15 .",Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1086/426397 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi .org/10.1146/annurev-ento-112408-085446 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1038/jid.2014 .150.,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
Front CellInfect Microbiol 3:43. http://dx.doi.org/10.3389/fcimb.2013.00043 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi .org/10.1080/0003498012011118 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
Front Microbiol 4:337. http://dx.doi.org/10 .3389/fmicb.2013.00337 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1017/S0031182004004834 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1111/j.1365-3024.2006.00807.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1111/j.1365-2915.1993 .tb00674.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10 .1099/0022-1317-70-7-1895 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1645 /0022-3395(2003)089[0014:TSGEAP]2.0.CO;2 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1016/j.ijmm.2008 .10.009 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
Parasit Vec-tors 5:26. http://dx.doi.org/10.1186/1756-3305-5-26 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.4269/ajtmh.2012 .12-0294 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1097/AIA.0b013e318034194e .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
Science 239:1306 – 1308. http://dx.doi.org/10.1126/science.3344436 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1128/JVI.01112-10 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1016/j.virol.2009.04.026 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1038 /nm1140 .,OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1099/vir.0.82359-0 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.1017 /S0031182004005633 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi.org/10.2307/3281330 .,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
Insect Biochem Mol Biol 36:111– 129. http://dx.doi.org/10.1016/j.ibmb.2005.11.005 .Hermance and Thangamani 7860 jvi.asm.org August 2015 Volume 89 Number 15 Journal of Virology,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/zjv7852.PMC4505606.pdf
http://dx.doi .org/10.1016/S1473-3099(07)70107-X .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1016/S0140-6736(07)61779-6 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Lancet Infect Dis 14:377. http://dx.doi.org/10.1016/S1473-3099(14)70762-5 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Lancet 383:514. http://dx.doi.org/10 .1016/S0140-6736(14)60185-9 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
"Emerg Infect Dis, vol 20. http://dx.doi.org /10.3201/eid2008.130696 .",OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1097/MD/0b013e31806010a5 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1093/infdis/jiq042 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
ClinInfect Dis 47:469 – 475. http://dx.doi.org/10.1086/590003 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.4049 /jimmunol.1202177 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.4049 /jimmunol.0900255 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1002/art.34631 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1371/journal .pntd.0003354 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1128/IAI.71.4.1755 -1762.2003 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Immunol 172:4123– 4132. http://dx.doi.org/10 .4049/jimmunol.172.7.4123 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Immunol 177:6215– 6226. http://dx.doi.org/10.4049/jimmunol.177.9.6215 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1172/JCI39387 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Virol 84:8021– 8032. http://dx.doi.org/10.1128/JVI .02603-09 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1016/j.cell .2008.05.009 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1126/science.1122927 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.4049/jimmunol.0904181 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1002/emmm.201200213 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
JImmunol 190:6295– 6302. http://dx.doi.org/10.4049/jimmunol.1300304 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Clin In-vest122:4447– 4460. http://dx.doi.org/10.1172/JCI63120 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1371 /journal.pone.0007468 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Nat Methods 9:671– 675. http://dx.doi.org/10 .1038/nmeth.2089 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1093/infdis/jir470 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Cytometry 29:233– 241. http://dx.doi.org/10.1002/(SICI)1097-0320(19971101)29:3 /H11021233 ::AID-CYTO6 /H110223.0.CO;2-C .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1126/science.2113314 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Exp Med 184:1– 8. http://dx.doi.org/10.1084/jem.184.1.1 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Nat Rev Immunol 7:599 – 609. http://dx.doi.org/10.1038 /nri2131 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org /10.1016/j.jim.2007.01.025 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10 .1016/0022-1759(94)90236-4 .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1134/S000629791302003X .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org /10.1038/73144 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1126/science.257.5073.1134 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.4049/jimmunol.180.3.1405 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
J Immunol 172:4676 – 4680. http://dx.doi.org/10.4049/jimmunol.172.8.4676 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1002/1521-4141(200006) 30:6/H110211538::AID-IMMU1538 /H110223.0.CO;2-X .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1097/01.bor.0000130537.76808.26 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10 .1128/JVI.76.7.3202-3211.2002 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1128/JVI.77.24.13323-13334.2003 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Immunol Cell Biol 85:33– 42. http://dx.doi.org/10.1038/sj.icb.7100012 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1038/ni1106-1130 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.1016/0167-5699(92)90137-V .,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org /10.4269/ajtmh.13-0455 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
http://dx.doi.org/10.4269/ajtmh.2010.09-0346 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Nat Rev Rheumatol 8:420 – 429. http://dx.doi.org /10.1038/nrrheum.2012.64 .,Non-OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Immunopharmacology 47:63– 83. http://dx.doi.org/10 .1016/S0162-3109(00)00186-7 .Lee et al.,OADS,/arxiv_data1/oa_pdf/64/76/zjv7893.PMC4505607.pdf
Infect Genet Evol 10:876 – 885. http://dx.doi .org/10.1016/j.meegid.2010.07.012 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1038/nrmicro2368 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1126/science.318.5858.1860 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Indian J Med Microbiol 24:83– 84. http://dx.doi.org/10.4103/0255-0857.25175 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
N Engl J Med 371: 885– 887. http://dx.doi.org/10.1056 /NEJMp1408509 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
J Med Virol 80:430 – 433. http://dx.doi .org/10.1002/jmv.21090 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.3201/eid1301.060617 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Emerg Infect Dis 15:836 – 837. http://dx.doi .org/10.3201/eid1505.081390 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10 .3201/eid1812.120471 .14.,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371/journal.pmed.0030263 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371/journal.ppat.0030089 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Virol J 5:33.http://dx.doi.org/10 .1186/1743-422X-5-33 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
J Gen Virol 91(Pt 4) :1067– 1076. http://dx.doi.org/10.1099/vir.0.015743-0 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.3201/eid1210.060610 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1258/ebm.2011.011078 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1016/j.antiviral.2009.10.008 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10 .1099/vir.0.070136-0 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Lancet 383:514. http://dx.doi.org/10 .1016/S0140-6736(14)60185-9 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi .org/10.1371/journal.ppat.0040029 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
J Exp Med 207:429 – 442. http://dx.doi.org/10.1084/jem .20090851 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi .org/10.1128/JVI.00956-12 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
EMBO Mol Med7:24 – 41. http://dx.doi.org/10.15252/emmm.201404459 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
J Clin In- vestig 122:4447– 4460. http://dx.doi.org/10.1172/JCI63120 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1172/JCI40104 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.4049/jimmunol .0904181 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Virol 88: 6862– 6872. http://dx.doi.org/10.1128/JVI.03364-13 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.4049 /jimmunol.1202177 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1128/JVI.02666-13 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
JImmunol 190:6295– 6302. http://dx.doi.org/10.4049/jimmunol.1300304 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
J Virol 84:8021– 8032. http://dx.doi.org/10.1128/JVI.02603-09 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.3201/eid1210 .060596 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1002/emmm.201200213 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371 /journal.pone.0007468 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1016/j.jviromet .2004.11.002 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371/journal.ppat .1003172 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1021/cn3000197 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org /10.1016/0167-5699(93)90318-F .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371/journal.ppat.0030201 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371 /journal.pone.0001168 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10 .3201/eid2008.140333 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
BMC Infect Dis 8:99. http://dx.doi.org/10.1186/1471-2334-8-99 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1002/art.34631 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Eur J Immunol 42:80 – 88.http://dx.doi.org/10.1002/eji.201141820 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1038/labinvest .2014.62 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10.1371 /journal.ppat.1002268 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
Microbes Infect 14:457– 469. http://dx.doi.org/10 .1016/j.micinf.2011.12.008 .,OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10 .4049/jimmunol.0900255 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
JImmunol 178:605– 612. http://dx.doi.org/10.4049/jimmunol.178.1.605 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org/10 .1111/1523-1747.ep12338505 .,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
http://dx.doi.org /10.1002/eji.1830260716 .Caribbean CHIKV Induces a Debilitated Joint Pathology August 2015 Volume 89 Number 15 jvi.asm.org 7969 Journal of Virology,Non-OADS,/arxiv_data1/oa_pdf/90/bb/zjv7955.PMC4505608.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 21, Number 7, 2015, pp.",Non-OADS,/arxiv_data1/oa_pdf/2f/5b/acm.2014.0295.PMC4505754.pdf
"Online document at: http://report.nih.gov/ categorical_spending.aspx, accessed January 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/5b/acm.2014.0295.PMC4505754.pdf
"Online document at: https://nccih.nih .gov/about/plans/2011/objective3.htm, accessed January 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/5b/acm.2014.0295.PMC4505754.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 31, Number 7, 2015Mary Ann Liebert, Inc.DOI: 10.1089/aid.2014.0170 723",Non-OADS,/arxiv_data1/oa_pdf/5c/91/aid.2014.0170.PMC4505765.pdf
"ThisisanOpenAccessarticledistributedundertheterms oftheCreativeCommons AttributionNon-CommercialLicense(http://creativecommons.or g/licenses/by-nc/4.0/),whichpermits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/2e/jeu314.PMC4505791.pdf
<http://www.fda.gov/downloads/Drugs/Guidances/UCM072137.pdf >(1999).,Non-OADS,/arxiv_data1/oa_pdf/98/be/psp40004-0313.PMC4505824.pdf
"These initial results were not lost altogetherand were the starting point when the idea was picked upagain in 2011, with the initiation of the Drug Disease ModelResources (DDMoRe) project (http://ddmore.eu) 2under the European Innovative Medicines Initiative (IMI).",Non-OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
"Another major part of DDMoRe, the Model Repository (http://repository.ddmore.eu), is the place where PharmML-coded models can bestored, retrieved, and shared with the community.",OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
"In this arti-cle we discuss the scope and structure of PharmML v. 0.6,which was released publicly in January 2015 as the secondpublic release (see related websites http://ddmore.eu/pharmml and http://www.pharmml.org for more information).",Non-OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
"PharmML BASICS PharmML is based on XML (http://www.w3.org/XML), a standard developed by the World Wide Web Consortium.",OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
"Users will be able to write models using ahuman readable language also developed withinDDMoRe, the Modeling Description Language (MDL)(http://ddmore.eu/mdl).",OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
"Alterna-tively, in cases when only the Structural Model is required, modelers can use the web-editor infix2pharmml(http://infix2pharmml.sourceforge.net/) to draft ready-to-use PharmML models.",OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
<http://lixoft.com >.,Non-OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)PharmML – Pharmacometrics Markup Language Swat et al.,OADS,/arxiv_data1/oa_pdf/eb/cb/psp40004-0316.PMC4505825.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Incorporation of Resistance into TS Models Terranova et al .,OADS,/arxiv_data1/oa_pdf/47/44/psp40004-0320.PMC4505826.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary/psp4)A Tutorial on Target-Mediated Drug Disposition (TMDD) Models Dua et al.,Non-OADS,/arxiv_data1/oa_pdf/2c/e9/psp40004-0324.PMC4505827.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)PBPK for Transporter Substrates in Liver Cirrhosis Liet al.,Non-OADS,/arxiv_data1/oa_pdf/42/15/psp40004-0338.PMC4505828.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)A Systems Approach to Liver Cancer Chemoprevention Michailidou et al.,Non-OADS,/arxiv_data1/oa_pdf/71/e6/psp40004-0350.PMC4505829.pdf
"European Medicines Agency; Committee for Medicinal Products for Human Use (CHMP), <http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000235/WC500124973.pdf >(2012).",Non-OADS,/arxiv_data1/oa_pdf/71/fd/psp40004-0362.PMC4505830.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)SemiPhysiologically Based Pharmacokinetic Model Hopkins et al.,OADS,/arxiv_data1/oa_pdf/71/fd/psp40004-0362.PMC4505830.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/63/ijp-25-176.PMC4505965.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3d/f5/ijp-25-177.PMC4505966.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ba/f5/ijp-25-183.PMC4505967.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/68/7f/ijp-25-184.PMC4505968.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Scorpion envenomation is a public health problem  in tropical and subtropical countries.",Non-OADS,/arxiv_data1/oa_pdf/3a/94/ijp-25-199.PMC4505969.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ed/3b/ijp-25-245.PMC4505970.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor,  Williams-Beuren Syndrome (WBS) is a rare genetic dis - order.",Non-OADS,/arxiv_data1/oa_pdf/1e/90/ijp-25-247.PMC4505971.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0a/57/ijp-25-248.PMC4505972.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.A term male infant with a birth weight of 2.5 kg was  born to primigravida mother through normal vaginal  delivery .",Non-OADS,/arxiv_data1/oa_pdf/cd/30/ijp-25-250.PMC4505973.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/6d/ijp-25-252.PMC4505974.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/77/2d/ijp-25-253.PMC4505975.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/70/e8/ijp-25-265.PMC4505976.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1f/af/ijp-25-266.PMC4505977.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/37/b6/ijp-25-307.PMC4505978.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b0/99/ijp-25-321.PMC4505979.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijp-25-323.PMC4505980.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ca/f5/ijp-25-324.PMC4505981.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/55/8b/ijp-25-174.PMC4505982.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a2/27/ijp-25-198.PMC4505983.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, West Nile virus (WNV) is a member of the family flavi - viridae.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ijp-25-246.PMC4505984.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, The current scientific literature states that Intralipid  10% emulsion has a higher ratio of phospholipids to tri - glycerides, and contains more lypozomal phospholip - ids as compared to Intralipid 20% and Intralipid 30%, so  it causes higher plasma concentrations of triglycerides,  cholesterol and phospholipids (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/ea/11/ijp-25-256.PMC4505985.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/76/57/ijp-25-322.PMC4505986.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor,  Propionic acidemia is one of the intoxication type or - ganic acidemias, which often present in the neonatal  period with lethargy , feeding difficulties, hypotonia,  vomiting and coma if not identified and treated appro - priately .",Non-OADS,/arxiv_data1/oa_pdf/b1/d4/ijp-25-339.PMC4505987.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Non-specific orbital inflamation (NSOI) syndrome is a  non-granulomatous, non-infectious and non-neoplastic  orbital disease with unknown etiology .",Non-OADS,/arxiv_data1/oa_pdf/3a/18/ijp-25-371.PMC4505988.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/00/e2/ijp-25-401.PMC4505989.pdf
Available from:  http://www.who.int/dietphysicalactivity/childhood_conse - quences.,Non-OADS,/arxiv_data1/oa_pdf/00/e2/ijp-25-401.PMC4505989.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f1/25/ijp-25-427.PMC4505990.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/58/7c/ijp-25-474.PMC4505991.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/6b/ijp-25-494.PMC4505992.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a9/e1/ijp-25-532.PMC4505993.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, The clinical signs and symptoms of perinatal arterial  ischemic stroke (PAIS) may be subtle and nonspecific.",Non-OADS,/arxiv_data1/oa_pdf/99/fc/ijp-25-533.PMC4505994.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ed/c2/ijp-25-809.PMC4505995.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4b/5b/ijp-25-175.PMC4505996.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/22/0c/ijp-25-182.PMC4505997.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Myxedema heart disease is a well-known entity .",Non-OADS,/arxiv_data1/oa_pdf/ea/4e/ijp-25-249.PMC4505998.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Horseshoe lung is an uncommon congenital mal - formation in which the bases of the right and the left  lungs are fused to each other by a narrow isthmus pos - terior to the cardiac apex (1).",Non-OADS,/arxiv_data1/oa_pdf/a5/32/ijp-25-251.PMC4505999.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor Sogrens Syndrome (SS) is an uncommon condition in  the pediatric age group.",Non-OADS,/arxiv_data1/oa_pdf/e1/ca/ijp-25-254.PMC4506000.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Cystic Fibrosis (CF), characterized by abnormal trans - port of chloride and sodium ion across the epithelium,  leads to thick, viscous secretions (1).",Non-OADS,/arxiv_data1/oa_pdf/ef/2e/ijp-25-255.PMC4506001.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Takayasu arteritis (TA) is a rare granulomatous pan- arteritis that involves large vessels predominantly the  thoracoabdominal aorta and its branches (1).",Non-OADS,/arxiv_data1/oa_pdf/84/6a/ijp-25-262.PMC4506002.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Chronic Granulomatous Disease (CGD) is a result of de - ficient oxidative burst and impaired generation of reac - tive oxygen species due to mutations in genes encoding  for NADPH oxidase complex (1).",Non-OADS,/arxiv_data1/oa_pdf/38/ae/ijp-25-365.PMC4506003.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6e/a6/ijp-25-366.PMC4506004.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/df/c8/ijp-25-367.PMC4506005.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/56/a6/ijp-25-368.PMC4506006.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Cystic Fibrosis is an autosomal recessive disorder,  which is caused by mutations in CFTR gene on chromo - some 7q31.2.",Non-OADS,/arxiv_data1/oa_pdf/31/67/ijp-25-369.PMC4506007.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e9/46/ijp-25-381.PMC4506008.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c2/35/ijp-25-386.PMC4506009.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b7/99/ijp-25-425.PMC4506010.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/db/51/ijp-25-461.PMC4506011.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/38/0b/ijp-25-502.PMC4506012.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ff/36/ijp-25-510.PMC4506013.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.With interest we read the article by Khosroshahi et al.",Non-OADS,/arxiv_data1/oa_pdf/20/48/ijp-25-511.PMC4506014.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/19/ijwh-7-685.PMC4506023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 685–692International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  685OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8521 5Increased cesarean section rate in central saudi  arabia: a change in practice or different maternal  characteristics Hanan M al-Kadri1 sultana a al-anazi1 Hani M Tamim2 1Department of Obstetrics and  gynecology, King abdulaziz Medical  city, 2college of Medicine, King saud  Bin abdulaziz University for Health  sciences, riyadh,  Kingdom of saudi  arabiaBackground:  Cesarean section (CS) rate has shown an alarming increase.",Non-OADS,/arxiv_data1/oa_pdf/54/19/ijwh-7-685.PMC4506023.pdf
"Keywords:  cesarean section, maternal morbidity, neonatal morbidity, cesarean section rate Introduction Cesarean sections (CSs) are performed for various fetal and maternal indications;  these include labor and delivery abnormalities, placental and cord abnormalities, and  repeated CS deliveries.1 Recently, CS has been performed to satisfy women’s desire;  therefore, cesarean delivery on maternal request (CDMR) was added to the known  common CS indications.2 CS delivery is associated with increased maternal and fetal complications:3–5  higher rate of injuries of abdominal organs, infections, thromboembolic complications,  placenta previa, placenta accreta, placenta increta, placenta percreta, and neonatal  respiratory problems.6 These complications may result in serious consequences for  both mother and baby.7 Even when a high-standard practice is implemented and most correspondence: Hanan M al-Kadri Obstetrics and gynecology, King saud  Bin abdulazizz University for Health  sciences, college of Medicine, PO 57374,  riyadh 11574, Kingdom of saudi arabia Tel +966 11 801 1111 ext 13611 Fax +966 11 801 1111 ext 13128 email halkadri@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Al-Kadri et al Running head recto: Increased cesarean section rate DOI: http://dx.doi.org/10.2147/IJWH.S85215",Non-OADS,/arxiv_data1/oa_pdf/54/19/ijwh-7-685.PMC4506023.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/54/19/ijwh-7-685.PMC4506023.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/19/ijwh-7-685.PMC4506023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1305–1312International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1305OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7673 9The inspiratory capacity/total lung capacity ratio  as a predictor of survival in an emphysematous  phenotype of chronic obstructive  pulmonary disease Correspondence: David Balfe Cedars-sinai Medical Center, Division  of Pulmonary and Critical Care Medicine,  8700 Beverly Blvd, suite 6732, los  angeles, Ca, Usa  Tel +1 310 423 1835 Fax +1 310 423 0129 email balfed@csmc.ed u aimee French David Balfe  James M Mirocha  Jeremy a Falk  Zab Mosenifar  Cedars-sinai Medical Center, Division  of Pulmonary and Critical Care  Medicine, los angeles, C a, UsaBackground:  Forced expiratory volume in 1 second (FEV1) grades severity of COPD and  predicts survival.",Non-OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
"Keywords:  emphysema, pulmonary function testing, mortality Introduction COPD represents an important public health challenge that is both treatable and  preventable.1 Currently, COPD is the fourth leading cause of death worldwide and  is expected to be the third leading cause of death by 2020.2 Despite efforts from the  medical community, the Centers for Disease Control (CDC) reports that smoking rates  in the US have only slightly declined since 1997 from 24.7% to 20.8%.3 With COPD  prevalence increasing, accurate assessments of COPD comorbidities and mortality  are needed.4–25 COPD results from the interplay between genetic susceptibility and  exposure to environmental stimuli.26Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: French et al Running head recto: Inspiratory capacity to total lung capacity in COPD  DOI: http://dx.doi.org/10.2147/COPD.S76739",Non-OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
"Available from:  http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pd f. Accessed  January 20, 2015.",OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
"Available from: http://www.goldcopd.org/ uploads/users/files/GOLDWkshp2001.pd f. Accessed January 20, 2015.",OADS,/arxiv_data1/oa_pdf/f1/e7/copd-10-1305.PMC4506024.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/bb/ceg-8-183.PMC4506025.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 183–189Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  183OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S8132 1alcoholic liver disease in nepal: identifying  homemade alcohol as a culprit Bickram Pradhan1 antoine hadengue2 François Chappuis3 shatdal Chaudhary1 Dharanidhar Baral4 Pascal Gache5 Prahlad Karki6 suman rijal6 1Division of Gastroenterology and  hepatology, Department of internal  Medicine, B P Koirala institute of  health sciences, Dharan, nepal;   2Department of Gastroenterology  and hepatology, 3Division of  Tropical and humanitarian Medicine,   Geneva University hospital, Geneva,   switzerland; 4Department of  Community Medicine and school  of Public health, B P Koirala  institute of health sciences,   Dharan, nepal; 5Department of  health and Community Medicine.",Non-OADS,/arxiv_data1/oa_pdf/e0/bb/ceg-8-183.PMC4506025.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/e0/bb/ceg-8-183.PMC4506025.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/bb/ceg-8-183.PMC4506025.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/d6/opth-9-1233.PMC4506026.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1233–1238Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1233Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8593 9results of endocapsular phacofracture debulking  of hard cataracts Correspondence: James a Davison Wolfe eye Clinic, 309 east Church street,  Marshalltown, ia 50158, Usa Tel +1 641 754 6200 email jdavison@wolfeclinic.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Davison Running head recto: Debulking DOI: http://dx.doi.org/10.2147/OPTH.S85939 James a Davison Wolfe eye Clinic, Marshalltown, ia,   UsaPurpose/aim of the study:  To present a phacoemulsification technique for hard cataracts  and compare postoperative results using two different ultrasonic tip motions during quadrant  removal.",Non-OADS,/arxiv_data1/oa_pdf/94/d6/opth-9-1233.PMC4506026.pdf
"Surgically induced  astigmatism (SIA) was calculated using IOLMaster mea - surements in a proprietary formula derived by Warren Hill,  MD (available at http://www.doctor -hill.com/physicians/ download.ht m).",OADS,/arxiv_data1/oa_pdf/94/d6/opth-9-1233.PMC4506026.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/94/d6/opth-9-1233.PMC4506026.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/d6/opth-9-1233.PMC4506026.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/36/cia-10-1155.PMC4506027.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1155–1162Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1155OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7169 0Agreement for depression diagnosis between  DSM-IV-TR  criteria, three validated scales,  oncologist assessment, and psychiatric clinical  interview in elderly patients with advanced  ovarian cancer Wadih rhondali1 gilles Freyer2 Virginie Adam3 Marilène Filbet4 Martine Derzelle5 gaelle Abgrall-Barbry6 sophie Bourcelot7 Jean-louis Machavoine8 Muriel Chomat-n eyraud9 Olivier gisserot10 rémi largillier11 Annick le rol12 Frank Priou13 Pierre saltel14 Claire Falandry15 1Clinique Mon repos, Clinea, Marseille, France;   2Medical Oncology Unit, Centre hospitalier l yon  sud, Université lyon 1, Pierre-Benite, France;   3Institut de Cancérologie de lorraine Alexis  Vautrin, Vandoeuvre-lès-n ancy, France; 4Palliative  Unit, Centre hospitalier lyon sud, Université lyon  1, Pierre-Benite, France; 5Institut Jean godinot,   reims, France; 6T enon hospital, Assistance Publique  hôpitaux de Paris, Paris, France; 7Centre léon  Bérard, lyon, France; 8Centre François Baclesse,   Caen, France; 9Centre hospitalier de la région  d’Annecy, Pringy, France; 10hôpital d’Instruction  des Armées sainte-Anne, T oulon, France; 11Centre  Azuréen de Cancérologie, Mougins, France;   12Medical Oncology, hôpital Perpétuel secours,   levallois-Perret, France; 13Medical Oncology,   Centre hospitalier Départemental les Oudairies,   la roche-sur-Y on, France; 14supportive Care  Department, Centre léon Bérard, lyon, France;   15geriatrics and Oncology Unit, Centre hospitalier  lyon sud, Université lyon 1, Pierre-Bénite, FranceBackground:  Depression, a major outcome in cancer patients, is often evaluated by physicians  relying on their clinical impressions rather than patient self-report.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/cia-10-1155.PMC4506027.pdf
"Keywords:  depression, elderly, cancer, screening, geriatric assessment Introduction Depression is a major outcome in cancer patients, with an estimated frequency of  16%,1 and this frequency is reported to be higher for elderly patients (45%).2 Depres - sion is the most common psychiatric illness in patients with cancer and it is known to  reduce patients’ quality of life and to decrease their adherence to medical treatments.3–5  Depressive symptoms (asthenia, sleep disturbances, anorexia, etc) have been reported  to significantly affect patients and their families.3,6 Moreover, recent studies have Correspondence: Claire Falandry geriatrics and Oncology Unit, Centre hospitalier lyon  sud, Université lyon 1, 165 Chemin du grand revoyet,  69495 Pierre Bénite Cedex, France email claire.falandry@chu-lyon.f r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rhondali et al Running head recto: Assessing depression in patients with advanced ovarian cancer DOI: http://dx.doi.org/10.2147/CIA.S71690",Non-OADS,/arxiv_data1/oa_pdf/bc/36/cia-10-1155.PMC4506027.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/cia-10-1155.PMC4506027.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/bc/36/cia-10-1155.PMC4506027.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/9f/opth-9-1255.PMC4506028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1255–1268Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1255Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8050 0real-world assessment of intravitreal  dexamethasone implant (0.7 mg) in patients  with macular edema: the Chr OMe study Wai-Ching lam1 David a albiani2 Pradeepa Y oganathan3 John Chanchiang Chen4 amin Kherani5 David al Maberley6 alejandro Oliver7 Theodore rabinovitch3 Thomas g sheidow8 eric T ourville9 leah a Wittenberg10 Chris sigouin11 Darryl C Baptiste12  1Department of Ophthalmology and  Vision sciences, University of T oronto,   T oronto, On , 2West Coast retinal  Consultants, Vancouver, BC, 3north  T oronto eye Care, north Y ork, On ,   4Department of Ophthalmology,   Mcgill University, Montreal, QC,   5southern alberta eye Center, Calgary,   aB, 6Department of Ophthalmology  and Visual sciences, University of  British Columbia, Vancouver, BC,   7Timmins and District hospital,   Timmins, On , 8ivey eye institute,   london, On , 9Center Oculaire  de Quebec, Quebec City, QC,   10retina surgical associates, new  Westminster, BC, 11Clinwest research  inc, Burlington, On , 12allergan inc.,   Markham, On , CanadaBackground:  The purpose of this study was to evaluate the real-world use, efficacy, and safety  of one or more dexamethasone intravitreal implant(s) 0.7 mg (DEX implant) in patients with  macular edema (ME).",Non-OADS,/arxiv_data1/oa_pdf/68/9f/opth-9-1255.PMC4506028.pdf
"Research into the pathophysiology of ME has led to a greater understanding of the  underlying mechanisms and the role of inflammatory mediators that facilitate cellular  damage, leading to accumulation of fluid within the retina.1,2 The anti-inflammatory, Correspondence: Wai-Ching lam Department of Ophthalmology and  Vision sciences, University of Toronto,  University health network-Toronto  Western hospital, 399 Bathurst street,  east Wing 6-432, Toronto, On, Canada  M5T 2s8 Tel +1 416 603 5376 Fax +1 416 603 5059 email waiching.lam@utoronto.c a Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lam et al Running head recto: Real-world assessment of intravitreal DEX implants in ME DOI: http://dx.doi.org/10.2147/OPTH.S80500",Non-OADS,/arxiv_data1/oa_pdf/68/9f/opth-9-1255.PMC4506028.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/68/9f/opth-9-1255.PMC4506028.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/9f/opth-9-1255.PMC4506028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/5b/jbm-6-229.PMC4506029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 229–238Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  229Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S6051 5Hematopoietic stem cell transplantation in sickle   cell disease: patient selection and special  considerations Monica Bhatia1 Sujit Sheth2 1Division of Pediatric Hematology/ Oncology/Stem Cell Transplantation,   Columbia University Medical Center,   2Division of Pediatric Hematology  and Oncology, weill Cornell Medical  College, New Y ork, NY, USA Correspondence: Sujit Sheth   Division of Pediatric Hematology   and Oncology, weill Cornell Medical  College,  525 east  68th Street, P –  695,  New York, NY  10065, USA   Tel +1 212 746 3400  Fax +1 212 746 8609  email shethsu@med.cornell.ed uAbstract:  Hematopoietic stem cell transplantation remains the only curative treatment currently  in use for patients with sickle cell disease (SCD).",Non-OADS,/arxiv_data1/oa_pdf/bf/5b/jbm-6-229.PMC4506029.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/bf/5b/jbm-6-229.PMC4506029.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/5b/jbm-6-229.PMC4506029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/4a/jpr-8-375.PMC4506030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 375–386Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  375ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8448 4Pregabalin and placebo responders show different  effects on central pain processing in chronic  pancreatitis patients stefan aW Bouwense1 søren s Olesen2 asbjørn M Drewes2 harry van goor1 Oliver hg Wilder-smith3 1Pain and nociception neuroscience  Research group, Department of  surgery, Radboud university medical  center, nijmegen, The netherlands;   2Mech- sense, Department of  gastroenterology and hepatology,   aalborg University hospital, aalborg,   Denmark;  3Pain and nociception  neuroscience Research group,   Department of anaesthesiology, Pain  and Palliative Medicine, Radboud  university medical center, nijmegen,   The netherlands correspondence: Oliver hg Wilder- smith   Pain and nociception neuroscience  Research group, Department of  anaesthesiology, Pain and Palliative  Medicine, Radboud university medical  center, PO Box  9101/520,    6500 hB nijmegen, The netherlands   Tel +31 24 366 8120  Fax +31 24 361 3585  email o liver.wilder- smith@radboudumc.n lBackground:  Pain control in chronic pancreatitis is a major challenge; the mechanisms behind  analgesic treatment are poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/07/4a/jpr-8-375.PMC4506030.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/07/4a/jpr-8-375.PMC4506030.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/4a/jpr-8-375.PMC4506030.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHepatic Medicine: Evidence and Research 2015:7 37–42Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  37ORiginal REsEaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/HMER.S8759 4Overt hepatic encephalopathy in italy: clinical  outcomes and healthcare costs Daniela Paola Roggeri1 alessandro Roggeri1 Elisa Rossi2 Elisa cinconze2 antonio gasbarrini3 Pieralessandro Monici Preti4 Marisa De Rosa2 1Procure solutions, nembro,   Bergamo,  2cinEca, interuniversity  consortium, Bologna,  3catholic  University of sacred Heart, Policlinic  a gemelli, Rome,  4alfa Wassermann,   Bologna, italy correspondence: alessandro Roggeri   Procure solutions, Via camozzi  1/c,  24027 nembro, Bergamo, italy   Tel +39 035 521 121   Email alessandro.roggeri@ procuresolutions.i tPurpose:  Hepatic encephalopathy (HE) is a recurrent severe complication of progressive hepatic  cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
"Available  from: http://osservatorioarno.cineca.or g. Accessed May  21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
Available from: http://www.easl.eu/research/our-contributions/clinical- practice-guidelines/detail/hepatic-encephalopathy-in-chronic-liver- disease-2014/report/ 9.,Non-OADS,/arxiv_data1/oa_pdf/1e/d2/hmer-7-037.PMC4506032.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/91/ndt-11-1677.PMC4506033.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1677–1684Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1677OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8595 9Differences in maladaptive schemas between  patients suffering from chronic and acute  posttraumatic stress disorder and healthy controls alireza ahmadian1,2 Jafar Mirzaee1 Maryam Omidbeygi1 edith holsboer-Trachsler3 serge Brand3,4 1Department of Psychology, Kharazmi  University, 2sadr Psychiatric hospital,   Janbazan Medical and engineering  research center (JM erc), T ehran,   iran; 3Psychiatric clinics of the  University of Basel, center for  affective, stress and sleep Disorders,   4Department of sport, exercise  and health, sport science section,   University of Basel, Basel, switzerlandBackground:  War, as a stressor event, has a variety of acute and chronic negative consequences,  such as posttraumatic stress disorder (PTSD).",Non-OADS,/arxiv_data1/oa_pdf/af/91/ndt-11-1677.PMC4506033.pdf
"Findings from correspondence: Jafar Mirzaee sadr Psychiatric hospital, Delpazir  alley, rahmani street, Piroozi square,  sadr highway, 1939974431 Tehran, iran Tel +98 912 317 0267 Fax +98 212 254 59 94 email Jafarmirzaee48@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Ahmadian et al Running head recto: Maladaptive schemas in chronic and acute PTSD DOI: http://dx.doi.org/10.2147/NDT.S85959",Non-OADS,/arxiv_data1/oa_pdf/af/91/ndt-11-1677.PMC4506033.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/af/91/ndt-11-1677.PMC4506033.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/91/ndt-11-1677.PMC4506033.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/9f/ijwh-7-693.PMC4506034.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 693–697International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  693OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8380 0Factors associated with successful vaginal birth  after cesarean section and outcomes in rural  area of anatolia Mehmet Baki senturk1 Yusuf cakmak2 Halit atac2 Mehmet sukru Budak3 1Department of Obstetrics and  gynecology, Bakirkoy Dr sadi Konuk  T eaching and research Hospital,   Istanbul, T urkey; 2Department of  Obstetrics and gynecology, Batman  state Hospital, Batman, T urkey;   3Department of Obstetrics and  gynecology, Diyarbakir research  Hospital, Diyarbakir, T urkeyAbstract:  Successful vaginal birth after cesarean section is more comfortable than repeat  emergency or elective cesarean section.",Non-OADS,/arxiv_data1/oa_pdf/41/9f/ijwh-7-693.PMC4506034.pdf
"Women with a history of CS mostly undergo initial labor at home and present to hos - pitals with advanced labor to ensure vaginal delivery, opt for vaginal delivery at home,  or present at hospitals with complications.5 This study evaluated 127 patients with a  history of CS and without indication of prior CS who were admitted in the active or correspondence: Mehmet Baki senturk Department of Obstetrics and  gynecology, Bakirkoy Dr sadi Konuk  Teaching and Research Hospital, Tevfik  saglam street, number 11, Zuhuratbaba,  Bakirkoy 34147, Istanbul, Turkey Tel +90 541 773 7176 email dr.baki77@gmail.co mJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Senturk et al Running head recto: Vaginal birth after cesarean section DOI: http://dx.doi.org/10.2147/IJWH.S83800",Non-OADS,/arxiv_data1/oa_pdf/41/9f/ijwh-7-693.PMC4506034.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/9f/ijwh-7-693.PMC4506034.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/9f/ijwh-7-693.PMC4506034.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/4e/ott-8-1701.PMC4506035.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1701–1706OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1701ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8674 3Significance of downregulation of renal organic  cation transporter (SLC47A1) in cisplatin-induced  proximal tubular injury T omohiro Mizuno1–3 Waichi Sato2,3 Kazuhiro Ishikawa4 Yuki T erao1 Kazuo Takahashi2 Yukihiro Noda5 Yukio Yuzawa2 Tadashi Nagamatsu1 1Department of Analytical  Pharmacology, Meijo University  Faculty of Pharmacy, Nagoya,   2Department of Nephrology, School  of Medicine, Fujita Health University,   Toyoake, 3Department of Nephrology,   Nagoya University School of  Medicine, Nagoya, 4Department of  Neuropsychopharmacology and  Hospital Pharmacy, Nagoya University  Graduate School of Medicine, Nagoya,   5Division of Clinical Sciences and  Neuropsychopharmacology, Meijo  University Faculty of Pharmacy,   Nagoya, JapanBackground/aim:  To elucidate the mechanism responsible for developing acute kidney injury  in patients with diabetes mellitus, we also evaluated the issue of whether advanced glycation  endproducts (AGEs) influence the expressions of multi antimicrobial extrusion protein (MATE1/ SLC47A1) in tubular cells.",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/ott-8-1701.PMC4506035.pdf
"Advanced glycation endproducts (AGEs) interact with the cell-surface receptor Correspondence: Tomohiro Mizuno Department of Analytical Pharmacology,  Meijo University Faculty of Pharmacy,  150 Yagotoyama, Tempaku,  Nagoya 468-8503, Japan Email mizunot@meijo-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 8 Running head verso: Mizuno et al Running head recto: Down-regulation of SLC47A1 facilitated proximal tubular injury DOI: http://dx.doi.org/10.2147/OTT.S86743",OADS,/arxiv_data1/oa_pdf/9e/4e/ott-8-1701.PMC4506035.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/ott-8-1701.PMC4506035.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/4e/ott-8-1701.PMC4506035.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/fc/mder-8-295.PMC4506036.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 295–296Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  295CoRRig EnDuMopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S9052 7Soya oil-based shampoo superior to 0.5% permethrin lotion for head louse  infestation [Corrigendum] Burgess IF , Kay K, Burgess NA, Brunton ER.",Non-OADS,/arxiv_data1/oa_pdf/05/fc/mder-8-295.PMC4506036.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/05/fc/mder-8-295.PMC4506036.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1249–1254Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1249Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7232 1The clinical utility of new combination  phenylephrine/ketorolac injection in cataract  surgery Lola elizabeth Lawuyi Avinash Gurbaxani Moorfields eye Hospital Dubai,    Dubai, UAeAbstract:  The maintenance of mydriasis throughout cataract extraction surgery and the control  of ocular inflammation are crucial for successful surgical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
"Complications that occur when miosis develops include posterior capsular tear  and associated vitreous loss,3 longer surgical time, and postoperative inflammation.4 Correspondence: Lola elizabeth Lawuyi Moorfields Eye Hospital Dubai,  Al Razi Building 64, Block e, Floor 3,  Oud Meetha Road, Dubai, UAe Tel +971 50 832 5955 Fax +971 4 442 9788 email lola27law@yahoo.co.u k Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lawuyi and Gurbaxani Running head recto: Phenylephrine/ketorolac combination injection in cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S72321",Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
Available from: http://www.omidria.co m,Non-OADS,/arxiv_data1/oa_pdf/b6/09/opth-9-1249.PMC4506037.pdf
"The ABCA4  gene encodes the ABCA4 protein, which is  an ATP-binding cassette (ABC) transporter protein located Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> Received 14 May 2015 | Accepted 15 July 2015 | Published 17 July 2015© 2015 Molecular Vision 767Reduced macular function in ABCA4  carriers Ulrika Kjellström Department of Ophthalmology, University of Lund, Lund, Sweden Purpose:  To study retinal function and morphology in ABCA4  carriers to investigate if ABCA4  carriership is associated  with any functional or morphological changes and, if so, to explore whether certain mutations may be associated with  particularly severe alterations.",Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  768in the rims of the photoreceptor discs [ 14-16].,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  769Table  1.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  770Table  2.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
"Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  771Subject/ GenderAge Mutation BCVA (RE,  LE)Goldmann visual  fieldffERG mERG  AmplmERG IT Fundus photos AF 15/F 41 c.2894 A>G 1.0, 1.0 N N RE ↓ LE ↓ RE ↑ LE ↑ LE; pigmentary  changes sup to the  maculaLE; hyper- fluorescence sup to  the macula 16/M 57 c.5714+5G>A 1.0, 1.0 N N N RE ↑ LE ↑ OA; very subtle  pigmentary changes  in the maculaN 17/F 47 c.2894 A>G 0.9, 0.9 N N N RE ↑ LE ↑ N N 18/M 48 c.4297 G>A/  c.4667+2T>C1.0, 1.0 N N RE ↓ LE ↓ RE ↑ LE ↑ RE; subtle pigmen - tary changes in the  maculaRE; hyper- fluorescence in the  macula F=female, M=male, BV A=best corrected Snellen visual acuity, RE=right eye, LE=left eye, Ampl=amplitude, IT=implicit time, AF=autofluorescence, inf=inferior, temp=temporal,  ↓ reduced, ↑prolonged, n=normal, sup=superior, OA=both eyes a The patient has myelinated nerve fibers corresponding to the scotoma.",Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  772members.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  773 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  774reduced in subject 1 (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  775 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  776Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
"Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  777the control group (right eye: IT1, p=0.002; IT2–5, p<0.0001;  left eye: IT1–5, p<0.0001; Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  778OCT images.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  779in a study done in Denmark [ 30].,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  780[51].,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  781map outside known functional regions of ABCR (ABCA4).,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
Molecular Vision  2015; 21:767-782 <http://www.molvis.org/molvis/v 21/767> © 2015 Molecular Vision  782Graefes Arch Clin Exp Ophthalmol  2002; 240:628-38.,Non-OADS,/arxiv_data1/oa_pdf/dd/0f/mv-v21-767.PMC4506055.pdf
"Within these  semi-isolated ethnic groups, the need and desire to maintain Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> Received 4 November 2014 | Accepted 15 July 2015 | Published 17 July 2015© 2015 Molecular Vision 783Nonsyndromic retinitis pigmentosa is highly prevalent in the  Jerusalem region with a high frequency of founder mutations Dror Sharon, Eyal Banin Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel Purpose:  Nonsyndromic retinitis pigmentosa (RP) is the most common inherited retinal degeneration, and prevalence  of the disease has been reported in populations of American and European origin with a relatively low consanguinity  rate.",Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  784religion and culture led to relatively high levels of intracom - munity marriages.,Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
"Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  785To date, the prevalence of inherited retinal diseases  has been estimated in studies that were performed mainly  in North America or Europe.",Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
"Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  786Table  2. d isease -causing  MuTaTions iden Tified  in rp paTienTs froM  The vicini Ty of Jerusale M. Gene Name Mutation name # of Families (# of  alleles)% of the total number of  allelesOrigin ADAM9 c.1087T>A (p.C363S) 2 (4) 3.4% Iraqi Jewish BBS1 c.479G>A (p.R160Q) 1 (2) 1.7% Arab-Muslim CDHR1 c.1381C>T (p.Gln461*)   c.2087_2090del4 (p.D696Afs*3)1 (2)  1 (2)1.7%   1.7%Arab-Muslim  Arab-Muslim CNGB1 c.2284C>T (p.R762C) 2 (4) 3.4% Buchara Jewish CRB1 c.1148G>A (p.C383Y)  c.2498G>A (p.G833D)   c.3306G>A (p.G1103R)1 (2)  2 (4)  2 (4)1.7%   3.4%   3.4%Kurdish Jewish  Iraqi Jewish  Arab-Muslim c2orf71 c.2950C>T (p.R984*)   c.3289C>T (p.Q1097*)1 (1)  1 (1)0.8%   0.8%Turkey Jewish  Iranian Jewish C8orf37 c.529C>T (p.R177W) 1 (2) 1.7% Arab-Muslim DHDDS c.124A>G (p.K42E) 8 (16) 13.8% Ashkenazi Jewish EYS c.403delA,c.406G>T,c.del410_424 (p.T135Lfs*25)   c.1211_1212insA (p.N404Kfs*2)   c.8218_8219delCA (p.H2740Yfs*27)   c.9286_95del10 (p.V3096Lfs*28)5 (9)  1 (2)  1 (1)  1 (2)7.7%  1.7%  0.8%   1.7%North-African Jewish  North-African Jewish  Iraqi Jewish  Ashkenazi Jewish FAM161A c.1355_6delCA (p.T452Sfs*3)   c.1567C>T (p.R523*)6 (12)  1 (2)10.3%   1.7%North-African Jewish  Syrian Jewish MAK c.1296_7ins353 (Alu insertion) 2 (4) 3.4% Ashkenazi Jewish NR2E3 c.119–2A>C (IVS1–2A>C)   c.932G>A (p.R311Q)   c.747+1G>C (IVS5+1G>C)   c.194–202del9bp (p.N65-C67del)2 (2)  2 (2)  1 (1)  1 (1)1.7%  1.7%   0.8%  0.8%Arab-Muslim   Ashkenazi Jewish  Ashkenazi Jewish  Ashkenazi Jewish PDE6A c.1960C>T (p.Q654*) 1 (2) 1.7% Arab-Muslim RDH12 c.295C>A (p.L99I)   c.377C>T (p.A126V)  c.658G>A (IVS5+1G>A)   c.740T>C (p.L274P)2 (4)  2 (4)  1 (2)  1 (2)3.4%   1.7%   1.7%  3.4%North-African Jewish  Arab-Muslim   Arab-Muslim   Arab-Muslim",Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  787Gene Name Mutation name # of Families (# of  alleles)% of the total number of  allelesOrigin RPGR c.259G>T (p.E87*)  c.592G>A (p.G198R)  c.2964_5delGG (p.G998Gfs*88)   c.2797delG (p.E943Kfs*155)   c.2405_6delAG (p.E802Gfs*31)1 (1)  2 (2)  1 (1)  1 (1)  1 (1)0.8%   1.7%   0.8%  0.8%  0.8%Bedouin  Arab-Muslim   Ashkenazi Jewish  Ashkenazi Jewish  Ashkenazi Jewish RP2 c.530_531delTT (p.F177Yfs*40) 1 (1) 0.8% Ashkenazi Jewish SPATA7 c.288T>A (p.C96*) 1 (2) 1.7% Arab-Muslim USH1C c.1220delG (p.G407Efs*56) 3 (6) 5.2% Yemenite Jewish USH2A c.377delG (p.S126Ifs*18)   c.3959C>T (p.P1320L)  c.6937G>T (p.G2313C)   c.12052G>A (p.A4018T)1 (1)  1 (1)  1 (1)  1 (1)0.8%  0.8%  0.8%   0.8%Arab-Muslim   Arab-Muslim   Arab-Muslim   Arab-Muslim,Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
"Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  788to be populated by 945,000 individuals (data collected from  the Israeli Bureau of Statistic s), resulting in an estimated  prevalence of 1:2,086 individuals.",Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  789with AR inheritance pattern.,Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
"Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  790populations in which other genes such as USH2A  (GeneID  7399, OMIM: 608400 ), ABCA4  (GeneID 24, OMIM: 601691 ),  and RHO  (GeneID 6010, OMIM: 180380 ) are the major  RP-causing genes when mutated [ 4].",Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  791Abraham’s children in the genome era: major Jewish diaspora  populations comprise distinct genetic clusters with shared  Middle Eastern Ancestry.,Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
Molecular Vision  2015; 21:783-792 <http://www.molvis.org/molvis/v 21/783> © 2015 Molecular Vision  792France: assessment of 21-year data management.,Non-OADS,/arxiv_data1/oa_pdf/a6/77/mv-v21-783.PMC4506056.pdf
"Ȉhttp://www.e-crt.org Ȉ 534Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/69/64/crt-2013-151.PMC4506095.pdf
"2015;47(3):534-538pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.151 Open Access Novel Germline Mutation ofBRCA1Gene in a 56-Year-Old Woman with Breast Cancer, Ovarian Cancer, and Diffuse Large B-Cell LymphomaCase Report  We report a case of a 56-year-old woman with breast cancer, ovarian cancer, and  diffuse large B-cell lymphoma with a BRCA1gene mutation.",Non-OADS,/arxiv_data1/oa_pdf/69/64/crt-2013-151.PMC4506095.pdf
"Ȉhttp://www.e-crt.org Ȉ 436Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/1c/f5/crt-2013-184.PMC4506096.pdf
"2015;47(3):436-440pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.184 Open Access Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or NeckOriginal Article Purpose The purpose of this study is to assess the clinicopathologic features, treatment outcomes, and role of adjuvant radiation therapy (RT) in cervical thymic neoplasm involving the thyroid gland or neck.",Non-OADS,/arxiv_data1/oa_pdf/1c/f5/crt-2013-184.PMC4506096.pdf
"2015;47(3):441-447 Ȉhttp://www.e-crt.org Ȉ 441 Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.219 Original Article Open Access Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in  Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma Purpose Concurrent chemoradiation (CRT) with 3-weekly doses of cisplatin is a standard treatment for loco-regionally advanced head and neck squamous cell carcinoma (HNSCC).",Non-OADS,/arxiv_data1/oa_pdf/18/ad/crt-2013-219.PMC4506097.pdf
"Ȉhttp://www.e-crt.org Ȉ 544Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/f0/68/crt-2013-220.PMC4506098.pdf
"2015;47(3):544-548pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.220    Case Report Open Access Usefulness of Digital Tomosynthesis for the Detection of Airway Obstruction: A Case Report of Bronchial Carcinosarcoma Bronchial carcinosarcoma is a very rare malignant tumor that is composed of carcinomatous and sarcomatous elements.",Non-OADS,/arxiv_data1/oa_pdf/f0/68/crt-2013-220.PMC4506098.pdf
"2015;47(3):399-405 Ȉhttp://www.e-crt.org Ȉ 399 Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.229 Original Article Open Access Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer Purpose The response to haloperidol as a first-line neuroleptic and the pattern of neuroleptic rotation after haloperidol failure have not been well defined in palliative care.",Non-OADS,/arxiv_data1/oa_pdf/98/91/crt-2013-229.PMC4506099.pdf
"Ȉhttp://www.e-crt.org Ȉ 518Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/fa/4e/crt-2013-241.PMC4506100.pdf
"2015;47(3):518-526pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.241 Original Article Open Access Improved Efficacy of a Dendritic Cell-Based Vaccine against  a Murine Model of Colon Cancer: The Helper Protein Effect Purpose Targeted immunotherapy using dendritic cells (DCs) has been employed in numerous  investigations aiming at combating neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/fa/4e/crt-2013-241.PMC4506100.pdf
"6.00 for Windows, GraphPad Software (http://www.graphpad.com; La Jolla, CA), and reported as mean±standard deviation.",OADS,/arxiv_data1/oa_pdf/fa/4e/crt-2013-241.PMC4506100.pdf
"Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.539Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/87/35/crt-2013-245.PMC4506101.pdf
"2015;47(3):539-543pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.245    Case Report Open Access Diffuse Large B-Cell Lymphoma with Involvement of the Breast and Testis in a Male Patient Here we report a case of a 76-year-old man with diffuse large B-cell lymphoma (DLBCL) with simultaneous involvement of the right breast and left testicle.",Non-OADS,/arxiv_data1/oa_pdf/87/35/crt-2013-245.PMC4506101.pdf
"Ȉhttp://www.e-crt.org Ȉ 424Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/cb/d8/crt-2013-266.PMC4506102.pdf
"2015;47(3):424-435pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.266  Open Access Pemetrexed Continuation Maintenance in Patients with  Nonsquamous Non-small Cell Lung Cancer:  Review of Two East Asian Trials in Reference to PARAMOUNT Purpose A recent phase III study (PARAMOUNT) demonstrated that pemetrexed continuation  maintenance therapy is a new treatment paradigm for advanced nonsquamous non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/cb/d8/crt-2013-266.PMC4506102.pdf
Available from: http://www.nccn.org/ professionals/physician_gls/pdf/nscl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/d8/crt-2013-266.PMC4506102.pdf
"2015;47(3):387-398 Ȉhttp://www.e-crt.org Ȉ 387 Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.001  Original Article Open Access Economic Burden of Cancer in Korea during 2000-2010 Purpose This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component.",Non-OADS,/arxiv_data1/oa_pdf/f0/3c/crt-2014-001.PMC4506103.pdf
Avail- able from: http://databank.worldbank.org/data/home.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/crt-2014-001.PMC4506103.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/crt-2014-001.PMC4506103.pdf
Available from: http://ncc.re.kr/english/programs/ intro.jsp and http://ncc.re.kr/english/infor/kccr.jsp.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/crt-2014-001.PMC4506103.pdf
"2015;47(3):465-472 Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.010  Open Access Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple MyelomaOriginal Article Purpose The aim of this study is to determine the diagnostic and prognostic role of baseline spinal magnetic resonance imaging (MRI) in patients with multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/cf/b5/crt-2014-010.PMC4506104.pdf
"Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.509Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/48/b8/crt-2014-012.PMC4506105.pdf
"2015;47(3):509-517pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.012 Original Article Open Access Genetic Variations of Drug Transporters Can Influence on  Drug Response in Patients Treated with Docetaxel Chemotherapy Purpose Dose-limiting toxicities of docetaxel are widely considered to be neutropenia, anemia, skin toxicity, and nausea.",Non-OADS,/arxiv_data1/oa_pdf/48/b8/crt-2014-012.PMC4506105.pdf
All the primers for PCR amplification and DNA sequencing were designed using a Primer3 software (http://Frodo.wi.mit.edu/cgi-bin/ primer3/primer3);the sequences are available upon request.,OADS,/arxiv_data1/oa_pdf/48/b8/crt-2014-012.PMC4506105.pdf
"2015;47(3):489-494 Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.489pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.013 Original Article Open Access Which Patients Should We Follow up beyond 5 Years after Definitive Therapy for Localized Renal Cell Carcinoma?",Non-OADS,/arxiv_data1/oa_pdf/7c/f0/crt-2014-013.PMC4506106.pdf
"2015;47(3):379-386 Ȉhttp://www.e-crt.org Ȉ 379 Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.021 Original Article Open Access A Survey of Stereotactic Body Radiotherapy in Korea Purpose The purpose of this study is to investigate the current status of stereotactic body radiother- apy (SBRT) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/1b/23/crt-2014-021.PMC4506107.pdf
"Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.527Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/eb/be/crt-2014-026.PMC4506108.pdf
"2015;47(3):527-533pISSN 1598-2998, eISSN 2005-9256 doi: http://dx.doi.org/10.4143/crt.2014.026  Original Article Open Access In Vitroand In VivoRadiosensitizing Effect of Valproic Acid on  Fractionated Irradiation Purpose This study was conducted in order to validate the radiosensitization effect of valproic acid, a biologically available histone deacetylase inhibitor, for fractionated radiation.",Non-OADS,/arxiv_data1/oa_pdf/eb/be/crt-2014-026.PMC4506108.pdf
"Currently, 11 studies utilizing VA and RT are listed on the http://www.clinicaltrials.gov site.",Non-OADS,/arxiv_data1/oa_pdf/eb/be/crt-2014-026.PMC4506108.pdf
Available from: http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/eb/be/crt-2014-026.PMC4506108.pdf
"Ȉhttp://www.e-crt.org Ȉ 448Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/a8/1e/crt-2014-034.PMC4506109.pdf
"2015;47(3):448-457pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.034  Open Access Clinical Significance of Non-neutropenic Fever in the Management of  Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor AnalysisOriginal Article Purpose Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard chemotherapy in diffuse large B-cell lymphoma (DLBCL) patients.",Non-OADS,/arxiv_data1/oa_pdf/a8/1e/crt-2014-034.PMC4506109.pdf
"2015;47(3):495-500 Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.495pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.050    Open Access Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History Purpose The purpose of this study was to assess the correlation of previous bladder cancer history with the recurrence and progression of patients with high-risk non–muscle-invasive bladder cancer treated with adjuvant Bacillus Calmette–Guérin (BCG) and to evaluate their natural history.",Non-OADS,/arxiv_data1/oa_pdf/1a/0a/crt-2014-050.PMC4506110.pdf
"Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.501Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/20/8c/crt-2014-054.PMC4506111.pdf
"2015;47(3):501-508pISSN 1598-2998, eISSN 2005-9256 doi: http://dx.doi.org/10.4143/crt.2014.054  Original Article Open Access p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines Purpose p21-activated kinases (PAKs) are involved in cytoskeletal reorganization, gene transcription, cell proliferation and survival, and oncogenic transformation.",Non-OADS,/arxiv_data1/oa_pdf/20/8c/crt-2014-054.PMC4506111.pdf
"Ȉhttp://www.e-crt.org Ȉ 480Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/58/bd/crt-2014-058.PMC4506112.pdf
"2015;47(3):480-488pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.058  Original Article Open Access Prognostic Significance of Retroperitoneal Lymphadenectomy,  Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study Purpose The purpose of this study is to evaluate the prognostic role of preoperative neutrophil  to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) and the need for para-aortic  lymphadectomy in patients with primary fallopian tube carcinoma (PFTC).",Non-OADS,/arxiv_data1/oa_pdf/58/bd/crt-2014-058.PMC4506112.pdf
"Ȉhttp://www.e-crt.org Ȉ 406Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/8d/50/crt-2014-073.PMC4506113.pdf
"2015;47(3):406-415pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.073 Original Article Open Access A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by  Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer Purpose Given the promising activity of capecitabine and vinorelbine in metastatic breast cancer, this randomized phase II trial evaluated the efficacy and safety of this combination as neoad- juvant chemotherapy in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8d/50/crt-2014-073.PMC4506113.pdf
"Ȉhttp://www.e-crt.org Ȉ 416Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/60/82/crt-2014-079.PMC4506114.pdf
"2015;47(3):416-423pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.079 Original Article Open Access Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy Purpose The risk for lymphedema (LE) after neoadjuvant chemotherapy (NCT) in breast cancer  patients has not been fully understood thus far.",Non-OADS,/arxiv_data1/oa_pdf/60/82/crt-2014-079.PMC4506114.pdf
"Ȉhttp://www.e-crt.org Ȉ 370Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/b5/a3/crt-2014-084.PMC4506115.pdf
"2015;47(3):370-378pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.084 Open Access Current Practice and Barriers in Cancer Rehabilitation: Perspectives of Korean PhysiatristsOriginal Article Purpose The purpose of this study was to assess clinical practice and barriers associated with cancer rehabilitation from the perspective of Korean physiatrists.",Non-OADS,/arxiv_data1/oa_pdf/b5/a3/crt-2014-084.PMC4506115.pdf
"Ȉhttp://www.e-crt.org Ȉ 458Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/29/42/crt-2014-091.PMC4506116.pdf
"2015;47(3):458-464pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.091 Original Article Open Access The Clinical Utility of FDG PET-CT in Evaluation of  Bone Marrow Involvement by Lymphoma Purpose Bone marrow biopsy is a standard method for the evaluation of bone marrow infiltration by lymphoma; however, it is an invasive and painful procedure.",Non-OADS,/arxiv_data1/oa_pdf/29/42/crt-2014-091.PMC4506116.pdf
"Ȉhttp://www.e-crt.org Ȉ 362Copyright ⡋2015by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/93/11/crt-2014-110.PMC4506117.pdf
"2015;47(3):362-369pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.110 Original Article Open Access Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea Purpose South Korea has the highest incidence rate of thyroid cancer in the world, and the incidence rate continues to increase.",Non-OADS,/arxiv_data1/oa_pdf/93/11/crt-2014-110.PMC4506117.pdf
Available from: http://globocan.iarc.fr/.,Non-OADS,/arxiv_data1/oa_pdf/93/11/crt-2014-110.PMC4506117.pdf
"2015;47(3):473-479 Ȉhttp://www.e-crt.org Ȉ Copyright ˅2015    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.473pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2014.115 Original Article Open Access Body Mass Index and Doses at Organs at Risk in a Mediterranean  Population Treated with Postoperative Vaginal Cuff Brachytherapy Purpose Association between body mass index (BMI) and doses in organs at risk during postoperative vaginal cuff brachytherapy (VCB) treatment has not been evaluated.",Non-OADS,/arxiv_data1/oa_pdf/db/a3/crt-2014-115.PMC4506118.pdf
Retrieved from: http://www.ich.org/ products/guidelines/safety/article/safety-guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/39/9a/EM-56-520.PMC4506226.pdf
"8In brief, MOST AMD is a single-blind, randomised controlled clinical trial.Clinical assessments were carried out at the Institute ofEye Surgery (http://www.ioes.ie/), Waterford, Ireland.Before study enrolment, an eligibility screening visit wasconducted by an ophthalmologist with a special interestin retinal disease (SB).",Non-OADS,/arxiv_data1/oa_pdf/aa/8f/eye201564a.PMC4506345.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Macular carotenoid supplements in early AMD KO Akuffo et al 912 Eye",Non-OADS,/arxiv_data1/oa_pdf/aa/8f/eye201564a.PMC4506345.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.qThese authors have equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/d3/ec/main.PMC4506365.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d3/ec/main.PMC4506365.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.004J Ginseng Res 39 (2015) 257 e264,OADS,/arxiv_data1/oa_pdf/d3/ec/main.PMC4506365.pdf
Mol Pain 2008;4:29. http://dx.doi.org/10.1186/1744-8069-4-29 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ec/main.PMC4506365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/00/main.PMC4506366.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/c7/00/main.PMC4506366.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.003J Ginseng Res 39 (2015) 250e 256,OADS,/arxiv_data1/oa_pdf/c7/00/main.PMC4506366.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.” Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.005J Ginseng Res 39 (2015) 265e 273,OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
http://dx.doi.org/ 10.1007/978-0-387-77574-6_8 .,Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Nat Protoc 2009;4(9): 1350e62.http://dx.doi.org/10.1038/nprot.2009.120 .,OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Cancer lett 2012;326:123 e7.http://dx.doi.org/10.1016/ j.canlet.2012.05.016 .,OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Br J cancer 2013;109:1 e7.http://dx.doi.org/10.1038/bcj2013.280 .,Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Adv Pharmacol Sci 2014;2014:158936. http://dx.doi.org/10.1155/ 2014/158936 .,Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Chem Rev 2011;111:5944 e72.http://dx.doi.org/10.1021/cr200084z .,Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
http://dx.doi.org/10.1039/C1RA00474C .,Non-OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
Arch Toxicol 2008;82:183 e95.http://dx.doi.org/10.1007/s00204-007-0237-y .,OADS,/arxiv_data1/oa_pdf/b0/53/main.PMC4506367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/cb/main.PMC4506368.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/44/cb/main.PMC4506368.pdf
http://dx.doi.org/10.1016/j.jgr.2014.12.004J Ginseng Res 39 (2015) 230e 237,OADS,/arxiv_data1/oa_pdf/44/cb/main.PMC4506368.pdf
"[cited 2014 Jun 2] Available from:, http://www.cancer.gov/ cancertopics/types/colon-and-rectal .",Non-OADS,/arxiv_data1/oa_pdf/44/cb/main.PMC4506368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC4506369.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC4506369.pdf
http://dx.doi.org/10.1016/j.jgr.2014.11.004J Ginseng Res 39 (2015) 199 e205,Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC4506369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/c0/bf/main.PMC4506370.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.006J Ginseng Res 39 (2015) 274 e278,OADS,/arxiv_data1/oa_pdf/c0/bf/main.PMC4506370.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/04/main.PMC4506371.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/e8/04/main.PMC4506371.pdf
http://dx.doi.org/10.1016/j.jgr.2015.02.001J Ginseng Res 39 (2015) 279 e285,OADS,/arxiv_data1/oa_pdf/e8/04/main.PMC4506371.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/44/main.PMC4506372.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/fe/44/main.PMC4506372.pdf
http://dx.doi.org/10.1016/j.jgr.2014.12.002J Ginseng Res 39 (2015) 213 e220,OADS,/arxiv_data1/oa_pdf/fe/44/main.PMC4506372.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/85/main.PMC4506373.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/ed/85/main.PMC4506373.pdf
http://dx.doi.org/10.1016/j.jgr.2014.12.003J Ginseng Res 39 (2015) 221 e229,OADS,/arxiv_data1/oa_pdf/ed/85/main.PMC4506373.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/07/main.PMC4506374.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/90/07/main.PMC4506374.pdf
http://dx.doi.org/10.1016/j.jgr.2014.12.001J Ginseng Res 39 (2015) 206 e212,OADS,/arxiv_data1/oa_pdf/90/07/main.PMC4506374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.qAuthors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/main.PMC4506375.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/main.PMC4506375.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.002J Ginseng Res 39 (2015) 243 e249,OADS,/arxiv_data1/oa_pdf/e8/64/main.PMC4506375.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/df/84/main.PMC4506376.pdf
http://dx.doi.org/10.1016/j.jgr.2015.01.001J Ginseng Res 39 (2015) 238 e242,OADS,/arxiv_data1/oa_pdf/df/84/main.PMC4506376.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/00/main.PMC4506377.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/68/00/main.PMC4506377.pdf
http://dx.doi.org/10.1016/j.jgr.2014.11.001J Ginseng Res 39 (2015) 189 e198,OADS,/arxiv_data1/oa_pdf/68/00/main.PMC4506377.pdf
generated with speci ﬁc LTs standards and using analysis tools on the Cayman Chemical website ( http://www.caymanchem.com/ app/template/analysis%2CEIA.vm/a/z ).,OADS,/arxiv_data1/oa_pdf/68/00/main.PMC4506377.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-9-3p regulates TAZ in hepatocellular carcinoma 258 www.bjcancer.com | DOI:10.1038/bjc.2015.170,Non-OADS,/arxiv_data1/oa_pdf/43/82/bjc2015170a.PMC4506379.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Identification of the isoform pVHL172 344 www.bjcancer.com | DOI:10.1038/bjc.2015.189,Non-OADS,/arxiv_data1/oa_pdf/13/d5/bjc2015189a.PMC4506380.pdf
Patient management was according to BC Cancer Agency Guidelines (http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines).,Non-OADS,/arxiv_data1/oa_pdf/0a/52/bjc2015190a.PMC4506381.pdf
Society CC Canadian Cancer Statistics (2014) http://www.cancer.ca /~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/52/bjc2015190a.PMC4506381.pdf
"R Foundation for Statistical Computing: Vienna, Austria http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/0a/52/bjc2015190a.PMC4506381.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER 310 www.bjcancer.com | DOI:10.1038/bjc.2015.190,Non-OADS,/arxiv_data1/oa_pdf/0a/52/bjc2015190a.PMC4506381.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CXCL10 signalling drives metastasis development BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.193 335,Non-OADS,/arxiv_data1/oa_pdf/53/85/bjc2015193a.PMC4506383.pdf
The current microarray data were deposited by the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) and were assigned GEO accession number GSE66498.,OADS,/arxiv_data1/oa_pdf/09/03/bjc2015195a.PMC4506384.pdf
Gene expression data were adapted to Kyoto Encyclopaedia of Genes and Genomes pathway categories by the GENECODIS program (http://genecodis.da- cya.ucm.es).,OADS,/arxiv_data1/oa_pdf/09/03/bjc2015195a.PMC4506384.pdf
"We merged these data sets and selected putative miR-144-5p target genes using microRNA.org (August, 2010 release, http://www.microrna.org).",OADS,/arxiv_data1/oa_pdf/09/03/bjc2015195a.PMC4506384.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miR-144-5p regulates CCNE1/2 in bladder cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.195 289,Non-OADS,/arxiv_data1/oa_pdf/09/03/bjc2015195a.PMC4506384.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Sunitinib in gastro-oesophageal cancers BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.197 225,Non-OADS,/arxiv_data1/oa_pdf/c8/69/bjc2015197a.PMC4506385.pdf
Cancer Research UK cancer statistics (2014) http://www.cancerresearchuk.org/ cancer-info/cancerstats/types/uterus/uk-uterine-cancer-statistics.,Non-OADS,/arxiv_data1/oa_pdf/32/21/bjc2015200a.PMC4506386.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/32/21/bjc2015200a.PMC4506386.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER NLR and PLR predict endometrial cancer survival 320 www.bjcancer.com | DOI:10.1038/bjc.2015.200,Non-OADS,/arxiv_data1/oa_pdf/32/21/bjc2015200a.PMC4506386.pdf
A list of miRNAs contained in the array is available from version 14.0 of the Sanger miRNA database (http://microrna.sanger.ac.uk).,OADS,/arxiv_data1/oa_pdf/52/8b/bjc2015201a.PMC4506387.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Serum exosomal microRNA in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.201 281,Non-OADS,/arxiv_data1/oa_pdf/52/8b/bjc2015201a.PMC4506387.pdf
"R Foundation for Statistical Computing: Vienna, Austria, ISBN 2-900051-07-0, URL http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/15/54/bjc2015205a.PMC4506389.pdf
After 12 months the work will become freely available andthe license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Tissue-specific expression of cancer-related genes BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.205 353,Non-OADS,/arxiv_data1/oa_pdf/15/54/bjc2015205a.PMC4506389.pdf
"All statistical analyses were performed using R, version 2.15.2 (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/92/66/bjc2015206a.PMC4506390.pdf
R package version 2.2-7. http://CRAN.R-project.org/package=cmprsk.,Non-OADS,/arxiv_data1/oa_pdf/92/66/bjc2015206a.PMC4506390.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic role of miR-30e* in breast cancer 298 www.bjcancer.com | DOI:10.1038/bjc.2015.206",Non-OADS,/arxiv_data1/oa_pdf/92/66/bjc2015206a.PMC4506390.pdf
Oncol Lett ; http://dx.doi.org/10.3109/ 00016489.2015.1048378.,Non-OADS,/arxiv_data1/oa_pdf/bb/d6/bjc2015207a.PMC4506391.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Selumetinib Study 16 KRAS codon analysis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.215 203",Non-OADS,/arxiv_data1/oa_pdf/1f/99/bjc2015215a.PMC4506393.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Synergistic inhibition of survivin and MAOA in prostate cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.228 251,Non-OADS,/arxiv_data1/oa_pdf/76/fd/bjc2015228a.PMC4506394.pdf
Available from: http://www.cancer.org/cancer/skincancer-basalandsquamouscell/detailedguide/skin-cancer-basal-and-squamous-cell-what-is-basal-and-squamous-cell.,Non-OADS,/arxiv_data1/oa_pdf/e6/2d/bjc2015231a.PMC4506395.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)MC1R and non-melanoma skin cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.231 363,Non-OADS,/arxiv_data1/oa_pdf/e6/2d/bjc2015231a.PMC4506395.pdf
Available at http://www.cancerresearchuk.org/cancer- info/cancerstats/types/prostate/ (accessed on 22 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/88/7b/bjc2015234a.PMC4506396.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Systemic NLR in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.87 211,Non-OADS,/arxiv_data1/oa_pdf/ee/73/bjc201587a.PMC4506398.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/77/ncomms8590.PMC4506498.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, S.-H. et al.",Non-OADS,/arxiv_data1/oa_pdf/76/77/ncomms8590.PMC4506498.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/72/rjv090.PMC4506531.pdf
The airport network wasdownloaded from the Bureau of Transportation Statistics http://transtats.bts.gov/ on 5 November 2011.,Non-OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
"The Nash equilibrium networks of NNGs .The hyperbolic or physical, in the airport and brain cases, coordinates are then supplied to the GNU Linear Programming Kit (GLPK) http://www.gnu.org/software/glpk/ used to ﬁnd asolution to the corresponding minimum set cover problem.",Non-OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
First the cities in Hungary are mapped to their geographic coordinates using the database in http://www.kemitenpet.hu/letoltes/ tables.helyseg_hu.xls.,OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsNATURE COMMUNICATIONS | DOI: 10.1038/ncomms8651 ARTICLE NATURE COMMUNICATIONS | 6:7651 | DOI: 10.1038/ncomms8651 | www.nature.com/naturecommunications 9 &2015 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Gulya ´s, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8651 10 NATURE COMMUNICATIONS | 6:7651 | DOI: 10.1038/ncomms8651 | www.nature.com/naturecommunications &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f2/50/ncomms8651.PMC4506547.pdf
"1316  American Journal of Hypertension  28(11)  November 2015 Original article This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/62/hpv029.PMC4506785.pdf
Available from: http://www.tobaccoinaustralia.org.au/chapter-10-tobacco- industry/10-4-the-tobacco-companies-operating-in-australia 2.,Non-OADS,/arxiv_data1/oa_pdf/31/8a/nihms679940.PMC4506928.pdf
Available from: http://www.tobaccoinaustralia.org.au/chapter-13-taxation/ 13-3-the-price-of-tobacco-products-in-australia 3.,Non-OADS,/arxiv_data1/oa_pdf/31/8a/nihms679940.PMC4506928.pdf
Available from: http://www.tobaccoinaustralia.org.au/chapter-11- advertising 5.,Non-OADS,/arxiv_data1/oa_pdf/31/8a/nihms679940.PMC4506928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/46/main.PMC4506931.pdf
"H3T58p has not been http://dx.doi.org/10.1016/j.fob.2015.06.009 2211-5463/Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Ab, amyloid- b; APP, amyloid precursor protein; MRM, multiple reaction monitoring; PTM, post-translational modiﬁcation; S57, serine-57; T58, threonine-58 ⇑Corresponding author at: Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850, USA.",Non-OADS,/arxiv_data1/oa_pdf/19/46/main.PMC4506931.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.06.009 .",OADS,/arxiv_data1/oa_pdf/19/46/main.PMC4506931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/f1/main.PMC4506956.pdf
Animals Heterozygous Cbs+//C0mice in a C57BL/6J background (B6.129P2- Cbstm1Unc/J) were obtained from the Jackson Laboratory http://dx.doi.org/10.1016/j.fob.2015.06.008 2211-5463/ /C2112015 The Authors.,OADS,/arxiv_data1/oa_pdf/01/f1/main.PMC4506956.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AFP, a-fetoprotein; CBS, cystathionine b-synthase; CTH, cystathionine c-lyase; DTT, dithiothreitol; HCC, hepatocellular carcinoma; IEF, isoelectric focusing; IPG, immobilized pH gradient; MALDI-TOF/MS, matrix-assistedlaser desorption/ionization-time of ﬂight/mass spectrometry; NAFLD, non-alcoholicfatty liver disease; PAGE, polyacrylamide gel electrophoresis; qPCR, quantitativepolymerase chain reaction; 2D DIGE, two-dimensional difference gel electrophoresis ⇑Corresponding author at: Department of Biochemistry, Keio University Graduate School of Pharmaceutical Sciences, Shibakoen 1-5-30, Minato-ku, Tokyo105-8512, Japan.",Non-OADS,/arxiv_data1/oa_pdf/01/f1/main.PMC4506956.pdf
"Protein database search Proteins were identiﬁed by matching the peptide mass ﬁnger- print with the Swiss-Prot protein database using the MASCOT Search engine (Matrix Science, http://www.matrixscience.com ).",OADS,/arxiv_data1/oa_pdf/01/f1/main.PMC4506956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/0d/main.PMC4506957.pdf
http://dx.doi.org/10.1016/j.fob.2015.06.007 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/0d/main.PMC4506957.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: YAP, yes-associated protein; TAZ, transcriptional coactivator with PDZ-binding motif; TEAD, TEA domain family member; GPCR, G-protein coupled receptor; FDA, food and drug administration; NF2, neuroﬁbromin 2; HMG-CoA,hydroxymethylglutaryl-coenzyme A; CTGF, connective tissue growth factor ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/90/0d/main.PMC4506957.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.06.007 .",OADS,/arxiv_data1/oa_pdf/90/0d/main.PMC4506957.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.009 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1007/s00415-007-0599- 317940723 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1016/S1474- 4422(06)70349-016426992 .,OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
"Annual Review of Statistics and its Application 1, 61– 85.http://dx.doi.org/10.1146/an nurev-statistics-022513-11561125309940 .",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1212/01.WNL.0000036271.49066.0612427893 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1016/j.autrev.2006.02.,OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1002/jmri.,OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1001/archneur.1989.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1212/ WNL.33.11.14446685237 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1038/gene.,OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1177/105122840528286416385023 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
"Brain 121 (1), 3–24.http://dx.doi.org/10.1093/brain/121.1.39549485 .",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
"N e u r o l .5 8( 6 ) ,8 4 0 –846.http://dx.doi.org/10.1002/ana.2070316283615 .",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1038/ni0901-76211526378 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1191/1352458504ms1061oa15327037 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/ 10.1002/jmri.1005311836778 .,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
"13 (4), 490 –501.http://dx.doi.org/10.1177/135245850607044617463072 .610 A.  S. Chua et al.",OADS,/arxiv_data1/oa_pdf/b6/3f/main.PMC4506959.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.005,OADS,/arxiv_data1/oa_pdf/7c/57/main.PMC4506961.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.008,OADS,/arxiv_data1/oa_pdf/32/60/main.PMC4506962.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.003,OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
<http://ar.wikipedia.org/wiki/%D9%85%D8%AD%D8%A7 %D9%81%D8%B8%D8%A7%D8%AA_%D9%85%D8% B5%D8%B1 > [updated 29.11.11; cited 26.11.11].,Non-OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
< http://www.unhabitat.org/downloads/docs/032- Waste%20Management%20System%20in%20Alexandria% 20(Egypt).doc >; 2006 [updated 12.01.13; cited 10.01.13].,Non-OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
< http://www-wds.worldbank.org/ external/default/WDSContentServer/WDSP/IB/2006/02/21/ 000011823_20060221153642/Rendered/INDEX/ E12870v10EIA0A1aft0Revised020010005.txt >; 2005 [updated 20.10.12; cited 11.10.12].,Non-OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
< http://cdm.unfccc.int/ﬁlestorage/Y/ X/S/YXSB0UQTOE2G714ALZ3WP6FHNKMR5V/Monitoring%20Report.pdf?t=WUp8bHdodTM0fDBwuXQy2ZSnx1TTc8o0Y-ln >; 2011.,Non-OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
< http://www.env.gov.bc.ca/wsd/ plan_protect_sustain/groundwater/library/ground_fact_sheets/pdfs/fe_mg(020715)_ﬁn2.pdf >; 2007.,Non-OADS,/arxiv_data1/oa_pdf/d2/93/main.PMC4506963.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 549–554 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2013.11.002 2090-1232 ª2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/95/b0/main.PMC4506964.pdf
country proﬁles: Israel http://www.nti.org/country-proﬁles/israel/biological.,Non-OADS,/arxiv_data1/oa_pdf/95/b0/main.PMC4506964.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.002,OADS,/arxiv_data1/oa_pdf/e9/9c/main.PMC4506965.pdf
< http://geotech.civen.okstate.edu/ ejge/ppr9803/index.html >.,OADS,/arxiv_data1/oa_pdf/e9/9c/main.PMC4506965.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 539–547 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2013.07.007 2090-1232 ª2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/cd/83/main.PMC4506966.pdf
"Introduction Water crisis and risk of infectious diseases in the developing world On July 28, 2010, the General Assembly of the United Nations voted to recognize access to clean water and sanitation as a human right (URL: http://www.un.org/News/Press/docs/ 2010/ga10967.doc.htm ), a long-awaited decision that had been advocated and endorsed by the scientiﬁc community [1].",Non-OADS,/arxiv_data1/oa_pdf/cd/83/main.PMC4506966.pdf
"Cartograms or map projections were downloaded from http://www.worldmapper.org (ªCopyright SASI Group, University of Shefﬁeld; and Mark Newman, University of Michigan).Water as a source of H. pylori infection 541",Non-OADS,/arxiv_data1/oa_pdf/cd/83/main.PMC4506966.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.009,OADS,/arxiv_data1/oa_pdf/04/c2/main.PMC4506967.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.009,OADS,/arxiv_data1/oa_pdf/05/63/main.PMC4506968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/ab/main.PMC4506969.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.05.004 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/ab/main.PMC4506969.pdf
http://dx.doi.org/10.1016/j.bmc.2014.12.066 .,OADS,/arxiv_data1/oa_pdf/c3/ab/main.PMC4506969.pdf
http://dx.doi.org/10.1007/s40265-015-0388-8 .,Non-OADS,/arxiv_data1/oa_pdf/c3/ab/main.PMC4506969.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.001,OADS,/arxiv_data1/oa_pdf/4c/0e/main.PMC4506971.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.010,OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC4506972.pdf
Phys Scr 2013;88(3):035701.http://dx.doi.org/10.1088/0031-8949/88/03/035701 .,OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC4506972.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.004,OADS,/arxiv_data1/oa_pdf/98/2b/main.PMC4506973.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.007,OADS,/arxiv_data1/oa_pdf/c6/5e/main.PMC4506974.pdf
There was noContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.06.005 2211-7539/ &2015 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/main.PMC4506975.pdf
The latterContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.06.004 2211-7539/ &2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/4c/e6/main.PMC4506976.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/1c/main.PMC4506977.pdf
"All patients were treated with antipla-telet agents (ie, aspirin), statins (ie, atorvastatin or rosuvastatin),angiotensin converting enzyme inhibitors (ie, perindopril orContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2015.06.001 0011-393X/ &2015.",Non-OADS,/arxiv_data1/oa_pdf/58/1c/main.PMC4506977.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/1c/main.PMC4506977.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.004,Non-OADS,/arxiv_data1/oa_pdf/03/a3/main.PMC4506978.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,5 0–51 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/03/a3/main.PMC4506978.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.001,Non-OADS,/arxiv_data1/oa_pdf/b0/91/main.PMC4506979.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,4 8–49 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/b0/91/main.PMC4506979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"These include damage to sulfur-containing, aromatic,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.06.005 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AP, alkaline phosphatase; BAL, bronchoalveolar; BCIP, 5-bromo-4- chloro-3-indolyl phosphate; BHT, butylated hydroxytoluene; DMSO, dimethylsulfoxide; DNP, 2,4-dinitrophenyl; DNPH, 2,4-dinitrophenylhydrazine; DTT, di-thiothreitol; EDTA, ethylenediaminetetraacetic acid; ELISA, enzyme-linked im-munosorbent assay; HCl, hydrochloric acid; HPLC, high performance liquid chro-matography; HRP, horseradish peroxidase; Hsf1, heat shock factor 1; IgG, im- munoglobulin G; KLH, keyhole limpet hemocyanin; n.a., not available; NBT, nitro blue tetrazolium; PVDF, polyvinylidene di ﬂuoride; RT, room temperature; SDS, sodium dodecyl sulfate; TCA, trichloroacetic acid; TFA, tri ﬂuoracetic acid nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"35 (2000) 161 –253, http://dx.doi.org/10.1016/S0065-2423(01) 35017-5 11040960 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Stadtman, Protein oxidation and aging, Respirology 40 (12) (2006) 1250 –1258, http://dx.doi.org/10.1080/10715760600918142 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Acta 1703 (2) (2005) 93 –109, http://dx.doi.org/10.1016/j.bbapap.2004.08.007 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Acta 1504 (2 –3) (2001) 196 –219, http://dx.doi.org/ 10.1016/S0005-2728(00)00252-8 11245785 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"11 (11) (1998) 1265 –1273, http://dx.doi.org/10.1021/tx980118h 9815186 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"19 (3) (1995) 281 –292, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"270 (3) (2000) 852 –857, http://dx.doi.org/10.1006/bbrc.2000.2533 10772915 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"271 (26) (1996) 15504 –15509, http://dx.doi.org/10.1074/jbc.271.26.15504 8663134 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"270 (5) (1995) 2344 –2351, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"27(11–12) (1999) 1151 –1163, http://dx.doi.org/10.1016/S0891-5849(99)00206-3 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Acta 1840 (2) (2014) 901 –905, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"19 (13) (2013) 1539 –1605, http://dx.doi.org/10.1089/ ars.2012.4599 23397885 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"36 (9) (2004) 1175 –1184, http://dx.doi.org/10.1016/j.free- radbiomed.2004.02.017 15082071 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"17 (5) (1994) 429 –437, http://dx.doi.org/ 10.1016/0891-5849(94)90169-4 7835749 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"23 (3) (1997) 361 –366, http://dx.doi.org/10.1016/S0891-5849(97)00104-4 9214571 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"[21] H. Tammen, I. Schulte, R. Hess, C. Menzel, M. Kellmann, T. Mohring, P. Schulz- Knappe, Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display, Proteomics 5 (13) (2005) 3414 –3422, http://dx.doi.org/10.1002/pmic.200401219 16038021 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"6 (4) (1993) 430 –433, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Grif ﬁths, Analysis of protein carbonylation –pitfalls and promise in commonly used methods, Respirology 48 (10) (2014) 1145 –1162, http://dx.doi.org/10.3109/ 10715762.2014.944868 25072785 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"266 (1) (1999) 48 –57,http://dx.doi.org/10.1006/ abio.1998.2932 9887212 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"119 (4) (1996) 768 –774, http://dx.doi.org/10.1093/ox- fordjournals.jbchem.a021306 8743580 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"2012 (2012) 435214, http://dx.doi.org/ 10.5402/2012/435214 22530141 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"11 (1959) 475 –476, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Acta 329 (1 –2) (2003) 23–38,http://dx.doi.org/10.1016/S0009-8981(03)00003-2 12589963 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"4 (2015) 149 –157, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"7 (4) (2012) 226 –232, http://dx.doi.org/10.4103/1817-1737.102182 23189100 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"4 (2011) 11 –19,http://dx.doi.org/10.4137/ CMAMD.S6793 21487454 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"29 (2) (2000) 101 –104, http://dx.doi.org/10.1016/S0891-5849(00)00288-4 10980398 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Cell Death 4 (2013) e691, http://dx.doi.org/10.1038/ cddis.2013.211 23807220 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Cell Death 19 (5) (2012)743 –755, http://dx.doi.org/10.1038/cdd.2011.172 22139129 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Di, F. Amicarelli, Long term running biphasically improves methylglyoxal-related metabolism, redox homeostasis and neurotrophic support within adult mousebrain cortex, PLOS One 7 (2) (2012) e31401, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"28 (2) (2007) 206 –215, http://dx.doi.org/10.1016/j.nbd.2007.07.013 17719231 .",OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"237 (2) (2009) 188 –195, http://dx.doi.org/10.1016/j.taap.2009.03.010 19332086 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"B 13 (3) (2012) 176 –185, http://dx.doi.org/10.1631/jzus.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"2012 (2012) 428538, http://dx.doi.org/10.1155/2012/428538 22792413 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"22 (6) (2009) 1034 –1049, http://dx.doi.org/10.1021/tx9000094 19449826 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"49 (2) (2011) 102 –108, http://dx.doi.org/10.3164/jcbn.10-135 21980225 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"90 (1) (2012) 229 –242, http://dx.doi.org/10.1002/jnr.22748 21932365 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Kuhn, Proin ﬂammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase, Neuroscientist 41 (2) (2009) 274 –285, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"101 (36) (2004) 13227 –13232, http://dx.doi.org/10.1073/ pnas.0401896101 15328416 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"12 (3) (2010) 327 –336, http://dx.doi.org/10.1089/ars.2009.2810 19686046 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"[52] K. Nagai, T. Betsuyaku, T. Kondo, Y. Nasuhara, M. Nishimura, Long term smoking with age builds up excessive oxidative stress in bronchoalveolar la- vage ﬂ uid, Thorax 61 (6) (2006) 496 –502, http://dx.doi.org/10.1136/ thx.2005.049148 16537669 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"263 (1) (1998) 31 –38, http://dx.doi.org/10.1006/abio.1998.2752 9750139 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"44 (4) (2000) 867 –872, http://dx.doi.org/10.1128/AAC.44.4.867- 872.2000 10722483 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"21 (19) (2002) 5164 –5172, http://dx.doi.org/10.1093/emboj/cdf528 12356732 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Rao, Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through speci ﬁc protein oxidation and autophagy in a syngeneic breast tumor pre- clinical model, PLOS One 8 (8) (2013) e70575, http://dx.doi.org/10.1371/jour- nal.pone.0070575 23940596 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"26 (1 – 2) (2003) 19 –28,http://dx.doi.org/10.1007/s11357-003-0003-x 23604915 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"170 (1) (2007) 20 –30,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"423 (2) (2012) 241 –245, http://dx.doi.org/10.1016/j.ab.2012.01.031 22326366 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"2008 (2008) 168652, http://dx.doi.org/10.1155/2008/168652 18566692 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"37 (5) (2012) 1057 –1062, http://dx.doi.org/10.1007/s11064-012-0707-3 22270909 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"110 (1) (2010) 1 –11,http://dx.doi.org/10.1016/j.envres.2009.10.006 19926083 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"263 (2) (2008) 212 –222, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Barr, Plasma carbonyls do not correlate with lung function or computed tomography measures of lungdensity in older smokers, Biomarkers 13 (4) (2008) 422 –434, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"106 (2) (2008) 219 –225, http://dx.doi.org/ 10.1016/j.envres.2007.09.008 17996865 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"69 (7) (2009) 2966 –2972, http://dx.doi.org/10.1158/0008-5472.CAN-08- 3418 19339271 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"[70] M. Venojärvi, S. Aunola, R. Puhke, J. Marniemi, H. Hämäläinen, J.P. Halonen, J. Lindström, M. Rastas, K. Hällsten, P. Nuutila, O. Hänninen, M. Atalay, Exercise training with dietary counselling increases mitochondrial chaperone expres- sion in middle-aged subjects with impaired glucose tolerance, Disorders 8 (2008) 3, http://dx.doi.org/10.1186/1472-6823-8-3 18371210 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"17 (2) (2006)96–102, http://dx.doi.org/10.1016/j.jnutbio.2005.05.010 16111878 .",OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"48 (2) (2010) 284 –291, http://dx.doi.org/10.1016/j.freeradbiomed.2009.10.052 19879940 .",OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"11 (5) (2007) 1138 –1148, http://dx.doi.org/10.1111/j.1582-4934.2007.00097.x 17979889 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"51 (7) (2011) 1355 –1364, http://dx.doi.org/10.1016/j.freeradbiomed.2011.06.015 21767633 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"4 (2) (2007) 195 –202, http://dx.doi.org/10.1093/ecam/nel080 17549236 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"15 (1) (2012) 71 –81,http://dx.doi.org/10.1089/ rej.2011.1245 22236145 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"9 (2011) 10, http://dx.doi.org/10.1186/1479-5876-9-10 21244679 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Lora, S. Torres-Schumann, M. Vogel, M. Allhorn, C. González, M.J. Bastiani, E. Rassart, D. Sanchez, Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress, Aging Cell 7 (4) (2008) 506 –515, http://dx.doi.org/10.1111/j.1474- 9726.2008.00395.x 18419796 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"Enot, V. Fellman, Metabolite pro ﬁles reveal energy failure and impaired beta-oxi- dation in liver of mice with complex III de ﬁciency due to a BCS1L mutation, PLOS One 7 (7) (2012) e41156, http://dx.doi.org/10.1371/journal.pone.0041156 22829922 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"11 (4) (2009) 715 –724, http://dx.doi.org/10.1089/ARS.2008.2171 18823256 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"400 (3) (2006) 511 –520, http://dx.doi.org/10.1042/BJ20060463 16939415 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"9 (2009) 6, http://dx.doi.org/10.1186/1472-6793-9-6 19374741 .",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
"[87] P. Voss, L. Horakova, M. Jakstadt, D. Kiekebusch, T. Grune, Ferritin oxidation and proteasomal degradation: protection by antioxidants, Respirology 40 (7) (2006) 673 –683, http://dx.doi.org/10.1080/10715760500419357 16983994 .D.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/main.PMC4506980.pdf
New Microbe and New Infect 2015; 7:41–47 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.05.008,Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"There were a total of 279 nt and 93 aa positions in the ﬁnal data set.42 New Microbes and New Infections , Volume 7 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"HEV in Italian wild boar 43 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"CA, Canada; CN, China; DE, Germany; EG, Egypt; ES, Spain; FR, France; GB, United Kingdom; HEV, hepatitis E virus; HU,human; IN, India; IT, Italy; JP, Japan; KG, Kyrgyzstan; MA, Morocco; MX, Mexico; NL, Netherlands; ORF, open reading frame; SW, swine; TD, Chad; TW, Taiwan; WB, wild boar.44 New Microbes and New Infections , Volume 7 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"HEV in Italian wild boar 45 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"Int J Infect Dis 2013;17:228 –33.46 New Microbes and New Infections , Volume 7 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
"HEV in Italian wild boar 47 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,7,4 1 –47 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/64/ef/main.PMC4506981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/c6/main.PMC4506982.pdf
Hyperglycemia in diabetes mellitus causes glycation of membrane enzymes along with oxidative stress leading to decrease in activity of Na þ/Kþ-ATPase and other changes in erythrocyte membranes [1].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.06.011 2213-2317/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/c6/main.PMC4506982.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ATPase, adenosinetriphosphatase; BSA, bovine serum albumin; EDTA, ethylenediaminetetraacetic acid; EGTA, ethylene glycol tetraacetic acid; FITC,ﬂuorescein isothiocyanate; GLUT1, glucose transporter 1; GR, glutathione re- ductase; GSH, reduced glutathione; GSSG, oxidized glutathione; GST, glutathione S- transferase; Hb, hemoglobin; HMF, 5-(hydroxymethyl)-2-furaldehyde; PBS, phos- phate-buffered saline; PMCA, plasma membrane Ca 2þ-ATPase; PS, phosphati- dylserine; RBCs, red blood cells; RQB, redox quenching buffer; TCA, trichloroaceticacid nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/f0/c6/main.PMC4506982.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/13/main.PMC4506983.pdf
http://dx.doi.org/10.1016/j.nicl.2015.03.0232213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/13/main.PMC4506983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/13/main.PMC4506983.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
A complete listing ofADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_ to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.nicl.2015.05.0062213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"For up-to-date information, see http://www.adni- info.org.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
Detailed inclusion criteria for LMCI can be found at the ADNI web site (http://adni.loni.usc.edu/methods/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
More detailed information on the different imaging protocols employed across ADNI sites and standardized image pre-processing steps for MRI and PET acquisitions can be found on the ADNI web site ((http://adni.loni.usc.edu/methods/ )).,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Imaging data processing Imaging data were processed by using statistical parametric mapping (SPM8, Wellcome Trust Center for Neuroimaging) and the VBM8-toolbox (http://dbm.neuro.uni-jena.de/vbm/ ) implemented in Matlab R2013b (MathWorks, Natick, MA).584 S.J.",OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Therefore, the reference template in this study was derived by DARTEL —aligning 50 healthy elderly subjects and 50 subjects with very mild, mild and moderate AD retrieved from an open access MRI da-tabase ( http://www.oasis-brains.org ), and thus re ﬂects unbiased aging/ AD-speci ﬁc structural characteristics.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Models to predict time to conversion To check for multicollinearity, we determined the variance in ﬂation factor (VIF) (Belsley, 1991) for each dependent variable on the set of the remaining dependent variables using the Matlab function colldiag.m, available at ( http://www.subcortex.net/research/code/collinearity- diagnostics-matlab-code ).",OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
Penalized regression models were calculated using the package glmnet (available at http://cran.r-project.org/web/packages/glmnet/ index.html ) in R version 3.1.0 (The R Foundation for Statistical Comput- ing).,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
Private sector contribu- tions are facilitated by the Foundation for the National Institutes of Health ( http://www.fnih.org ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1002/sim.47800807022672226 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1001/archneur.58.3.48011255453 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"http://dx.doi.org/10.1159/ 00008855816192725 .Booth, G.D., Niccolucci, M.J., Schuster, E.G., 1994.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1007/BF003088091759558 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1111/ene.1239824612390 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"JAMA 305 (3), 275– 283. http://dx.doi.org/10.1001/jama.2010.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.nbd.2014.05.00124825318 .,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Ecography 36 (1), 27 –46.http://dx.doi.org/10.1111/j.1600-0587.2012.07348.x .",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Psychiatry 19 (11), 951– 960. http://dx.doi.org/10.1097/JGP.0b013e3182107c6921422909 .",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.3233/JAD- 14105325201779 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2010.10.,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.2307/1937887 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/0022-3956(75)90026-61202204 .,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Aging 34 (4), 1210– 1220. http://dx.doi.org/10.1016/j.ne urobiolaging.2012.10.01823158764 .",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1002/hbm.1012312874777 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1371/journal.pone.006687723799136 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Technometrics 12 (1), 55 –67.http://dx.doi.org/10.1080/00401706.1970.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1148/ radiol.1211043322517954 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1214/13-AOS1175 .592 S.J.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1038/jcbfm.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
"Neu- rology 73 (10), 754 –760.http://dx.doi.org/10.1212/WNL.0b013e3181b2356419587325 .",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.mcna.2012.12.,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1007/s00259-011-1745-921336694 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1111/j.1467-9868.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/ j.neurobiolaging.2013.06.01823954175 .,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1002/ana.2159819475670 .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1016/j.nicl.2013.,OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1111/j.1467-9868.2005.00503.x .,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
http://dx.doi.org/10.1214/08-AOS62520445770 .593 S.J.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/main.PMC4506984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/d9/main.PMC4506985.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.04.003 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/d9/main.PMC4506985.pdf
malayi putative AChRs subunit genes retrieved from the NCBI website ( http://www.ncbi.nlm.nih.gov/ ) either by accession number (XM_00xxxxxxx) or Pub_Locus (Bm1_xxxxx).,Non-OADS,/arxiv_data1/oa_pdf/e6/d9/main.PMC4506985.pdf
"Primers for in situ listed in Table 1 were designed using PrimerQuest software ( http://idtdna.com/primerquest/home ), and these primers were produced by Integrated DNA Technology Inc. (Coralville, IA USA).",OADS,/arxiv_data1/oa_pdf/e6/d9/main.PMC4506985.pdf
BMC Genomics 13. http://dx.doi.org/10.1186/1471- 2164-13-184 .,OADS,/arxiv_data1/oa_pdf/e6/d9/main.PMC4506985.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.0082213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1016/ S1053-8119(03)00435-X14568475 .,OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1017/S003329171300051223507264 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0924-07.,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1093/cercor/bht02323395849 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1038/npp.2014.21125168685 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1002/hbm.2133321769991 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"Psychiatry 3, 30. http://dx.doi.org/10.3389/fpsyt.2012.0003022529822 .",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1073/ pnas.111310310922160708 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1016/j.neuron.2007.06.02617640522 .,OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"4 (1), 17 –18.http://dx.doi.org/10.1038/8285411135640 .",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1177/ 000486741245046922696548 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1111/j.1460-9568.2007.05430.x17439499 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
1 –4.http://dx.doi.org/10.1371/ journal.pone.0016569 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"J. Psychiatry 168(1), 55 –64.http://dx.doi.org/10.1176/appi.ajp.2010.1001005621123315 .",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1007/ s00221000043210985677 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"40 (2), 95 –101.http://dx.doi.org/10.1002/ eat.2034317080448 .",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"38 (1), 1 –6.http://dx.doi.org/10.1002/eat.2014415971233 .617 K. Dunlop et al.",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1038/npp.2013.22224150516 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1016/j.jad.2008.10.00619027962 .,OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1176/ajp.152.7.10737793446 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"7 (1), 61 –67.http://dx.doi.org/10.1016/ S1385-299X(00)00063-5 .",OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"http://dx.doi.org/ 10.1192/bjp.bp.111.09333622130749.Titova, O.E., Hjorth, O.C., Schiöth, H.B., Brooks, S.J., 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"Psychiatry 13, 110. http://dx.doi.org/10.1186/1471-244X-13- 11023570420 .",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1002/erv.116322052722 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
http://dx.doi.org/10.1002/eat.2069919434606 .,Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
"77 (1), 57 –60.http://dx.doi.org/ 10.1159/00011006118087209 .618 K. Dunlop et al.",Non-OADS,/arxiv_data1/oa_pdf/98/d4/main.PMC4506986.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Indeed, patients treated with the combination of 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU) and aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.06.006 2213-2317/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: DEXA, dexamethasone; GCs, glucocorticoids; IR, Irradiation; DDR, DNA Damage response; NHEJ, non-homologous end-joining pathway; DSBs, doublestrand breaks; GR, glucocorticoid receptor; MR, mineralocorticoid receptor.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.06.,OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"287 (35) (2012) 29825 –29836, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"22 (2) (2012) 127 –137, http://dx.doi.org/10.1007/s12640-012-9308-9 22237944 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"3 (8) (2004) 715 –718, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Rutz, Effects of corticosteroid use on treatment of solid tumours, Lancet 360 (9349) (2002) 1969 –1970, http://dx.doi.org/10.1016/S0140-6736(02) 11922-2 12493280 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Acta 1793 (5) (2009) 764 –771, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"112 (6) (2006) 651 –664, http://dx.doi.org/10.1007/s00401-006-0100-x 16855833 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Cancer 3 (1) (2004) 36,http://dx.doi.org/10.1186/1476-4598-3-36 15588281 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"30 (3) (1974) 217 –221, http://dx.doi.org/10.1001/ archneur.1974.00490330025004 4812957 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"25 (2) (1999) 104 –112, http://dx.doi.org/ 10.1046/j.1365-2990.1999.00166.x 10215998 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Goldberg, The effect of dexamethasone on brain edema in patients with metastatic brain tumors, Neurology 23 (2)(1973) 121 –129, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Russell, A. Goel, Dexamethasone-induced oxidative stress enhances myeloma cell radio- sensitization while sparing normal bone marrow hematopoiesis, Neoplasia 12 (12) (2010) 980 –992, http://dx.doi.org/10.1593/neo.101146 21170263 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Onkol.174 (2) (1998) 71 –74,http://dx.doi.org/10.1007/BF03038478 9487368 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"175 (8) (1999) 392 –396, http://dx.doi.org/10.1007/ s000660050027 10481771 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"207 (2014) 26 –31,http://dx.doi.org/ 10.1016/j.cbi.2013.11.004 24239970 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"16 (6) (2004) 593 –600, http://dx.doi.org/10.1097/01.",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"122 (1) (1990) 86 –94,http://dx.doi.org/10.2307/3577587 2320728 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Tracey, Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of in ﬂammation, Nature 421 (6921) (2003) 384 –388, http://dx.doi.org/10.1038/nature01339 12508119 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"19 (11) (2013) 1135 –1148, http://dx.doi.org/10.1089/ars.2012.4671 23311871 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"16 (1) (2008) 71 –75,http://dx.doi.org/10.1097/PAI.0- b013e31803156d5 18091316 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"40 (6) (2012) 1963 –1969, http://dx.doi.org/10.3892/ijo.2012.1409 22447336 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
"Psychiatry 83 (7) (2012) 753 –760, http://dx.doi.org/10.1136/jnnp-2011-300709 22396442 .",Non-OADS,/arxiv_data1/oa_pdf/79/01/main.PMC4506989.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2015.06.010 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"Independent component analysis The pre-processed image volumes from 72 datasets (18 datasets each for children with RD and TRs, both before and after training) were submitted to subject-wise group ICA implemented in the Group ICA of fMRI Toolbox (GIFT; http://mialab.mrn.org/software/gift/index.",OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1080/1380339070156281818569253 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1038/226177a05437004 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"Neuropsychologia 15 (1), 69 –80.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1080/0022132000959671810971914 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1080/ 0022132010959748411678364 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/S0093- 934X(03)00071-312744959 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"4, 1486. http://dx.doi.org/10.1038/ncomms248823403586 .",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/S0028- 3932(02)00046-512208010.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/hbm.104811559959 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/hbm.2058118438867 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"26 (1), 63 –80.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1037/ a002737522352396 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1093/brain/ awf09411960895.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1073/ pnas.060141710316945915 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"70 (2), 75 –96.http://dx.doi.org/10.1006/jecp.1998.24519729450 .",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/S0140-6736(04)16106-015121410 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.tics.2008.01.00118262825 .628 T. Horowitz-Kraus et al.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/hbm.2117021162045 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/S0010-9452(08)70840-210728901 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/ 0013-4694(91)90062-91712280 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1111/j.1469-7610.2010.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3069-13.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/S1364- 6613(00)01801-511728910 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.bandl.2011.12.00522230039 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"6 (1), 37 –48.http://dx.doi.org/10.1076/0929- 7049(200003)6:1;1-B;FT03710980667 .",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1177/002221941245308422907884 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.clinph.2008.06.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1177/088307381246091723112239 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"1544, 1 –14.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/ brb3.28125365797 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"8, 447. http://dx.doi.org/10.3389/fnhum.2014.0044724999322 .",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1111/j.1467- 7687.2009.00938.x20977558 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1093/cercor/bht31324275830 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.yebeh.2010.12.02921273134 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.yebeh.2010.11.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1371/ journal.pone.005545423408984 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.visres.2008.01.02518331749 .,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1212/WNL.0b013e3182a9f3ca24089388 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1177/073194871350726324914248 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"6 (3), 207– 213. http://dx.doi.org/10.1002/1098-2779(2000)6:3 b207::AID-MRDD8 N3.",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1001/ archneur.1997.005501700420139152113 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/ 10.1002/jmri.2000914994306 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.07.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1017/ S095457940800063118838044 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/dys.18611305228 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/dys.28415573964 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"14 (2), 57 –63.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1093/cercor/bhr10021690259 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.1002/hbm.2207722711620 .,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"8, 88. http://dx.doi.org/10.3389/fnhum.2014.0008824688462 .",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"10 (10), 16. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/59/main.PMC4506990.pdf
"The MyD88-independent Toll/IL-1 re- ceptor (TIR) domain-containing adaptor (TRIF)-dependent pathwayContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.06.008 2213-2317/ &2015 Published by Elsevier B.V.Abbreviations: AhR, aryl hydrocarbon receptor; ARNT, aryl hydrocarbon receptor nuclear translocator; Cyp1A1, cytochrome P450, family 1, subfamily A, polypeptide1; HE, hydroethidine; HIF-1 α, hypoxia inducible factor-1 α; iNOS, inducible nitric oxide synthase; IL-6, interleukin-6; Inf- β, interferon- β; IRF3, interferon regulatory factor 3; ISRE, interferon-sensitive response element; MyD88, myeloid differ-entiation factor-88; Nox, NADPH oxidase; PMA, phorbol myristate acetate; ROS,reactive oxygen species; SOD, superoxide dismutase; TEMPOL, 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TLR4, toll-like receptor-4; TNF α, tumor necrosis factor- α nCorrespondence to: Division of Digestive Diseases, University of Cincinnati, 231 Albert B. Sabin Way, MSB 7262B, Cincinnati, OH, 45267-0595 USA.Fax:þ1 513 558 1744.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"13 (2) (2001) 85 –94,http://dx.doi.org/10.1016/S0898-6568(00) 00149-2 11257452 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"16 (1) (2004) 11 –16,http://dx.doi.org/10.1016/j.smim.2003.10.007 14751758 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"91 (3) (2001) 179 –213, http://dx.doi.org/10.1016/S0163-7258(01)00155-3 11744067 .Fig.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"173 (1) (2001) 113 –118, http://dx.doi.org/10.1046/ j.1365-201X.2001.00891.x 11678733 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Zucker, Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats, Hepatology 40 (2) (2004) 424 –433, http://dx.doi.org/10.1002/hep.20334 15368447 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"19 (13)(2005) 1890 –1892, http://dx.doi.org/10.1096/fj.04-2368fje 16129699 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"73 (5) (2005) 2940 –2950, http://dx.doi.org/10.1128/IAI.73.5.2940-2950.2005 15845500 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"86 (1) (2006) 9 –22,http://dx.doi.org/10.1038/labinvest.3700366 16357866 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"16 (1) (2004) 3–9,http://dx.doi.org/10.1016/j.smim.2003.10.003 14751757 .",OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Ignarro, Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide, Diabetes 53 (7) (2004)1841 –1850, http://dx.doi.org/10.2337/diabetes.53.7.1841 15220209 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"130 (4) (2000) 932 –936, http://dx.doi.org/ 10.1038/sj.bjp.0703401 10864902 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"287 (3) (2004) G620 –G626, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"402 (2) (2002) 218 –226, http://dx.doi.org/10.1016/S0003-9861(02)00064-4 12051666 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"277 (25) (2002) 22131 –22139, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"37 (4) (2005) 323 –334, http://dx.doi.org/10.1038/ emm.2005.42 16155409 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"173 (6) (2004) 3589 –3593, http://dx.doi.org/10.4049/ jimmunol.173.6.3589 15356101 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"174 (6) (2005) 3709 –3718, http://dx.doi.org/ 10.4049/jimmunol.174.6.3709 15749910 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Ames, Bilirubin is an antioxidant of possible physiological importance, Science 235 (4792) (1987)1043 –1046, http://dx.doi.org/10.1126/science.3029864 3029864 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Acta 1840 (2) (2014)757 –767, http://dx.doi.org/10.1016/j.bbagen.2013.04.040 23660153 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Acta 1722 (2) (2005) 143 –147, http://dx.doi.org/10.1016/j.bba- gen.2004.12.008 15716123 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"75 (2) (2008) 494 –502, http://dx.doi.org/10.1016/j.bcp.2007.08.033 17920563 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"271 (42) (1996) 26026 –26031, http://dx.doi.org/10.1074/ jbc.271.42.26026 8824242 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"274 (16) (1999) 10852 –10862, http://dx.doi.org/ 10.1074/jbc.274.16.10852 10196162 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"174 (7) (2005) 4252 –4261, http://dx.doi.org/ 10.4049/jimmunol.174.7.4252 15778388 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Young, S. Akira, D.H. Hwang, Speci ﬁc inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex, J. Immunol.175 (5) (2005) 3339 –3346, http://dx.doi.org/10.4049/jimmunol.175.5.3339 16116226 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"[31] A. Cauwels, J. Bultinck, R. De Zwaef, B. Vandendriessche, S. Magez, P. Brouckaert, Nitric oxide production by endotoxin preparations in TLR4-de- ﬁcient mice, Nitric Oxide 36 (2014) 36 –43,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"277 (13) (2010) 2830 –2837, http://dx.doi.org/10.1111/j.1742-4658.2010.07700.x 20528914 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"16 (4 –5) (2005) 474 –486, http://dx.doi.org/10.1016/j.semcdb.2005.03.010 15905109 .",OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"[35] Z. Mi, A. Rapisarda, L. Taylor, A. Brooks, M. Creighton-Gutteridge, G. Melillo, L. Varesio, Synergystic induction of HIF-1alpha transcriptional activity by hypoxia and lipopolysaccharide in macrophages, Cell Cycle 7 (2) (2008) 232 –241, http://dx.doi.org/10.4161/cc.7.2.5193 18212534 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"357 (1) (1998) 155 –163, http://dx.doi.org/10.1006/ abbi.1998.0814 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"24 (9) (2004) 1652 –1658, http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"89 (7) (2001) 573 –582, http://dx.doi.org/10.1161/ hh1901.097083 11577022 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"210 (4) (1934) 181 –182, http://dx.doi.org/10.1056/NEJM193401252100404 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"172 (4) (2004) 2522 –2529, http://dx.doi.org/10.4049/ jimmunol.172.4.2522 14764725 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"276 (32) (2001) 30188 –30198, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"10 (5) (2008) 983 –996, http://dx.doi.org/ 10.1089/ars.2007.1825 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"70 (8) (2005) 1231 –1240, http://dx.doi.org/10.1016/j.bcp.2005.07.020 16140274 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"52 (9) (2012) 2047 –2056, http://dx.doi.org/10.1016/j.free- radbiomed.2012.01.027 22361747 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Zucker, Sodium taur- ocholate inhibits intestinal adenoma formation in APC Min/þmice, potentially through activation of the farnesoid X receptor, Carcinogenesis 31 (6) (2010) 1100 –1109, http://dx.doi.org/10.1093/carcin/bgq050 20194350 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"16 (19)(2009) 2373 –2394, http://dx.doi.org/10.2174/092986709788682155 19601787 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"192 (5) (2014) 2326 –2338, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Hopkins, R.H. Myers, G. Heiss, As- sociation of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study, Atherosclerosis154 (3) (2001) 747 –754, http://dx.doi.org/10.1016/S0021-9150(00)00420-2 11257278 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"de Jong, A functional polymorphism in UGT1A1 related to hyperbilirubinemia is asso-ciated with a decreased risk for Crohn ’s disease, J. Crohns Colitis 6 (5) (2012) 597 –602, http://dx.doi.org/10.1016/j.crohns.2011.11.010 22398043 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"Sherman, Serum bilirubin levels in the U.S. popu- lation: gender effect and inverse correlation with colorectal cancer, Hepatol- ogy 40 (4) (2004) 827 –835, http://dx.doi.org/10.1002/hep.20407 15382174 .",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
"2 (6) (2010) 256 –260, http://dx.doi.org/ 10.4021/jocmr444w 22043258 .G.",Non-OADS,/arxiv_data1/oa_pdf/0d/41/main.PMC4506991.pdf
ToContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.06.003 2211-7539/ &2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology nCorresponding author.Medical Mycology Case Reports 9 (2015) 12 –14,Non-OADS,/arxiv_data1/oa_pdf/74/59/main.PMC4506992.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/4d/main.PMC4506993.pdf
http://dx.doi.org/10.1016/j.mgene.2015.06.005 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/4d/main.PMC4506993.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/4d/main.PMC4506993.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/ad/ncomms8493.PMC4507019.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gao, M.-R. et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ad/ncomms8493.PMC4507019.pdf
"Cells 2015; 38(7): 587-596  http://dx.doi.org/10.14348/molcells.2015.0126     G                A Metabolomic Approach to Understanding the  Metabolic Link between Obesity and Diabetes   Seokjae Park1,2,3, Krishna Chaitanya Sadanala2,3, and Eun-Kyoung Kim1,2,*      Obesity and diabetes arise from an intricate interplay be- tween both genetic and environmental factors.",Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
"As one of the most widely-used  spectroscopic analytical techniques, NMR can identify and Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
Cells http://molcells.org  G Gquantify a large number of organic compounds simultaneously  in the micromolar range.,OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
"Cells http://molcells.org  G Goleic acid, palmitic acid, palmitoleic acid, stearic acid, tridecane,  undecane, triacylglycerol, 2-hydroxybutanoic acid, and aceto-  acetic acid are increased (Fiehn et al., 2010; Liu et al., 2013;  Salek et al., 2007; Villarreal-Pérez et al., 2014; Xu et al., 2013;  Yan et al., 2014; Zeng et al., 2011), whereas those of acyl-alkyl- phosphatidylcholines and ethanolamine are decreased (Fiehn  et al., 2010; Floegel et al., 2013; Suhre et al., 2010; Xu et al.,  2013).",Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
Cells http://molcells.org  G G Table 1.,OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
"Cells http://molcells.org  G GGougeon, R. (2005).",OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
"Cells http://molcells.org  G GGieger, C., Chang, D., Milburn, M.V., Gall, W.E., Weinberger,  K.M., et al.",OADS,/arxiv_data1/oa_pdf/16/40/molce-38-7-587.PMC4507023.pdf
Cells 2015; 38(7): 597-603  http://dx.doi.org/10.14348/molcells.2015.0152     G                New Insights into the Protein Turnover Regulation  in Ethylene Biosynthesis   Gyeong Mee Yoon*      Biosynthesis of the phytohormone ethylene is under tight  regulation to satisfy the need for appropriate levels of eth-ylene in plants in response to exogenous and endogenous  stimuli.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
"The family of ACS proteins can be grouped into 3 types,  Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
Cells http://molcells.org  G G               Fig.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
Ethylene Biosynthesis  Gyeong Mee Yoon    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
Cells http://molcells.org  G G                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
Ethylene Biosynthesis  Gyeong Mee Yoon    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
"Cells http://molcells.org  G GTogether, these studies indicate that there are molecular com- ponents that act as the points of cross-talk between ethylene  biosynthesis and other hormonal signaling pathways.",OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
Ethylene Biosynthesis  Gyeong Mee Yoon    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dd/03/molce-38-7-597.PMC4507024.pdf
"Cells 2015; 38(7): 604-609  http://dx.doi.org/10.14348/molcells.2015.2318     G                Vitamin D Promotes Odontogenic Differentiation of  Human Dental Pulp Cells via ERK Activation   Su-Mi Woo1,2,3,7, Hae-Soon Lim1,5,7, Kyung-Yi Jeong6, Seon-Mi Kim1,4, Won-Jae Kim1,2,3,*, and Ji-Yeon Jung1,3,*      The active metabolite of vitamin D such as 1 /g68,25-dihy- droxyvitamin D3 (1/g68,25(OH)2D3) is a well-known key regula- tory factor in bone metabolism.",Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
MATERIALS AND METHODS   Cell cultures and vitamin D preperation  Maxillary supernumerary incisors and third molars were ex-  tracted after obtaining informed consent from three healthy Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
Cells http://molcells.org  G G                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
"Cells http://molcells.org  G GDeficiency of 1 /g68,25(OH) 2D3 would result in hypocalcification of  the dentin and enamel, leading to unmineralized dental structure  (Barron et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/38/80/molce-38-7-604.PMC4507025.pdf
"Cells 2015; 38(7): 610-615  http://dx.doi.org/10.14348/molcells.2015.2328     G                Ursolic Acid Reduces Mycobacterium tuberculosis -  Induced Nitric Oxide Release in Human Alveolar A549 cells  Tamanna Zerin1, Minjung Lee1, Woong Sik Jang2, Kung-Woo Nam3, and Ho-yeon Song1,*      Alveolar epithelial cells have been functionally implicated  inMycobacterium tuberculosis  infection.",Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
"However, the role of infection Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
Cells http://molcells.org  G G A                          B                                             Both the cytosolic and nuclear extracts were stored at -80 /g113C until  use.,Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
Cells http://molcells.org  G G A                      B                            C                    D                       Fig.,Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/27/82/molce-38-7-610.PMC4507026.pdf
"Cells 2015; 38(7): 616-623  http://dx.doi.org/10.14348/molcells.2015.2357     G                The Signaling Mechanism of Contraction Induced   by ATP and UTP in Feline Esophageal Smooth  Muscle Cells   Tae Hoon Kwon1, Hyunwoo Jung1, Eun Jeong Cho1, Ji Hoon Jeong2, and Uy Dong Sohn1,*      P2 receptors are membrane-bound receptors for extracel- lular nucleotides such as ATP and UTP.",OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
"Recently, purinergic signaling has  begun to attract attention as a potential therapeutic target for a Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
Cells http://molcells.org  G G Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
Cells http://molcells.org  G G Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
Cells http://molcells.org  G G                                                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e3/65/molce-38-7-616.PMC4507027.pdf
"Cells 2015; 38(7): 624-629  http://dx.doi.org/10.14348/molcells.2015.0013     G                Identification of Protein Markers Specific for   Papillary Renal Cell Carcinoma Using Imaging Mass Spectrometry   Chan Hyun Na1,2,5, Ji Hye Hong1,2,5, Wan Sup Kim3, Selina Rahman Shanta1,2, Joo Yong Bang1,2, Dongmin Park4, Hark Kyun Kim4, and Kwang Pyo Kim1,2,*     Since the emergence of proteomics methods, many pro- teins specific for renal cell carcinoma (RCC) have been iden- tified.",OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
"Cancer-specific regions were identified by Principal Component  Analysis (PCA), and cancer-specific  m/z-species were selected Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
Cells http://molcells.org  G G A         C       B                        ther separated using a C8 reverse phase analytical column under the same conditions.,OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
"The acquired MS/MS spectra were generated by Extract- msn v4.0 and searched against the Human IPI protein data- base (ipi.Human.v3.58, http://www.ebi.ac.uk/IPI/, 79,794 pro-tein sequence entries) with TurboSEQUEST v.27 (Thermo  Finnigan, USA) using the following search parameters: enzyme  speciᚏcity/trypsin, precursor ion mass tolerances of /g114 2 Thom- son (Th) and fragment ion mass tolerances /g114 1 Th, number of  missed cleavage sites of 2, and oxidation on Met (+ 16 Da) as  variable modi ᚏcation.",OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
Cells http://molcells.org  G G A                            B                        C                            D                             A            B                C                  D                              Fig.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/molce-38-7-624.PMC4507028.pdf
"Cells 2015; 38(7): 630-637  http://dx.doi.org/10.14348/molcells.2015.0030     G                Morus alba  Accumulates Reactive Oxygen Species  to Initiate Apoptosis via FOXO-Caspase 3-Dependent Pathway in Neuroblastoma Cells  Young Hwi Kwon1,4, Kausik Bishayee1,4, Md.",Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
Another study on leukae- Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
Cells http://molcells.org  G G A                      B               C                            nent after 12 h of drug treatment and proliferation gradually  decreased as the incubation time increased in comparison with  the control (vehicle/DMSO-treated) sets.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
"Cells http://molcells.org  G G A                 B                 C                     preformed annexin V assay, cell viability assay and proliferation  assay.",OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
Cells http://molcells.org  G G                                             Fig.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e4/6b/molce-38-7-630.PMC4507029.pdf
"Cells 2015; 38(7): 638-642  http://dx.doi.org/10.14348/molcells.2015.0037     G                Quercetin Enhances Cisplatin Sensitivity of  Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis  Xian Zhang, Qinggong Guo, Jingtao Chen, and Zhaohui Chen*      Quercetin can suppress osteosarcoma cell growth and  metastasis.",Non-OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
The use of real-time quantitative PCR (RT-PCR) progress and primer sequences was Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
"Cells http://molcells.org  G G A                               B                            C                  A                          B                          C                   D                       DISCUSSION    Cisplatin is widely used as a chemotherapeutic agent, andthe  effects of which on osteosarcoma have been proven (Chou et  al., 2013; Martinez-Velez et al., 2014).",Non-OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
"Cells http://molcells.org  G Ghepatoma cells (Kim et al., 2008).",OADS,/arxiv_data1/oa_pdf/51/39/molce-38-7-638.PMC4507030.pdf
"Cells 2015; 38(7): 643-650  http://dx.doi.org/10.14348/molcells.2015.0050     G                Enhanced Healing of Rat Calvarial Bone Defects  with Hypoxic Conditioned Medium from Mesenchymal  Stem Cells through Increased Endogenous Stem  Cell Migration via Regulation of ICAM-1 Targeted- microRNA-221  Woochul Chang2,10, Ran Kim2,10, Sang In Park1, Yu Jin Jung3, Onju Ham4, Jihyun Lee2, Ji Hyeong Kim2, Sekyung Oh5, Min Young Lee6, Jongmin Kim7, Moon-Seo Park2, Yong-An Chung1, Ki-Chul Hwang8,9, and  Lee-So Maeng1,*     The use of conditioned medium from mesenchymal stem  cells may be a feasible approach for regeneration of bone  defects through secretion of various components of  mesenchymal stem cells such as cytokines, chemokines, and growth factors.",Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
(2012) demonstrated  that CM derived from rat MSCs (rMSCs) can enhance the mi- Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
"Cells http://molcells.org  G Ggration and adhesion capability of rMSCs in vitro , and bone  augmentation in vivo  compared to MSC transplantation.",Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
Cells http://molcells.org  G G A                B                               Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
miR-221 was selected to target ICAM-1 by Target  Scan (http://www.targetscan.org) and downregulated in HCM- treated rMSCs (Figs.,OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
Cells http://molcells.org  G G A         B                 C                                  more extensive in HCM-rMSCs than in the other groups.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
Cells http://molcells.org  G Grepair.,Non-OADS,/arxiv_data1/oa_pdf/37/f0/molce-38-7-643.PMC4507031.pdf
Cells 2015; 38(7): 651-656  http://dx.doi.org/10.14348/molcells.2015.0055     G                Mitogen-Activated Protein Kinase Kinase 3 Is  Required for Regulation during Dark-Light Transition   Horim Lee*      Plant growth and development are coordinately orchestrat- ed by environmental cues and phytohormones.,Non-OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
Because the mutant phenotypes of  the mkk1 mkk2  double mutant are similar to those of mpk4  and Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
"Cells http://molcells.org  G Gmekk1 , the MEKK1-MKK1/2-MPK4 cascade module was ge- netically established and this cascade was revealed to nega- tively regulate innate immune response and ROS signaling  (Gao et al., 2008; Pitzschke et al., 2009).",OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
MAPK Function in Light Signaling  Horim Lee    G http://molcells.org  Mol.,OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
Cells http://molcells.org  G G A                    B                              Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
MAPK Function in Light Signaling  Horim Lee    G http://molcells.org  Mol.,OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
"Cells http://molcells.org  G GHeberle-Bors, E., and Wilson, C. (2004).",OADS,/arxiv_data1/oa_pdf/60/72/molce-38-7-651.PMC4507032.pdf
"Cells 2015; 38(7): 657-662  http://dx.doi.org/10.14348/molcells.2015.0083     G                Anion Transport or Nucleotide Binding by Ucp2 Is  Indispensable for Ucp2-Mediated Efferocytosis   Suho Lee1,6, Hyunji Moon1,2,6, Gayoung Kim1,2, Jeong Hoon Cho3, Lee Dae-Hee4, Michael B. Ye5, and   Daeho Park1,2,*      Rapid and efficient engulfment of apoptotic cells is an  essential property of phagocytes for removal of the large  number of apoptotic cells generated in multicellular organ- isms.",OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
"Alt- hough Ucps can dissipate the mitochondrial membrane poten-  tial in vitro , their roles in a more physiologically relevant setting Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
"Cells http://molcells.org  G Gremain unclear (Krauss et al., 2005; Nedergaard et al., 2005).",OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
"Cells http://molcells.org  G G A                              C                      B                        A                                  B                         C                           transport defect) or Ucp2 R185Q (nucleotide binding defect) were  very weakly stained with MitoTracker, comparable to those  expressing Ucp2, indicating that these mutants still reduced the  mitochondrial membrane potential and that protons could flow  properly through these Ucp2 proteins (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
Cells http://molcells.org  G Gand Ucp2R185Q have a comparable affinity for endogenous Ucp2  and thus disrupt the activity of endogenous Ucp2 by dimerizing  with it.,Non-OADS,/arxiv_data1/oa_pdf/9f/07/molce-38-7-657.PMC4507033.pdf
"Cells 2015; 38(7): 663-668  http://dx.doi.org/10.14348/molcells.2015.0142     G                Induction of Angiogenesis by Matrigel Coating of  VEGF-Loaded PEG/PCL-Based Hydrogel Scaffolds for hBMSC Transplantation  Yeon Joo Jung2,8, Kyung-Chul Kim1,8, Jun-Young Heo1, Kaipeng Jing1,3, Kyung Eun Lee2, Jun Seok Hwang2, Kyu Lim1, Deog-Yeon Jo4, Jae Pyoung Ahn5, Jin-Man Kim6, Kang Moo Huh7,*, and Jong-Il Park1,3,*     hBMSCs are multipotent cells that are useful for tissue  regeneration to treat degenerative diseases and others for  their differentiation ability into chondrocytes, osteoblasts,  adipocytes, hepatocytes and neuronal cells.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
"Therefore, many polymer scaffolds have been  used as a substrate for tissue regeneration, providing mechani-  Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
"Cells http://molcells.org  G Gcal and structural support during tissue development (Mehdizadeh  et al., 2013).",OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
Cells http://molcells.org  G G A            B               C            D            E              Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
Cells http://molcells.org  G Ghydrogels based on poly(ethylene glycol) and poly( /g304-caprolactone)  blocks.,Non-OADS,/arxiv_data1/oa_pdf/b1/d7/molce-38-7-663.PMC4507034.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 31, Number 6, 2015DOI: 10.1089/jop.2014.0115 323",Non-OADS,/arxiv_data1/oa_pdf/1c/01/jop.2014.0115.PMC4507088.pdf
Supporting information Additional Supporting Information may be found in the online version of this article at the publisher’s web-site: http://dx.doi.org/10.1111/bph.13144 Figure S1 Characterization of netrin-1 isoforms synthesized by HUVECs.,Non-OADS,/arxiv_data1/oa_pdf/75/d9/bph0172-3548.PMC4507159.pdf
"Molecular & Cellular Oncology 2014; 1:e29904; http://dx.doi.org/10.4161/mco.29904Chromosomal rearrangements in cancer Detection and potential causal mechanisms Paul Hasty1 and Cristina Montagna2 1Department of Molecular Medicine/ institute of Biotechnology; The University of Texas Health Science Center at San Antonio; San Antonio, TX USA;   2Department of Genetics and Pathology; Albert e instein College of Medicine of Yeshiva University; Michael F. Price Center; Bronx, NY USA Keywords:  replication fork, DNA repair, chromosomal rearrangement, chromothripsis, oncogenesis Abbreviations:  aCGH, array comparative genomic hybridization; ALK, anaplastic lymphoma kinase; ALL, acute lymphoblastic  leukemia; AML, acute myelogenous leukemia; ATM, ataxia telangiectasia mutated; ATRA, all-trans-retinoic acid; BCR, breakpoint  cluster region; BIR, break-induced replication; BLM, Bloom Syndrome mutated; BRCA, breast cancer; CGH, comparative  genomic hybridization; cCGH, conventional CGH; CML, chronic myelogenous leukemia; CNV, copy number variation; DSB,  DNA double strand break; EF-PRR, error free-postreplication repair; EML4, echinoderm microtubule-associated protein like 4;  EPT, extra pericentromeres and telomere; ETO, Eight-Twenty One oncoprotein; FISH, fluorescence in situ hybridization; FOX,  forkhead box protein; HLTF, helicase-like transcription factor; HTGTS, high-throughput genome-wide translocation sequencing;  HR, homologous recombination; LCR, low copy number repeat; LSP, locus specific probe; MLL, mixed lineage leukemia; NGS,  next-generation sequencing; NHEJ, nonhomologous end joining; NSCLC, non-small cell lung cancer; PAX, paired box; PRR,  post replication repair; PML, promyelocytic leukemia; RARA, retinoic acid receptor alpha; ROS1, c-ros oncogene 1; SKY, spectral  karyotyping; SNP, single nucleotide polymorphism; TLS, translesion synthesis; WGS, whole genome sequencing Many cancers exhibit chromosomal rearrangements.",Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
"The most comprehensive of these are the Mitelman Database (http://cgap.nci.nih.gov/Chromosomes/Mitelman), which contains all published chromosome aber - rations in neoplastic disorders with clinical features of more than 64,000 cancers, and the Catalogue of Somatic Mutations in Cancer (COSMIC) database, 24 which currently reports the  characterization of 327 types of gene fusions identified in more than 60,000 cancer cases (accessed May 5, 2014).",OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2011; 144:9- 10; PMID:21215363 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 1973; 243:290-3; PMID:4126434 ;  http://dx.doi.org/10.1038/243290a0 3.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet 2014; 46:225- 33; PMID:24487277 ; http://dx.doi.org/10.1038/ ng.2891 4.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer Cell 2014; 25:379-92;  PMID:24613412 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Exp Cell Res  1969; 58:128-40;  PMID:5404060 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Exp Cell  Res 1970; 63:240-3; PMID:4250490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
"Biotechniques 2008; 45:385-6, 388,  390 passim;  PMID:18855767 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 1996; 273:494-7;  PMID:8662537 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet 1996; 14:312-5;  PMID:8896561 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet 1997; 15:406- 10; PMID:9090389 ; http://dx.doi.org/10.1038/ ng0497-406 11.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Expert Rev Mol Diagn 2004;  4:663-76;  PMID:15347260 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 2013; 501:569-72; PMID:24013173 ; http://dx.doi.org/10.1038/ nature12500 15.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 1992; 258:818- 21; PMID:1359641 ; http://dx.doi.org/10.1126/ science.1359641 17.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genes Chromosomes Cancer 1997; 20:399- 407; PMID:9408757 ; http://dx.doi.org/10.1002/ (SICI)1098-2264(199712)20:4<399::AID- GCC12>3.0.CO;2-I 18.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet 2011; 43:1074-81;  PMID:21964572 ; http://dx.doi.org/10.1038/ng.944 19.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Cancer 2007; 7:233-45; PMID:17361217 ;  http://dx.doi.org/10.1038/nrc2091 20.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2011; 144:27-40; PMID:21215367 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell  2011; 147:95-106;  PMID:21962510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2011; 147:107-19;  PMID:21962511 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
BMC Bioinformatics 2014; 15:78; PMID:24646301 ;  http://dx.doi.org/10.1186/1471-2105-15-78 24.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nucleic Acids Res 2011; 39:D945-50;  PMID:20952405 ; http://dx.doi.org/10.1093/nar/ gkq929 25.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
N Engl J Med 1988; 319:990- 8; PMID:3047582 ; http://dx.doi.org/10.1056/ NEJM19881013319150627.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Cancer  2005; 5:172-83;  PMID :15719031 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer Treat Rev 2014; 40:300- 6; PMID:23931927 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer 2013; 119:1627-35; PMID:23400546 ;  http://dx.doi.org/10.1002/cncr.27967 31.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Tuberc Respir Dis (Seoul) 2013; 75:236-7;  PMID:24416053 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A 1996; 93:5455-9; PMID:8643596 ; http://dx.doi.org/10.1073/ pnas.93.11.5455 34.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Cancer  2007; 7:847-59;  PMID:17943136 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet  1993; 5:230-5;  PMID:8275086 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
J Clin Oncol 2012; 30:1670- 7; PMID:22454413 ; http://dx.doi.org/10.1200/ JCO.2011.38.5591 39.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Semin Cell Dev Biol  2011; 22:866-74;  PMID:22020070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Curr Opin Genet Dev  2012; 22:211-20;  PMID:22440479 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Semin Cell Dev Biol 2011; 22:875-85; PMID:21802523 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 2010; 467:1109-13;  PMID:20981101 ; http://dx.doi.org/10.1038/ nature09460 48.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
J Pathol 2012; 227:446-55; PMID:22514011 ; http://dx.doi.org/10.1002/ path.4042 50.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet  2005; 37:320-7;  PMID :15711546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2013;  152:1226-36 ;  PMID:23498933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell  2012; 148:29-32;  PMID:22265399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature  2012; 482:53-8;  PMID:22258507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
DNA Repair (Amst) 2006; 5:1042-8;  PMID:16822724 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 1996; 86:379- 89; PMID:8756720 ; http://dx.doi.org/10.1016/ S0092-8674(00)80111-757.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell Biol  2000; 20:3772-80;  PMID:10805721 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Oncogene  2009; 28:1875-8;  PMID:19330025 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell  2010; 39:25-35;  PMID:20598602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer Cell  2012; 22:106-16;  PMID:22789542 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2010; 141:243- 54; PMID:20362325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Cancer 2013; 13:443- 54; PMID:23760025 ; http://dx.doi.org/10.1038/ nrc3537 66.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
PLoS Genet  2009; 5:e1000683;  PMID:19834534 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Trends Genet 2008; 24:529-38; PMID:18809224 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Annu Rev Biochem 2008; 77:229-57;  PMID:18275380 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Biochem J  2003; 374:577-606;  PMID:12803543 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 2003; 426:870-4; PMID:14685245 ;  http://dx.doi.org/10.1038/nature02253 73.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genes Dev 2005; 19:339- 50; PMID:15687257 ; http://dx.doi.org/10.1101/ gad.322605 74.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2003; 115:401- 11; PMID:14622595 ; http://dx.doi.org/10.1016/ S0092-8674(03)00886-9 75.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
J Biol Chem 2006;  281:13861-4;  PMID:16595695 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell Cycle 2008; 7:859-64;  PMID:18414031 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 2014; 343:88- 91; PMID:24310611 ; http://dx.doi.org/10.1126/ science.1243211 79.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Mol Cell Biol  2010; 11:208-19;  PMID:20177396 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell 2005; 17:153- 9; PMID:15629726 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nucleic Acids Res 2002; 30:656-66;  PMID:11809877 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 2002; 297:599- 602; PMID:12142537 ; http://dx.doi.org/10.1126/ science.1074023 83.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell 2010; 39:346-59;  PMID:20705238 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell 2010; 37:492-502; PMID:20188668 ;  http://dx.doi.org/10.1016/j.molcel.2010.01.021 85.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genes Dev 2011; 25:1320-7; PMID:21685366 ;  http://dx.doi.org/10.1101/gad.2053211,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2011; 145:529- 42; PMID:21565612 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mutat  Res 2014; In press; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 2014; 510:556- 9; PMID:24776801 ; http://dx.doi.org/10.1038/ nature13295 89.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
DNA Repair (Amst) 2009; 8:461-9; PMID:19217833 ;  http://dx.doi.org/10.1016/j.dnarep.2009.01.006 90.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Front Genet 2012; 3:174;  PMID:22973298 ; http://dx.doi.org/10.3389/ fgene.2012.00174 92.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
J Cell Biol 2006; 175:703-8; PMID:17130289 ; http://dx.doi.org/10.1083/ jcb.200606145 93.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A 2008; 105:12411- 6; PMID:18719106 ; http://dx.doi.org/10.1073/ pnas.0805685105 94.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell  2011; 42:237-49;  PMID:21396873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell Biol  2010; 30:684-93;  PMID:19948885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nucleic Acids Res  2014; 42:1711-20;  PMID:24198246 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A  1996; 93:819-23;  PMID:8570641 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Gene 1998; 223:187-94;  PMID:9858727 ; http://dx.doi.org/10.1016/ S0378-1119(98)00159-0 99.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell  2006; 21:595-604;  PMID:16507358 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature  2007; 447:102-5;  PMID:17410126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
DNA Repair (Amst) 2011; 10:408- 15; PMID:21317047 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genes Dev  2009; 23:2876-86;  PMID:20008937 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genes Dev  2009; 23:2861-75;  PMID:20008936 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genetics 2010;  186:1161-73;  PMID:20837992 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Microbiol Mol Biol Rev 2008; 72:686- 727; PMID:19052325 ; http://dx.doi.org/10.1128/ MMBR.00011-08 106.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cytogenet Genome Res  2006; 112:248-55;  PMID:16484780 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mutagenesis 2012; 27:1-15; PMID:21857006 ;  http://dx.doi.org/10.1093/mutage/ger052 110.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell Biol 2004; 24:4019- 31; PMID:15082794 ; http://dx.doi.org/10.1128/ MCB.24.9.4019-4031.2004 111.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science  1996; 272:1030-3;  PMID:8638128 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell 2003; 12:1525-36; PMID:14690605 ;  http://dx.doi.org/10.1016/S1097-2765(03)00456-8 113.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
PLoS Genet 2011; 7:e1001339; PMID:21437275 ;  http://dx.doi.org/10.1371/journal.pgen.1001339 114.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Struct Mol Biol  2009; 16:226-8;  PMID:19136957 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A 2008; 105:9936- 41; PMID:18632578 ; http://dx.doi.org/10.1073/ pnas.0804510105116.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
DNA Repair (Amst) 2007; 6:1726-31; PMID:17669698 ;  http://dx.doi.org/10.1016/j.dnarep.2007.06.003 117.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2011; 146:889-903;  PMID:21925314 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell 2007; 131:1235-47;  PMID:18160035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
PLoS Genet  2009; 5:e1000327;  PMID:19180184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Microbiol Mol Biol Rev  2007; 71:13-35;  PMID:17347517 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Am  J Hum Genet 2008; 82:763-71; PMID:18304490 ;  http://dx.doi.org/10.1016/j.ajhg.2007.12.011 123.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Genet 2006; 7:552-64; PMID:16770338 ;  http://dx.doi.org/10.1038/nrg1895 125.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 2006; 441:1103- 8; PMID:16710306 ; http://dx.doi.org/10.1038/ nature04789 126.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Genet  2000; 26:424-9;  PMID:11101838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell  2004; 14:491-500;  PMID :15149598 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell Biol  2003; 23:474-81;  PMID:12509447 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cell Cycle 2013; 12:3749- 58; PMID:24107634 ; http://dx.doi.org/10.4161/ cc.26640 132.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Cell Biol 2009; 11:592-603; PMID:19396164 ;  http://dx.doi.org/10.1038/ncb1865 133.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cell Biol 2007; 27:2562-71;  PMID:17242200 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nat Rev Cancer 2013; 13:772-87; PMID:24132104 ; http://dx.doi.org/10.1038/ nrc3612 136.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
N Engl J Med 2003; 349:1451-64; PMID:14534339 ;  http://dx.doi.org/10.1056/NEJMra020777 137.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Leuk  Lymphoma 2004; 45:639-48; PMID :15160934 ;  http://dx.doi.org/10.1080/10428190310001609933139.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 2010; 328:240-3; PMID:20378816 ;  http://dx.doi.org/10.1126/science.1183424 140.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Mol Cancer Ther 2013; 12:2663-74; PMID:24107448 ; http://dx.doi.org/10.1158/1535- 7163.MCT-13-0277 141.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
J Clin Oncol 2008; 26:3785- 90; PMID:18591545 ; http://dx.doi.org/10.1200/ JCO.2008.16.0812 143.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Science 2014; 343:1088- 9; PMID:24604189 ; http://dx.doi.org/10.1126/ science.1247472 145.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Genetics 2011; 188:787-97; PMID:21546543 ; http://dx.doi.org/10.1534/ genetics.111.129833146.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer Res 2009; 69:6676-84;  PMID:19654293 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-1208 147.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A 1999; 96:10770- 5; PMID:10485901 ; http://dx.doi.org/10.1073/ pnas.96.19.10770 148.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Cancer Res  2008; 68:9497-502;  PMID:19010925 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Proc Natl Acad Sci U S A 2002; 99:832-7;  PMID:11792868 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
Nature 1997; 386:804-10; PMID:9126738 ;  http://dx.doi.org/10.1038/386804a0,Non-OADS,/arxiv_data1/oa_pdf/92/24/kmco-01-01-10929904.PMC4507279.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/) Keywords: Brain-derived neurotrophic factor; Pittsburgh Compound B; PiB; Alzheimer’s disease; Mild cognitive impair- ment; Amyloid *Some data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database ( adni.lo- ni.usc.edu ).,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
A complete listingof ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/ uploads/how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
E-mail address: lapostolova@mednet.ucla.edu http://dx.doi.org/10.1016/j.dadm.2015.01.005 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) Alzheimer’ s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 187-193",Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Subjects Data used in preparing this article were obtained from the ADNI database ( http://adni.loni.usc.edu ).,OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Both raw and cor- rected image ﬁles are freely available for download athttp://adni.loni.usc.edu .,OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Detailed PET protocol information can be found athttp://www.adni-info.org/scientists/ADNIStudyProcedures.aspx but are brieﬂy described later.,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
"AllPET image ﬁles were assessed for artifacts and motion.Next, PET scans were coregistered, averaged, and smoothedwith a scanner-speciﬁc ﬁlter function to produce images of auniform isotropic resolution of 8-mm full-width at half-maximum (for details see http://adni.loni.usc.edu/wp- content/uploads/2010/09/PET_PIB_Tech_Procedures_Manual_Suppl_v1.3.pdf ).",OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
The smoothed coregistered PiB-PET scans were downloaded from the ADNI repository fromthe Laboratory of Neuroimaging ( https://ida.loni.usc.edu/ login.jsp ) for further processing.,OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Plasma protein biomarkers Fasting blood samples were collected in two potassiu- methylene diamine tetraacetic acid (K 2EDTA) tubes at the baseline visit and centrifuged at room temperature for 15 mi-nutes at 3000 rpm ( http://www.adni-info.org/scien tists/ADNIStudyProcedures.aspx# ).,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
BDNF met the quality control criteria for subsequent statistical analysis ( http://adni.loni.usc.edu/wp-content/ uploads/2010/11/BC_Plasma_Proteomics_Data_Primer.pdf ).,OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Available at: http://books.google.com/ books?id 5Q2RIPwAACAAJ .,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
Available at: http://www.worldeventsforum.com/ hai/HAI2015_Book.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e8/56/main.PMC4507280.pdf
(Cell Mol Gas- troenterol Hepatol 2015;1:381 –394; http://dx.doi.org/10.1016/ j.jcmgh.2015.05.001 )Keywords: Endothelium; Fenestrae; Hypertriglyceridemia; Hypoalbuminemia; Hypoproteinemia; Very Early Onset In-ﬂammatory Bowel Disease; Monogenic Diseases; Protein-Losing Enteropathy; Whole-Exome Sequencing.,Non-OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.05.001,OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
Acopy of the consent is available on the website of the Inter-National Early Onset Paediatric IBD Cohort Study (NEOPICS)athttp://www.neopics.org/NEOPICS_Documents.html .,Non-OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
"Using the 1000 genomes Variant Frequencies(phase 1), the Exome Aggregation Consortium Variant Fre-quency database version 0.3 (Cambridge, MA), and theNHLBI Exome Sequencing Project ( https://esp.gs.",OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
"The acquired imageswere processed for brightness and contrast and analyzedusing ImageJ ( http://imagej.nih.gov/ij/ ), and the ﬁgures were mounted using Adobe Photoshop and Adobe Illus-trator CS6.",OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
"The PLVAP c.1072C >T mutation is extremely rare with only one het- erozygote individual identi ﬁed from over 121,000 sequenced (estimated minor allelic frequency of 8.2e-06;http://exac.broadinstitute.org/variant/19-17476202-G-A ).",Non-OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/79/main.PMC4507283.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/03/main.PMC4507295.pdf
E-mail address: dodgeh@ohsu.edu http://dx.doi.org/10.1016/j.trci.2015.01.001 2352-8737/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/03/main.PMC4507295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/03/main.PMC4507295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/95/dev124.PMC4507330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/62/58/nihms700129.PMC4507353.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Limited.Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Jennifer ZJ Maccani Tobacco Center of Regulatory Science, Public Health Sciences Department, Suite PSHCi  T3425, 500 University Drive, PO Box 850, Hershey, PA 17033-0850, USA, Tel +1 717 531 0003 ext 289575, Fax +1 717 531 0480,  jmaccani@phs.psu.edu.",Non-OADS,/arxiv_data1/oa_pdf/62/58/nihms700129.PMC4507353.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.VECTOR-BORNE AND ZOONOTIC DISEASES Volume 15, Number 7, 2015DOI: 10.1089/vbz.2015.1807 404",Non-OADS,/arxiv_data1/oa_pdf/4b/0f/vbz.2015.1807.PMC4507354.pdf
"The  oncospheres hatch in the intestine and then penetrate the intestinal wall before dissemi -Rohan R. Mahale   Anish Mehta  Srinivasa Rangasetty Department of Neurology,   MS Ramaiah Medical College &   Hospital, Bangalore, Karnataka, IndiapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):203-211   /   http://dx.doi.org/10.3988/jcn.2015.11.3.203 Received  August 4, 2014 Revised  December 27, 2014 Accepted  December 29, 2014 Correspondence Rohan R. Mahale, DM Department of Neurology,  MS Ramaiah Medical College & Hospital, MSRIT post, New BEL road,   Bangalore-560054, Karnataka, IndiaTel    +91-80-40503125 Fax   +91-80-40503189 E-mail    rohanmahale83@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/3c/34/jcn-11-203.PMC4507373.pdf
"Clinique des Minimes, Toulouse,  FrancepISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):212-219   /   http://dx.doi.org/10.3988/jcn.2015.11.3.212 Received  December 8, 2014 Revised  January 2, 2015 Accepted  January 5, 2015 Correspondence Thierry Paillard, MD Laboratoire Activité Physique, Performance et Santé, Université de Pau et des Pays de l’ Adour, Département STAPS, ZA Bastillac Sud,11 rue Morane Saulnier, Tarbes 65000, FranceTel    +33-562566100 Fax   +33-562566110 E-mail    thierry.paillard@univ-pau.fr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/17/06/jcn-11-212.PMC4507374.pdf
"Low   Victoria A. Tomalia Department of Neurology, Mayo Clinic,  Rochester, MN, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):220-226   /   http://dx.doi.org/10.3988/jcn.2015.11.3.220 Received  January 19, 2015 Revised  January 20, 2015 Accepted  January 20, 2015 Correspondence Phillip A.",Non-OADS,/arxiv_data1/oa_pdf/2d/c4/jcn-11-220.PMC4507375.pdf
"Low, MD Department of Neurology, Mayo Clinic, 200 First Street SW ,Rochester, MN 55905, USATel    +1-507-284-3375 Fax   +1-507-284-3133 E-mail    low@mayo.edu cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access  REVIEW",Non-OADS,/arxiv_data1/oa_pdf/2d/c4/jcn-11-220.PMC4507375.pdf
"However, to the best of our knowledge, detailed clinical data on such patients have not yet been described.Jae-Won Hyuna,c  Jee Young Kimb  Kyung Gyu Choia  Ho Jin Kimc  Kee Duk Parka a Department of Neurology,   Ewha Womans University   Graduate School of Medicine,   Seoul, Korea b Department of Neurology,   Myongji Hospital, Goyang, Korea c Department of Neurology,   National Cancer Center, Goyang, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):227-233   /   http://dx.doi.org/10.3988/jcn.2015.11.3.227 Received  September 25, 2014 Revised  October 24, 2014 Accepted  October 27, 2014 Correspondence Kee Duk Park, MD, PhD Department of Neurology,  Ewha Womans University  Graduate School of Medicine,  1071 Anyangcheon-ro,  Y angcheon-gu, Seoul 158-710,  KoreaTel    +82-2-2650-6010 Fax   +82-2-2650-5958 E-mail    pkd1165@ewha.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/cd/6a/jcn-11-227.PMC4507376.pdf
"The National Cholesterol Education Program of Fatma Gu ¨l Yurdakula  Hatice Bodura  Özgu¨r Öztop Çakmakb  Can Ateşc  Filiz Sivasa  Filiz Esera  Özlem Yılmaz Taşdelena a Physical Medicine and   Rehabilitation Department,   Ankara Numune Training and   Research Hospital, Ankara, Turkey b Neurology Department,   Karabu ¨k Training and   Research Hospital, Karab u¨k, Turkey c Department of Biostatistics,   Ankara University School of Medicine,  Ankara, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):234-240   /   http://dx.doi.org/10.3988/jcn.2015.11.3.234 Received  September 23, 2014 Revised  December 9, 2014 Accepted  December 11, 2014 Correspondence Fatma Gül Yurdakul, MD  Physical Medicine and Rehabilitation   Department, Ankara Numune  Training and Research Hospital,  Ankara 06100, TurkeyTel    +90 505 9254214 Fax   +90 312 3114340 E-mail    fatmagulonder@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/be/bf/jcn-11-234.PMC4507377.pdf
"6,7 While correct identification of BMS is crucial for such Yu-Min Huang-Linka  Mats Fredriksonb   Hans Linkc a Division of Neurology, Department of   Clinical and Experimental Medicine,   Linköping University Hospital,   Linköping, Sweden b Department of Occupational and   Environmental Medicine and   Linköping Academic Research Center   (LARC), Linköping University,   Linköping, Sweden c Department of Clinical Neuroscience,   Karolinska Institute, Stockholm, SwedenpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):241-247   /   http://dx.doi.org/10.3988/jcn.2015.11.3.241 Received  September 30, 2014 Revised  December 20, 2014 Accepted  December 23, 2014 Correspondence Yu-Min Huang-Link, MD Division of Neurology, Department ofClinical and Experimental Medicine, Linköping University Hospital, Garnisonsvägen,581 85 Linköping, SwedenTel    +46-10103 1414 Fax   +46-10103 4438 E-mail    yumin.link@ regionostergotland.se cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/54/ba/jcn-11-241.PMC4507378.pdf
"1 DMD and BMD  usually affect men, but women also occasionally develop symptoms, and two-thirds of moth - ers of affected males are thought to be DMD carriers.3 Reportedly 2.5 –7.8% of female DMD carriers report muscle weakness and are therefore Seung Ha Leea  Jung Hwan Leea  Kyung-A Leeb,c  Young-Chul Choia,c a Departments of Neurology and   b Laboratory Medicine,   Gangnam Severance Hospital,   Yonsei University College of Medicine,   Seoul, Korea c Rehabilitation Institute   of Neuromuscular Disease,   Yonsei University College of Medicine,   Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):248-251   /   http://dx.doi.org/10.3988/jcn.2015.11.3.248 Received  September 29, 2014 Revised  February 5, 2015 Accepted  February 9, 2015 Correspondence Y oung-Chul Choi, MD, PhD Department of Neurology, Gangnam Severance Hospital, Y onsei University College of Medicine,211 Eonju-ro, Gangnam-gu, Seoul 135-720, KoreaTel    +82-2-2019-3323 Fax   +82-2-3462-5904 E-mail    ycchoi@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3b/6e/jcn-11-248.PMC4507379.pdf
"12 It has been estimated that 60% of incident epilepsy cases  in the elderly population for which the etiology was identified were associated with cerebro -Derek H. Tanga  Daniel C. Malonea  Terri L. Warholaka  Jenny Chongb  Edward P. Armstronga  Marion K. Slacka  Chiu-Hsieh Hsuc  David M. Labinera,b a Department of Pharmacy   Practice and Science, The University   of Arizona College of Pharmacy,   Tucson, AZ, USA  b Department of Neurology,   The University of Arizona College   of Medicine, Tucson, AZ, USA c Department of Epidemiology   and Biostatistics, The University   of Arizona College of Public Health,   Tucson, AZ, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):252-261   /   http://dx.doi.org/10.3988/jcn.2015.11.3.252 Received  August 26, 2014 Revised  February 10, 2015 Accepted  February 12, 2015 Correspondence Derek H. Tang, PhD, BSPharm Department of Pharmacy Practice   and Science, The University of  Arizona College of Pharmacy,  1295 N Martin, PO Box 210202,  Tucson, AZ 85721, USATel    +1-520-342-7683 E-mail    dhtang116@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3e/60/jcn-11-252.PMC4507380.pdf
Available from:  http://www.azahcccs.gov/.,Non-OADS,/arxiv_data1/oa_pdf/3e/60/jcn-11-252.PMC4507380.pdf
Available from: http://www.census.gov/.,OADS,/arxiv_data1/oa_pdf/3e/60/jcn-11-252.PMC4507380.pdf
"9Evangelos Anagnostou   Ioanna Kouzi   Konstantinos Spengos Department of Neurology,  Eginition Hospital, University of Athens, Athens, GreecepISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):262-267   /   http://dx.doi.org/10.3988/jcn.2015.11.3.262 Received  November 17, 2014 Revised  February 15, 2015 Accepted  February 16, 2015 Correspondence Evangelos Anagnostou, MD Department of Neurology,Eginition Hospital,  University of Athens,Vas.",Non-OADS,/arxiv_data1/oa_pdf/4f/bd/jcn-11-262.PMC4507381.pdf
"Sophias Avenue 74,Athens 11528, GreeceTel    +302107289291 Fax   +302107242020 E-mail    granavan@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/4f/bd/jcn-11-262.PMC4507381.pdf
"Quattrone et al.8 Yool-Hee Kima  Hyeo-Il Maa  Yun Joong Kima,b,c a Department of Neurology,   Hallym University College of Medicine,  Anyang, Korea b ILSONG Institute of Life Science,   Hallym University, Anyang, Korea c Hallym Institute of Translational Genomics  and Bioinformatics, Hallym University Medical Center, Anyang, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):268-274   /   http://dx.doi.org/10.3988/jcn.2015.11.3.268 Received  December 1, 2014 Revised  February 16, 2015 Accepted  February 17, 2015 Correspondence Hyeo-Il Ma, MD, PhD Department of Neurology,Hallym University College of Medicine, 22 Gwanpyeong-ro 170beon-gil, Anyang 431-796, KoreaTel    +82-31-380-3742 Fax   +82-31-381-4659 E-mail    hima@hallym.ac.kr Yun Joong Kim, MD, PhD ILSONG Institute of Life Science, Hallym University,15 Gwanpyeong-ro 170beon-gil, Anyang 431-815, KoreaTel    +82-31-380-1666 Fax   +82-31-388-3427 E-mail    yunkim@hallym.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/7d/56/jcn-11-268.PMC4507382.pdf
"All statistical analyses were performed using MedCalc  Statistical Software (version 13.2.2, MedCalc Software, Ostend,  Belgium; http://www.medcalc.org; 2014).",OADS,/arxiv_data1/oa_pdf/7d/56/jcn-11-268.PMC4507382.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2015.11.3.268.Conflicts of Interest The authors have no financial conflicts of interest.,Non-OADS,/arxiv_data1/oa_pdf/7d/56/jcn-11-268.PMC4507382.pdf
"Brain computed tomog - raphy (CT) angiography revealed tandem occlusion of the right distal internal carotid ar -Yoonju Leea   Han Yia   Byoung Moon Kimb   Dong Joon Kimb   Se Hoon Kimc   Hyo Suk Nama   Ji Hoe Heoa   Young Dae Kima aDepartments of Neurology,   bRadiology, and   c Pathology, Yonsei University   College of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):275-278   /   http://dx.doi.org/10.3988/jcn.2015.11.3.275 Received  September 13, 2013 Revised  November 1, 2013 Accepted  November 7, 2013 Correspondence Y oung Dae Kim, MD, PhD Department of Neurology, Y onsei University College of Medicine,50-1 Y onsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel    +82-2-2228-1619 Fax   +82-2-393-0705 E-mail    neuro05@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/4c/8a/jcn-11-275.PMC4507383.pdf
"The direction of spontaneous nystagmus was not changed during positional Seol-Hee Baeka   Jeong-Yoon Choib   Jin-Man Jungb   Do-Young Kwonb   Moon Ho Parkb   June Choic   Ji-Soo Kimd a Department of Neurology,   Korea University Anam Hospital,   Korea University College of Medicine,   Seoul, Korea b Departments of Neurology and  c Otorhinolaryngology-Head and Neck   Surgery, Korea University Ansan  Hospital, Korea University   College of Medicine, Ansan, Korea d Department of Neurology, Seoul National  University Bundang Hospital,   Seoul National University   College of Medicine, Seongnam, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):279-282   /   http://dx.doi.org/10.3988/jcn.2015.11.3.279 Received  August 20, 2013 Revised  December 19, 2013 Accepted  December 23, 2013 Correspondence Jeong-Y oon Choi, MD Department of Neurology, Korea University Ansan Hospital,Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, KoreaTel    +82-31-412-5150 Fax   +82-31-412-5154 E-mail    a-yeong@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/7d/90/jcn-11-279.PMC4507384.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2015.11.3.279.,Non-OADS,/arxiv_data1/oa_pdf/7d/90/jcn-11-279.PMC4507384.pdf
"Main - tenance intravenous immunoglobulin G (IgG; IVIG) infusions halted the neuropathy symp - tom progression, and a “watchful waiting” approach was chosen to manage the lymphoma.Joerg-Patrick Stübgen Department of Neurology, New York- Presbyterian Hospital, Weill Cornell  Medical College, New York,   NY, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):283-286   /   http://dx.doi.org/10.3988/jcn.2015.11.3.283 Received  October 22, 2013 Revised  April 21, 2014 Accepted  April 23, 2014 Correspondence Joerg-Patrick Stübgen, MB ChB, MD Department of Neurology,New Y ork-Presbyterian Hospital,Weill Cornell Medical College,525 East 68th Street, New Y ork, NY 10065-4885, USATel    +1-212-7462334 Fax   +1-212-7468742 E-mail    pstuebge@med.cornell.edu cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/f0/33/jcn-11-283.PMC4507385.pdf
"It is pos - sible that our patient presented with relative hypertension, since SC patients generally have Anne Landaisa  Nathalie Lemonneb  Maryse Etienne-Julanb aNeurology Department, b Sickle Cell Unit,   University Hospital of Pointe-à-Pitre/   CHU de Pointe-à-Pitre, Neurology Unit,  Abymes, FrancepISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):287-288   /   http://dx.doi.org/10.3988/jcn.2015.11.3.287 Received  December 4, 2014 Revised  January 27, 2015 Accepted  January 27, 2015 Correspondence Anne Landais, MD Neurology Department,University Hospital of Pointe-à-Pitre/   CHU de Pointe-à-Pitre, Neurology Unit, Route de Chauvel, 97139 Abymes, FranceTel    +3305 90 89 1430 Fax   +3305 90 89 1431 E-mail    landais-anne@voila.fr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/89/a6/jcn-11-287.PMC4507386.pdf
"4 Genomic DNA  and complementary DNA sequencing revealed a novel mutation, c.345-1G>A, which re - sulted in deletion of exon 7 and the introduction of a premature stop codon in exon 8, Sook Won Ryua  Jang Su Kimb  Seung-Hwan Leec a Departments of Laboratory Medicine and  c Neurology, Kangwon National University   School of Medicine, Chuncheon, Korea b Department of Laboratory Medicine,  S-Jungang Hospital, Jeju, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):289-291   /   http://dx.doi.org/10.3988/jcn.2015.11.3.289 Received  January 22, 2015 Revised  February 17, 2015 Accepted  February 17, 2015 Correspondence Seung-Hwan Lee, MD, PhD Department of Neurology,  Kangwon National University  School of Medicine,  1 Kangwondaehak-gil,  Chuncheon 200-701, KoreaTel    +82-33-250-8802 Fax   +82-33-259-5635 E-mail    movement@kangwon.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/0f/57/jcn-11-289.PMC4507387.pdf
"1 In the  present case, the left PICA branched out before the stenotic V A segment; therefore, the ini -Jeong-Yoon Choia  Woo-Keun Seob  Kyungmi Ohb  Sang-Il Seoc  Namhyung Ryoud  Sung Won Chaed a Department of Neurology,   Korea University College of Medicine,  Korea University Ansan Hospital,   Ansan, Korea b Departments of Neurology, c Radiology, and dOtorhinolaryngology- Head and Neck Surgery,   Korea University College of Medicine, Korea University Guro Hospital,   Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):292-294   /   http://dx.doi.org/10.3988/jcn.2015.11.3.292 Received  October 20, 2014 Revised  February 19, 2015 Accepted  February 22, 2015 Correspondence Woo-Keun Seo, MD, PhD Department of Neurology,  Korea University College of Medicine, Korea University Guro Hospital,   148 Gurodong-ro, Guro-gu,   Seoul 152-703, Korea Tel    +82-2-2626-3172 Fax   +82-2-2626-1257 E-mail    nukseo@korea.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/87/24/jcn-11-292.PMC4507388.pdf
"Disclosures WK Seo received study funds from DAEWOONG Pharmaceutical Co. LTD. Other authors: None.pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2015 ;11(3):295-295   /   http://dx.doi.org/10.3988/jcn.2015.11.3.295 cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ERRATUM",Non-OADS,/arxiv_data1/oa_pdf/b7/9a/jcn-11-295.PMC4507389.pdf
"Accession Numbers GSE68765GSE69132 Begun et al., 2015, Cell Reports 11, 1905–1918 June 30, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.05.045",Non-OADS,/arxiv_data1/oa_pdf/b6/1f/main.PMC4507440.pdf
http://dx.doi.org/10.1016/j.celrep.2015.05.045 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/1f/main.PMC4507440.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and three tables and can be found with this article online athttp://dx.doi.org/10.1016/j.celrep.2015.05.045 .",Non-OADS,/arxiv_data1/oa_pdf/b6/1f/main.PMC4507440.pdf
"Gut, Published online September24, 2014. http://dx.doi.org/10.1136/gutjnl-2014-307289 .",Non-OADS,/arxiv_data1/oa_pdf/b6/1f/main.PMC4507440.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/df/ceg-8-191.PMC4507450.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 191–196Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  191ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S8500 7Risk factors for recurrent hospital-acquired  Clostridium difficile  infection in a Japanese  university hospital Mayu Hikone1 Yusuke Ainoda1,2 Sayaka Tago2 Takahiro Fujita2 Yuji Hirai2 Kaori Takeuchi2 Kyoichi T otsuka3 1Department of Infectious Diseases,   T okyo Metropolitan Bokutoh General  Hospital,  2Department of Infectious  Diseases, Tokyo Women’s Medical  University,  3Department of Internal  Medicine, K itatama Hospital, T okyo,   Japan Correspondence: Yusuke Ainoda   Department of Infectious Diseases,  Tokyo Women’s Medical University,   8-1, Kawada-cho, Shinjuku-ku,   Tokyo  162-8666, Japan   Tel +81 3 3353 8111  Fax +81 3 3358 8995  Email ainoda.yusuke@twmu.ac.j pBackground:  Clostridium difficile  infection (CDI) is a highly prevalent hospital-associated  infection.",Non-OADS,/arxiv_data1/oa_pdf/e9/df/ceg-8-191.PMC4507450.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/e9/df/ceg-8-191.PMC4507450.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/df/ceg-8-191.PMC4507450.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1163–1172Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1163RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8580 8Mutations in presenilin 2 and its implications  in Alzheimer’s disease and other dementia- associated disorders Yan Cai1 Seong Soo A An1 SangYun Kim2 1Department of Bionano T echnology,   Gachon Medical Research Institute,   Gachon University, 2Department of  Neurology, Seoul National University  College of Medicine, Seoul National  University Bundang Hospital,   Seongnam-si, Gyeonggi-do, South  KoreaAbstract:  Alzheimer’s disease (AD) is the most common form of dementia.",Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
"In this review, Correspondence: Seong Soo A An Department of Bionano Technology,  Gachon Medical Research Institute,  Gachon University, 1342 Seongnam- daero, Sujeong-gu, Seongnam-si,  Gyeonggi-do 461-701, South Korea Tel +82 31 750 8755 Fax +82 31 750 8755 email seongaan@gachon.ac.k r  SangYun Kim Department of Neurology, Seoul  National University Bundang Hospital,  300 Gumidong, Bundang-gu, Seongnam-si,  Gyeonggi-do 463-707, South Korea Tel +82 31 787 7462 Fax +82 31 719 6815 email neuroksy@snu.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Cai et al Running head recto: Mutations in presenilin 2 and their implications DOI: http://dx.doi.org/10.2147/CIA.S85808",Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
Available from: http://www.molgen.ua.ac.,Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/31/8e/cia-10-1163.PMC4507455.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/btt-9-069.PMC4507456.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2015:9 69–74Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  69Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5735 9Giant-cell tumor of bone: treatment options   and role of denosumab Arun S Singh1 Neal S Chawla2 Sant P Chawla2 1Sarcoma Service, Division of  Hematology/Oncology, University  of California, Los Angeles,  2Sarcoma  Oncology Center, Santa Monica, CA,   USA Correspondence: Arun S Singh   Sarcoma Service, Division of Hematology/ Oncology, University of California, Los  Angeles,  2825 Santa Monica Boulevard –  Suite 200, Santa Monica, CA  90404, USA   Tel +1 310 829 5471  Fax +1 310 829 6192  email asingh@mednet.ucla.ed uAbstract:  Giant-cell tumor of bone is a rare, locally aggressive tumor that typically occurs in  the bones of skeletally mature young adults in their second to fourth decades.",Non-OADS,/arxiv_data1/oa_pdf/c8/60/btt-9-069.PMC4507456.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/c8/60/btt-9-069.PMC4507456.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/btt-9-069.PMC4507456.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/c8/60/btt-9-069.PMC4507456.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/05/ccide-7-065.PMC4507457.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2015:7 65–74Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  65OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S6887 4Cytotoxicity of a novel nano-silver particle  endodontic irrigant eric lK Chan1 Chengfei Zhang2 gary sP Cheung2 1Department of health, government  of hong Kong sar, hong Kong,   special administrative region;   2Comprehensive Dental Care  (endodontics), Faculty of Dentistry,   University of hong Kong, hong Kong  special administrative region of the  People’s republic of China Correspondence: gary sP Cheung   advanced endodontics Centre,   6/F, Prince Philip Dental hospital,   34 hospital road, saiyingpun, hong  Kong, special administrative region of  the People’s republic of China   Tel +852 2859 0288   Fax +852 25170544   email spcheung@hku.h kPurpose:  The aim of this study was to evaluate the cytotoxic effect of a novel nano-silver particle  (25.2 ±6.5 nm) endodontic irrigant (0.2 mM) and compare it with 3% sodium hypochlorite.",Non-OADS,/arxiv_data1/oa_pdf/78/05/ccide-7-065.PMC4507457.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/78/05/ccide-7-065.PMC4507457.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/78/05/ccide-7-065.PMC4507457.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/1d/bctt-7-179.PMC4507458.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 179–181Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S7870 5importance of perforating vessels in nipple-sparing  mastectomy: an anatomical description Claudio amanti1 Valeria Vitale1 augusto lombardi1 stefano Maggi1 laura Bersigotti1 gianni lazzarin1 emiliano nuccetelli1 Camilla romano1 laura Campanella1 lara Cristiano2 alessandra Bartoloni2 giuseppe argento2 1Breast surgery Unit,  2radiology  Unit, University of roma, la sapienza  sant’andrea hospital, rome, italy Correspondence: stefano Maggi   Breast surgery Unit, University   of roma, la sapienza sant’andrea   hospital, Via di grottarossa 1035-1039,  00189, rome, italy   email stefano.maggi@uniroma1.i tBackground:  Nipple-sparing mastectomy (NSM), understood as an oncologically valid proce - dure, is relatively new, and is an evolution of traditional mastectomy, particularly in relation to  breast-conserving surgery.",Non-OADS,/arxiv_data1/oa_pdf/a1/1d/bctt-7-179.PMC4507458.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a1/1d/bctt-7-179.PMC4507458.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/15/ccid-8-361.PMC4507484.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 361–370Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  361RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S5398 0Hair restoration surgery: challenges and solutions Paul T Rose Hair Transplant Institute of Miami,   Coral Gables, FL, USA Correspondence: Paul T Rose   4425 Ponce de Leon Blvd, Suite 230,   Coral Gables, FL 33146, USA   email paultrose@yahoo.co mAbstract:  Hair loss is a common problem affecting both men and women.",Non-OADS,/arxiv_data1/oa_pdf/cd/15/ccid-8-361.PMC4507484.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/cd/15/ccid-8-361.PMC4507484.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/15/ccid-8-361.PMC4507484.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/copd-10-1313.PMC4507485.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1313–1320International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1313OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7818 0Pulmonary hemodynamic profile in chronic  obstructive pulmonary disease Karina Portillo1 Y olanda T orralba1,2 Isabel Blanco1,2 Felip Burgos1,2 roberto rodriguez-roisin1,2 Jose rios3 Josep roca1,2 Joan a Barberà1,2 1Department of Pulmonary  Medicine, hospital Clínic-Institut  d’Investigacions Biomèdiques august  Pi isunyer (IDIB aPs), University of  Barcelona, Barcelona, spain; 2Centro  de Investigación Biomédica en  red de enfermedades respiratorias  (CIBeres), Madrid, spain; 3Biostatistics  and Data Management Core Facility,  hospital Clínic-Institut d’Investigacions  Biomèdiques august  Pi isunyer  (IDIB aPs), Biostatistics Unit, school  of Medicine, Universitat autònoma  de Barcelona, Barcelona, spainIntroduction:  Few data are available in regards to the prevalence of pulmonary hypertension  (PH) in the broad spectrum of COPD.",Non-OADS,/arxiv_data1/oa_pdf/a7/83/copd-10-1313.PMC4507485.pdf
"Patients with COPD may develop PH during exercise, a condition associated with  an increased risk for subsequently developing PH at rest.12 Current understanding of Correspondence: Joan a Barberà Department of Pulmonary Medicine,  hospital Clínic, Villarroel 170, 08036  Barcelona, spain Tel +34 932 275 747 Fax +34 932 255 455 email jbarbera@clinic.ub.e sJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Portillo et al Running head recto: Hemodynamic characterization in COPD DOI: http://dx.doi.org/10.2147/COPD.S78180",Non-OADS,/arxiv_data1/oa_pdf/a7/83/copd-10-1313.PMC4507485.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a7/83/copd-10-1313.PMC4507485.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/copd-10-1313.PMC4507485.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/5d/dddt-9-3589.PMC4507486.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3589–3597Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3589Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8189 1apparent Km of mitochondria for oxygen  computed from Vmax measured in permeabilized  muscle fibers is lower in water enriched in oxygen  by electrolysis than injection Joffrey Zoll1 Jamal Bouitbir1 Pascal sirvent2 alexis Klein3 antoine charton1,4 liliana Jimenez3 François r Péronnet5 Bernard geny1 ruddy richard6 1Physiology Department, Faculty of  Medicine and ea3072, Université de  strasbourg, strasbourg, 2clermont  Université, Université Blaise  Pascal, ea 3533, laboratoire des  adaptations Métaboliques à l’exercice  en conditions Physiologiques et  Pathologiques, clermont-Ferrand,   3Danone research, centre Daniel  carasso, Palaiseau, 4Department  of anesthesia and critical care and  ea3072, hôpital de hautepierre,   Université de strasbourg, France;   5Kinesiology Department, Université  de Montréal, Montréal, Qc , canada;   6Department of sport Medicine and  Functional explorations and inra  UMr 1019, Faculty of Medicine,   Université d’auvergne, clermont- Ferrand, FranceBackground:  It has been suggested that oxygen (O2) diffusion could be favored in water  enriched in O2 by a new electrolytic process because of O2 trapping in water superstructures  (clathrates), which could reduce the local pressure/content relationships for O2 and facilitate  O2 diffusion along PO2 gradients.",Non-OADS,/arxiv_data1/oa_pdf/13/5d/dddt-9-3589.PMC4507486.pdf
"Interestingly, a series of studies conducted in vitro and in animal correspondence: ruddy richard service de Médecine du sport et des  explorations Fonctionnelles, chU g,  Montpied, 58 rue Montalembert, 63003  clermont-Ferrand cedex 1, France email richard.ruddy@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zoll et al Running head recto: Mitochondrial respiration in water enriched in oxygen DOI: http://dx.doi.org/10.2147/DDDT.S81891",Non-OADS,/arxiv_data1/oa_pdf/13/5d/dddt-9-3589.PMC4507486.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/13/5d/dddt-9-3589.PMC4507486.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/5d/dddt-9-3589.PMC4507486.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/36/dddt-9-3617.PMC4507487.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3617–3624Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3617Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8458 7selective oropharyngeal decontamination versus  selective digestive decontamination in critically ill  patients: a meta-analysis of randomized controlled  trials Di Zhao1,* Jian song2,* Xuan gao3 Fei gao4 Yupeng Wu2 Yingying lu5 Kai hou1 1Department of n eurosurgery,   The First hospital of hebei  Medical University, 2Department  of neurosurgery, 3Department of   neurology, The second hospital of  hebei Medical University, 4hebei  Provincial Procurement centers  for Medical Drugs and Devices,   5Department of neurosurgery, The  second hospital of hebei Medical  University, shijiazhuang People’s  republic of china *These authors contributed equally  to this workBackground:  Selective digestive decontamination (SDD) and selective oropharyngeal  decontamination (SOD) are associated with reduced mortality and infection rates among patients  in intensive care units (ICUs); however, whether SOD has a superior effect than SDD remains  uncertain.",Non-OADS,/arxiv_data1/oa_pdf/0b/36/dddt-9-3617.PMC4507487.pdf
"Keywords:  selective digestive decontamination, selective oropharyngeal decontamination,  intensive care units, meta-analysiscorrespondence: Di Zhao Department of neurosurgery, The First  hospital of hebei Medical University, 89  Donggang road, shijiazhuang, People’s  republic of china Tel +86 133 6383 3833 email 179381749@qq.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhao et al Running head recto: Meta-analysis of RCT to compare SOD with SDD in critically ill patients  DOI: http://dx.doi.org/10.2147/DDDT.S84587",Non-OADS,/arxiv_data1/oa_pdf/0b/36/dddt-9-3617.PMC4507487.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0b/36/dddt-9-3617.PMC4507487.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/36/dddt-9-3617.PMC4507487.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/74/dddt-9-3599.PMC4507488.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3599–3606Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3599Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7981 2Depot injectable biodegradable nanoparticles  loaded with recombinant human bone  morphogenetic protein-2: preparation,  characterization, and in vivo evaluation ali habiballah hassan1 Khaled Mohamed hosny2,3 Zuahir a Murshid1 adel alhadlaq4 ahmed alyamani5 ghada n aguib6 1Department of Orthodontics,   Faculty of Dentistry, 2Department  of Pharmaceutics and industrial  Pharmacy, Faculty of Pharmacy, King  abdulaziz University, Jeddah, saudi  arabia; 3Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, Beni suef University, Beni  suef, egypt; 4Department of Pediatric  Dentistry and Orthodontics, college  of Dentistry, King saud University,   riyadh, 5Department of Oral surgery,   6Department of restorative Dentistry,   Faculty of Dentistry, King abdulaziz  University, Jeddah, saudi arabiaObjective:  The aim of this study is to utilize the biocompatibility characteristics of  biodegradable polymers, viz, poly lactide- co-glycolide (PLGA) and polycaprolactone (PCL),  to prepare sustained-release injectable nanoparticles (NPs) of bone morphogenetic protein-2  (BMP-2) for the repair of alveolar bone defects in rabbits.",Non-OADS,/arxiv_data1/oa_pdf/34/74/dddt-9-3599.PMC4507488.pdf
"Keywords:  BMP-2, biodegradable polymers, nanoparticle, PLGA, PCL, alveolar defects Introduction Bone morphogenetic proteins (BMPs) are members of the transforming growth  factor- β superfamily that act as osteoinductive factors by inducing the differentiation  of osteoblasts from mesenchymal cells.1 Previous studies have shown the ability of  BMPs to induce bone formation in a variety of models having many clinical applica - tions in orthopedics and in oral and maxillofacial/dentistry,2–5 Delivery systems for  growth factors with, for example, biodegradable carriers, are used to achieve slow  and controlled release of the growth factor at the site of implantation.4 These include  collagen, tricalcium phosphate, lactideglycolide copolymers, ehyleneglycol–lactic  acid copolymer, and gelatin hydrogels.2,4–8correspondence: ali habiballah hassan Department of Orthodontics, Faculty of  Dentistry, King abdulaziz University, PO  Box 80209, Jeddah, 21589, saudi arabia email aakbr@kau.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hassan et al Running head recto: Depot injectable biodegradable NPs loaded with rhBMP-2 DOI: http://dx.doi.org/10.2147/DDDT.S79812",Non-OADS,/arxiv_data1/oa_pdf/34/74/dddt-9-3599.PMC4507488.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/74/dddt-9-3599.PMC4507488.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/74/dddt-9-3599.PMC4507488.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3507–3518Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3507Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8477 0effect of Clausena excavata Burm.",Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
"Its leaves and stem are used in folk medicine for treatment disorders such correspondence: noorlidah abdullah institute of Biological sciences, Faculty  of science, University of Malaya,  50603 Kuala lumpur, Malaysia Tel +60 3 7967 4371 email noorlidah@um.edu.m y rasedee abdullah Department of Veterinary Pathology  and Microbiology, Faculty of Veterinary  Medicine, Universiti Putra Malaysia,  43400 serdang, selangor Darul ehsan,  Malaysia email raseede@gmail.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Albaayit et al Running head recto: Effect of Clausena excavata  on cutaneous wound healing in rats DOI: http://dx.doi.org/10.2147/DDDT.S84770",Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
Avail - able from: http://www.ncbi.nlm.nih.gov/books/NBK144065 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/23/dddt-9-3507.PMC4507489.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/ea/bctt-7-183.PMC4507490.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 183–191Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  183Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S8520 2Identification of genes involved in breast cancer  and breast cancer stem cells Panagiotis apostolou Maria T oloudi ioannis Papasotiriou research and Development  Department, research genetic  Cancer Centre ltd, Florina, greece Correspondence: ioannis Papasotiriou   research and Development Department,  research genetic Cancer Centre ltd,  Industrial Area of Florina GR- 53100,  Florina, greece   email papasotiriou.ioannis@rgcc-genlab.",Non-OADS,/arxiv_data1/oa_pdf/c2/ea/bctt-7-183.PMC4507490.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/c2/ea/bctt-7-183.PMC4507490.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/dddt-9-3579.PMC4507491.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3579–3588Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3579Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8504 1Wound healing:  a new perspective on glucosylated  tetrahydrocurcumin adari Bhaskar rao1 ernala Prasad1 seelam siva Deepthi1 Vennapusa haritha1 sistla ramakrishna1 Kuncha Madhusudan1 Mullapudi Venkata surekha2 Yerramilli sri rama  Venkata  rao3 1Medicinal chemistry and  Pharmacology Division, council  of scientific and industrial  research – indian institute of  chemical T echnology, 2Pathology  Division, national institute of  nutrition, 3ashian herbex ltd,   hyderabad, aP , indiaAbstract:  Wound healing represents a dynamic set of coordinated physiological processes  observed in response to tissue injury.",Non-OADS,/arxiv_data1/oa_pdf/ce/24/dddt-9-3579.PMC4507491.pdf
"The smooth progression of all these events leads to  a successful completion of wound healing, and restoration of the disrupted anatomical  continuity and functional state of the skin.6–9 Phenolic compounds of natural origin have been shown to possess potent antioxidant  activity and are also known to accelerate the process of wound healing.10–12 Among  such phytochemicals, the curcuminoids present in the rhizomes of Curcuma longa   have attracted a lot of attention due to their wide application in traditional medications,  food coloration, cosmetics, and the fabric-dying industry.13,14 In addition, curcuminoids  possess a broad range of therapeutic activities, such as anticancer, antiangiogenic,  antimicrobial, antioxidant, anti-inflammatory, and wound healing properties.15–21 correspondence: adari Bhaskar rao Medicinal chemistry and Pharmacology  Division, Council of Scientific and  industrial research – indian institute  of chemical Technology, Tarnaka,  hyderabad 500 007, Telangana, india Tel +91 2719 3374 email adarirao2002@yahoo.co.i n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bhaskar Rao et al Running head recto: Wound healing: glucosylated tetrahydrocurcumin DOI: http://dx.doi.org/10.2147/DDDT.S85041",Non-OADS,/arxiv_data1/oa_pdf/ce/24/dddt-9-3579.PMC4507491.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ce/24/dddt-9-3579.PMC4507491.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/dddt-9-3579.PMC4507491.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/67/amep-6-489.PMC4507492.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 489–495Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  489MEthodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8470 8A framework for clinical reasoning   in adult cardiology Carlos S de la Calzada department of Medicine, Universidad  Complutense de Madrid, Madrid, Spain Correspondence: Carlos S de la Calzada   department of Medicine, Universidad  Complutense de Madrid, Avda de Séneca,  2, Ciudad Universitaria, 28040 Madrid,  Spain   Email cscalzada@hotmail.e sAbstract:  It is well known that an expert clinician formulates a diagnostic hypothesis with little  clinical data.",Non-OADS,/arxiv_data1/oa_pdf/8a/67/amep-6-489.PMC4507492.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/8a/67/amep-6-489.PMC4507492.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/67/amep-6-489.PMC4507492.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/b1/dddt-9-3301.PMC4507493.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3301–3312Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3301Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8171 7synergistic antitumor effect of adenovirus  armed with Drosophila melanogaster   deoxyribonucleoside kinase and nucleoside  analogs for human breast carcinoma in vitro  and in vivo Miao Tang1 cong Zu2 anning he2 Wenqian Wang1 Bo chen1 Xinyu Zheng1,2 1Department of Breast surgery,   The First hospital of china Medical  University, 2laboratory 1, cancer  institute, china Medical University,   shenyang, People’s republic of chinaBackground:  Suicide gene therapy in cancer can selectively kill tumors without damaging  normal tissues.",Non-OADS,/arxiv_data1/oa_pdf/b3/b1/dddt-9-3301.PMC4507493.pdf
"The curative rate of advanced or recurrent breast cancer is correspondence: Xinyu Zheng Department of Breast surgery,   The First hospital of china Medical  University, north nanjing sreet 155,  hepin District, shenyang city 110001,  People’s republic of china Tel +86 24 8328 2348 Fax +86 24 8328 2233 email zhengxyshy@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Tang et al Running head recto: ZD55–dNK combined with DFDC therapy for breast carcinoma DOI: http://dx.doi.org/10.2147/DDDT.S81717",Non-OADS,/arxiv_data1/oa_pdf/b3/b1/dddt-9-3301.PMC4507493.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b3/b1/dddt-9-3301.PMC4507493.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/b1/dddt-9-3301.PMC4507493.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/fe/ccid-8-371.PMC4507494.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 371–388Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  371RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S6913 5Linking diet to acne metabolomics, inflammation,  and comedogenesis: an update Bodo C Melnik Department of Dermatology,   environmental Medicine and Health  Theory, University of Osnabrück,   Germany Correspondence: Bodo C Melnik   Department of Dermatology,  environmental Medicine and Health  Theory, University of Osnabrück,  Sedanstrasse  115, D-49090   Osnabrück, Germany   Tel +49 52 4198 8060  Fax +49 52 412 5801  email melnik@t-online.d eAbstract:  Acne vulgaris, an epidemic inflammatory skin disease of adolescence, is closely  related to Western diet.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/ccid-8-371.PMC4507494.pdf
Or use: http://youtu.be/mEoNubW276 8,Non-OADS,/arxiv_data1/oa_pdf/15/fe/ccid-8-371.PMC4507494.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/ccid-8-371.PMC4507494.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/fe/ccid-8-371.PMC4507494.pdf
"4, 415–419 doi:10.1093/fampra/cmv031 Advance Access publication 8 May 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/fa/cmv031.PMC4507514.pdf
"http://www.mental- health.org.uk/content/assets/PDF/publications/truth_hurts.pdf , published  2006 (accessed on 18 March 2014).",Non-OADS,/arxiv_data1/oa_pdf/8f/fa/cmv031.PMC4507514.pdf
"2013. http://www.cel- logroup.com/pdfs/talking_self_harm.pdf , published 2013 (accessed on 28  May 2014).",Non-OADS,/arxiv_data1/oa_pdf/8f/fa/cmv031.PMC4507514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/0d/ccide-7-075.PMC4507741.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2015:7 75–81Clinical, Cosmetic and Investigational Dentistry Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/c8/0d/ccide-7-075.PMC4507741.pdf
"Or use: http://youtu.be/O00yLpBXiz gDove press submit your manuscript | www.dovepress.co m Dove press  75RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S7608 0Papillon–Lefèvre syndrome: clinical presentation  and management options Basapogu Sreeramulu1 Naragani D vN Shyam2 Pilla Ajay1 Pathipaka Suman1 1Department of Prosthodontics,   2Department of Oral Pathology,   Government Dental College and  Hospital, Hyderabad, T elangana State,   India Correspondence: Basapogu Sreeramulu   Department of Prosthodontics,  Government Dental College and  Hospital, Afzalgunj, Hyderabad,   Telangana State –  500012, India   email drsreeramulub@gmail.co mAbstract:  Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive disorder,  characterized by diffuse palmoplantar keratoderma and precocious aggressive periodontitis,  leading to premature loss of deciduous and permanent dentition at a very young age.",Non-OADS,/arxiv_data1/oa_pdf/c8/0d/ccide-7-075.PMC4507741.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/c8/0d/ccide-7-075.PMC4507741.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c8/0d/ccide-7-075.PMC4507741.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/ae/ccid-8-389.PMC4507742.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 389–396Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  389OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8090 6In vitro antioxidant, collagenase inhibition,   and in vivo anti-wrinkle effects of combined  formulation containing Punica granatum , Ginkgo  biloba , Ficus carica , and Morus alba  fruits extract amal Kumar ghimeray1 Un sun Jung1,2 ha Y oun lee1 Y oung hoon Kim1 eun Kyung ryu1 Moon sik Chang1 1r&D Center, natural solution  Co., ltd, gojan-dong, namdong-gu,   Incheon, republic of Korea;   2Department of horticultural  Biotechnology, Kyung hee University,   Y ongin, republic of Korea Correspondence: Moon sik Chang   r&D Center, natural solution Co., ltd,  158B 11l, #504, 730-10, gojan-dong,  namdong-gu, Incheon, 23050, republic  of Korea   Tel +82 32 812 0530   Fax +82 32 812 0531   email justin0510@naturalsolution.co.k rBackground:  In phytotherapy, the therapeutic potential is based on the combined action of  different herbal drugs.",Non-OADS,/arxiv_data1/oa_pdf/39/ae/ccid-8-389.PMC4507742.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/39/ae/ccid-8-389.PMC4507742.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/ae/ccid-8-389.PMC4507742.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"The gridsOptimized exosome isolation protocol Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"SC: Stirred Cell.Optimized exosome isolation protocol Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"UC: ultracentrifugation; UF: ultraﬁltration.Optimized exosome isolation protocol Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"CL: cell lysate; EQ: ExoQuickTM; ES: Exo-spinTM; qEV: size exclusion columns.Optimized exosome isolation protocol Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2013;2:22390, doi: http://dx.doi.org/10.3402/jev.v2i0.22390 3.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2014;3:24858, doi: http://dx.doi.org/ 10.3402/jev.v3.24858 7.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2012;1: 18374, doi: http://dx.doi.org/10.3402/jev.v1i0.18374 11.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2013;2:19861, doi: http://dx.doi.org/10.3402/jev.v2i0.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"J Extracell Vesicles.2013;2:20389, doi: http://dx.doi.org/10.3402/jev.v2i0.20389 19.",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2014;3:23111, doi: http://dx.doi.org/10.3402/jev.v3.23111 20.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2012;1: 18397, doi: http://dx.doi.org/10.3402/jev.v1i0.18397 22.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"J Extracell Vesicles.2014;3:23430, doi: http://dx.doi.org/10.3402/jev.v3.23430 24.",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"2014;3:25011, doi: http://dx.doi.org/10.3402/jev.v3.25011Optimized exosome isolation protocol Citation: Journal of Extracellular Vesicles 2015, 4: 27031 - http://dx.doi.org/10.3402/jev.v4.27031 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/f0/07/JEV-4-27031.PMC4507751.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"Locations of Sample collection in Bangladesh.Antimicrobial-resistant and ESBL-producing E. coli Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"The genotype, MLST, and clone proﬁle of ESBL producers Sample ID Source (location) Species Antimicrobial-resistant phenotypes ESBL genotype MLST Clone 86 OBS (Padmar Char) E. coli ATM-NA-TE-AMP-CXM CTX-M-15 ST2689 C 88 OBS (Padmar Char) E. coli ATM-NA-TE-AMP-CXM CTX-M-15 ST4016(New) D 7AE.W25 Water (Padma River) E. coli CIP-ATM-NA-TE-AMP-C-CXM-SXT CTX-M-15 ST156 complex 156 B 7BE.W28 Water (Padma River) E. coli CIP-ATM-NA-TE-AMP-C-CXM-SXT CTX-M-15 ST156 complex 156 B 10BE.W40 Water (Buriganga River) E. coli ATM-TE-AMP-CXM-SXT CTX-M-15 ST10 complex 10 D 10BE.W41 Water (Buriganga River) E. coli CN-ATM-NA-TE-AMP-CXM-SXT CTX-M-15 ST46 complex 46 CAntimicrobial-resistant and ESBL-producing E. coli Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
"Clin Microbiol Infect 2011; 17: 1279.Antimicrobial-resistant and ESBL-producing E. coli Citation: Infection Ecology and Epidemiology 2015, 5: 26712 - http://dx.doi.org/10.3402/iee.v5.26712 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a6/1a/IEE-5-26712.PMC4507753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 199–211Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  199Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4604 2Review of advanced catheter technologies in  radiation oncology brachytherapy procedures Jun Zhou1,2 Leonid Zamdborg1 evelyn Sebastian1 1Department of Radiation Oncology,   Beaumont Health System, 2Oakland  University william Beaumont School  of Medicine, Royal Oak, M i, USA Correspondence: Jun Zhou   Department of Radiation Oncology,  Beaumont Health System, Oakland  University william Beaumont School of  Medicine, 3601 west Thirteen Mile Road,  Royal Oak, Mi 48073, USA   Tel +1 248 551 7078   Fax +1 248 551 3784   email jun.zhou@beaumont.or gAbstract:  The development of new catheter and applicator technologies in recent years has sig - nificantly improved treatment accuracy, efficiency, and outcomes in brachytherapy.",Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
Available from: http://www.osti.,Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
Available from: http://www.icru.org/home/reports/ dose-and-volume-specification-for-reporting-intracavitary-therapy-in- gynecology-report-3 8.,Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/23/cmar-7-199.PMC4507789.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1331–1341International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1331RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S8242 0Underrecognized comorbidities of chronic  obstructive pulmonary disease Joanna Miłkowska- Dymanowska1,2 Adam J Białas1,2 Anna Zalewska-Janowska3 Paweł Górski1,2 Wojciech J Piotrowski1,2 1Department of Pneumology and  Allergy, 1st Chair of Internal Medicine,   2Healthy Aging Research Centre  (HARC), 3Unit of Psychodermatology,   Chair of Clinical Immunology and  Microbiology, Medical University  of Lodz, Łódź, PolandAbstract:  COPD is associated with different comorbid diseases, and their frequency increases  with age.",Non-OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
"Comorbidities, like the mere index disease, may represent accelerated aging processes  with shared pathological mechanisms, when chronic systemic inflammation and  oxidative stress result in telomere dysfunction and DNA damage.10–13 Inflammatory  local response to inhaled particles and gases (mostly tobacco smoking) may spread  out of the respiratory tract (the “spill-over” theory) or, alternatively, one common Correspondence: Wojciech J Piotrowski Department of Pneumology and Allergy,  Medical University of Lodz, Kopcińskiego  22, 90-153 Łódź, Poland Tel +48 426 787 505 Fax +48 426 782 129 email wojciech.piotrowski@umed.lodz.p l Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Miłkowska-Dymanowska et al Running head recto: Underrecognized COPD comorbidities DOI: http://dx.doi.org/10.2147/COPD.S82420",Non-OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
Available from: http://web.archive.org/web/20150227051533/http:// www.goldcopd.org.,OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/0c/copd-10-1331.PMC4507790.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/81/dddt-9-3635.PMC4507791.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3635–3644Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3635Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8622 52-acetylphenol analogs as potent reversible  monoamine oxidase inhibitors lesetja J legoabe1 anél Petzer1 Jacobus P Petzer1,2 1centre of excellence for  Pharmaceutical sciences, 2Department  of Pharmaceutical chemistry, school  of Pharmacy, north-West University,   Potchefstroom, south africaAbstract:  Based on a previous report that substituted 2-acetylphenols may be promising  leads for the design of novel monoamine oxidase (MAO) inhibitors, a series of C5-substituted  2-acetylphenol analogs (15) and related compounds (two) were synthesized and evaluated as  inhibitors of human MAO-A and MAO-B.",Non-OADS,/arxiv_data1/oa_pdf/58/81/dddt-9-3635.PMC4507791.pdf
"Although both  isoforms metabolize dopamine in the central nervous system, only MAO-B inhibi - tors are used in Parkinson’s disease, in part because MAO-B activity is higher than  that of MAO-A in the affected region, the basal ganglia.6 MAO-A inhibitors have correspondence: lesetja J legoabe centre of excellence for Pharmaceutical  sciences, north-West University,  Private Bag X6001, Potchefstroom 2520,  south africa Tel +27 18 299 2182 Fax +27 18 299 4243 email lesetja.legoabe@nwu.ac.z a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Legoabe et al Running head recto: 2-acetylphenols as MAO inhibitors DOI: http://dx.doi.org/10.2147/DDDT.S86225",Non-OADS,/arxiv_data1/oa_pdf/58/81/dddt-9-3635.PMC4507791.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/58/81/dddt-9-3635.PMC4507791.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/81/dddt-9-3635.PMC4507791.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/0b/dddt-9-3625.PMC4507792.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3625–3633Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3625Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8603 2a meta-analysis for c-X-c chemokine receptor  type 4 as a prognostic marker and potential drug  target in hepatocellular carcinoma Fei hu lin Miao Yu Zhao Yuan-Yuan Xiao Qing Xu Department of Medical Oncology,   shanghai T enth People’s hospital,   T ongji University, school of Medicine,   shanghai, People’s republic of chinaAbstract:  Chemokines (CKs), small proinflammatory chemoattractant cytokines that bind to  specific G-protein coupled seven-span transmembrane receptors, are major regulators of cell  trafficking and adhesion.",Non-OADS,/arxiv_data1/oa_pdf/bc/0b/dddt-9-3625.PMC4507792.pdf
"However, some other ligands3,4 such as MIF5 can bind and activate CXCR4,  while CXCL12 activates not only CXCR4 but also CXCR7.6 CXCL12–CXCR4 sig - naling has been found to be involved in migration of tumor cells to sites of metastasis  in various malignancies, such as breast, ovarian, prostate, lung, pancreatic, colorectal, correspondence: Fei hu; Qing Xu Department of Medical Oncology,  shanghai Tenth People’s hospital, Tongji  University, school of Medicine, no 301,  Yanchang Zhong road, shanghai 200072,  People’s republic of china email f eihu68@126.co m;   xuqingmd@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hu et al Running head recto: CXCR4 as a potential strategy for HCC patients DOI: http://dx.doi.org/10.2147/DDDT.S86032",Non-OADS,/arxiv_data1/oa_pdf/bc/0b/dddt-9-3625.PMC4507792.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bc/0b/dddt-9-3625.PMC4507792.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/0b/dddt-9-3625.PMC4507792.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1321–1330International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1321OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8866 7What pulmonologists think about the asthma– COPD overlap syndrome Marc Miravitlles,1,2 Bernardino alcázar,3  Francisco Javier alvarez,4 T eresa Bazús,5  Myriam Calle,6 Ciro Casanova,7 Carolina  Cisneros,8 Juan P de-T orres,9 luis M  entrenas,10 Cristóbal esteban,11 Patricia  garcía-sidro,12 Borja g Cosio,13 arturo  huerta,14 Milagros Iriberri,15 José luis  Izquierdo,16 antolín lópez-Viña,17 José  luis lópez-Campos,2,4 eva Martínez- Moragón,18 luis Pérez de llano,19 Miguel  Perpiñá,20 José antonio ros,21 José  serrano,22 Juan José soler-Cataluña,23  alfons T orrego,24 Isabel Urrutia,11  Vicente Plaza24 1Pneumology Department, hospital Universitari  Vall d’hebron, Barcelona, 2CIBer de enfermedades  respiratorias (CIBeres), Madrid, 3respiratory  Department, hospital de alta resolucion de loja,  granada, 4Medical- surgical Unit of respiratory  Diseases, Virgen del rocio University hospital,  Biomedicine Institute of seville (IBis), seville,  5Department of Pneumology, hospital Universitario  Central de asturias, Oviedo, 6Department of  Pneumology, hospital Clínico san Carlos, Madrid,  7Department of Pneumology, hospital nuestra  señora de la Candelaria, santa Cruz de T enerife,  8Department of Pneumology, hospital Universitario  de la Princesa/Instituto de Investigación sanitaria  (IIs-IP), Madrid, 9Pulmonary Department, Clínica  Universidad de navarra, Pamplona, 10Department  of Pneumology, hospital Universitario reina sofia,  Córdoba, 11Department of Pneumology, hospital  galdakao-Usansolo, galdakao, 12Department of  Pneumology, hospital Universitario de la Plana,  Vila-real, 13Department of Pneumology, hospital  Universitario son espases IdIsPa, Palma de Mallorca,  14sección Urgencias Medicina – neumología,  Institut d’Investigacions Biomèdiques august Pi i  sunyer (IDIB aPs), hospital Clinic de Barcelona,  Barcelona, 15Department of Pneumology, hospital  Universitario de Cruces, Bilbao, 16Department of  Pneumology, hospital Universitario de guadalajara,  guadalajara, 17Department of Pneumology, hospital  Universitario Puerta de hierro Majadahonda,  Madrid, 18Department of Pneumology, hospital  Universitario Dr Peset, Valencia, 19Department  of Pneumology, hospital Universitario lucus  augusti, lugo, 20Department of Pneumology,  hospital Universitario y Politécnico la Fe, Valencia,  21Department of Pneumology, hospital Clínico  Universitario Virgen de la arrinxaca, Murcia,  22Department of Pneumology, hospital Comarcal  de Inca, Inca, 23Pneumology Department, hospital  arnau de Vilanova-lliria, Valencia, 24Department of  respiratory Medicine, hospital de la santa Creu  i sant Pau, Institut d’Investigació Biomédica sant Pau  (IIB sant Pau), Department of Medicine, Universitat  autònoma de Barcelona, Barcelona, spainBackground:  Some patients with COPD may share characteristics of asthma; this is the  so-called asthma–COPD overlap syndrome (ACOS).",Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
"The mixed asthma–COPD phenotype  (asthma–COPD overlap syndrome [ACOS]) has been defined as symptoms of increased  variability of airflow in association with incompletely reversible airflow obstruction.6  These patients are of special interest, since they are usually excluded from clinical  trials with medications and also represent a clinically very important population with  particular characteristics: more respiratory symptoms, more frequent exacerbations, Correspondence: Marc Miravitlles Pneumology Department, hospital Universitari Vall  d’hebron, Passeig de la Vall d’hebron 119-129,  Barcelona 08035, spain Tel/fax +34 93 274 6083 email mmiravitlles@vhebron.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Miravitlles et al Running head recto: Asthma–COPD overlap: pulmonologists’ views DOI: http://dx.doi.org/10.2147/COPD.S88667",Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
"Available from: http://www.goldcopd.org/asthma- copd-overlap.htm l. Accessed August 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/copd-10-1321.PMC4507793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/clep-7-325.PMC4507794.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 325–334Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  325Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7861 9Population-based study of the association  between asthma and pneumococcal disease   in children Kimberly M shea1,2 Timothy l lash3,4 sussie antonsen4 susan s Jick1,5 henrik T sørensen1,4 1Department of Epidemiology, Boston  University school of Public health,   2Department of Pediatrics, Boston  University school of Medicine, Boston,   Ma, 3Department of Epidemiology,   rollins school of Public health,   Emory University, atlanta, ga, Usa;   4Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   Denmark;  5Boston Collaborative  Drug surveillance Program, Boston  University, Boston, M a, Usa Correspondence: Kimberly M shea   Department of Epidemiology, Boston  University school of Public health,   715 albany street, Boston,   Ma 02118, Usa   Tel +1 617 638 7725  Fax +1 617 638 4458  Email kimshea@bu.ed uBackground:  Although asthma has recently been established as a risk factor for pneumococcal  disease (PD), few studies have specifically evaluated this association in children.",Non-OADS,/arxiv_data1/oa_pdf/bb/6c/clep-7-325.PMC4507794.pdf
Available  from: http://www.who.int /mediacentre/factsheets/fs307/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/clep-7-325.PMC4507794.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/bb/6c/clep-7-325.PMC4507794.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/27/copd-10-1343.PMC4507795.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1343–1351International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1343OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8433 7Clinical significance of laryngopharyngeal reflux  in patients with chronic obstructive pulmonary  disease Y oung ho Jung1,* Doh Y oung Lee2,* Dong Wook Kim1 sung soo Park3 eun Y oung heo3 Hee Soon Chung3 Deog Kyeom Kim3 1Department of Otorhinolaryngology- Head and Neck Surgery, Seoul  Metropolitan Government-Seoul  National University Boramae Medical  Center, Seoul National University  College of Medicine, 2Department  of Otorhinolaryngology-Head and  Neck Surgery, Anam Hospital, Korea  University Medical Center, 3Division  of Pulmonary and Critical Care  Medicine, Department of Internal  Medicine, seoul Metropolitan  Government-Seoul National  University Boramae Medical Center,   Seoul National University College of  Medicine, Seoul, Republic of Korea *These authors contributed equally  to this workBackground:  Although chronic obstructive pulmonary disease (COPD) is closely associated  with gastroesophageal reflux disease (GERD), the clinical significance of laryngopharyngeal  reflux (LPR) is not fully understood in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/27/copd-10-1343.PMC4507795.pdf
"Although little is known about the prevalence  and role of GERD in COPD, exaggerated intrathoracic pressure shifts, increased fre - quency of coughing, diaphragmatic flattening, and use of β2-agonists are thought to  exacerbate reflux.2,3 However, patients with respiratory disease are often asymptomatic  for reflux, and show isolated abnormal proximal reflux, resulting in symptoms that Correspondence: Deog Kyeom Kim Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, seoul Metropolitan  Government-Seoul National University  Boramae Medical Center, Seoul National  University College of Medicine, 20  Boramaero-5-Gil, Dongjak-Gu, Seoul,  156-707, Republic of Korea Tel +82 2870 2228 Fax +82 2831 2826 email kimdkmd@snu.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Jung et al Running head recto: Laryngopharyngeal reflux in COPD DOI: http://dx.doi.org/10.2147/COPD.S84337",Non-OADS,/arxiv_data1/oa_pdf/a2/27/copd-10-1343.PMC4507795.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/27/copd-10-1343.PMC4507795.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/27/copd-10-1343.PMC4507795.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/4/e1400254/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/e5/fe/1400254.PMC4507831.pdf
Bureau of Labor Statistics American Time Use Survey ; available at http://www.bls.gov/tus/tables.htm.,OADS,/arxiv_data1/oa_pdf/e5/fe/1400254.PMC4507831.pdf
"With the adul T infeCTious diseases no Tes This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/58/3f/idmm-26-119.PMC4507833.pdf
"<http://hepcbc.ca/2015/01/price-abbvie-holkira-pak-hepatitis-c-treatment-canada/> (Accessed May 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/58/3f/idmm-26-119.PMC4507833.pdf
"<http://hepcbc.ca/2014/02/updates-canadian-sofosbuvir-pricing-cadth-queuing-schedule/> (Accessed May 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/58/3f/idmm-26-119.PMC4507833.pdf
"The two-year period before the introduction original arTiCle This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/ae/5a/idmm-26-130.PMC4507837.pdf
"<https://capa-acam.ca/about-pas/> (Accessed May 6, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ae/5a/idmm-26-130.PMC4507837.pdf
"original arTiCle This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/01/2c/idmm-26-133.PMC4507838.pdf
"To further reduce the risk of trans-mission, North American guidelines recommend elective Caesarean original arTiCle This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/24/35/idmm-26-145.PMC4507840.pdf
"<http://hivforumannals.org/index.php/ annals/article/download/12/9 > (Accessed May 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/24/35/idmm-26-145.PMC4507840.pdf
"<http://publications.msss.gouv.qc.ca/acrobat/f/documentation/2006/ 06-271-02W-vol8_no5.pdf> (Accessed May 4, 2014).",Non-OADS,/arxiv_data1/oa_pdf/1d/67/idmm-26-151.PMC4507841.pdf
"<http://nationalphysiciansurvey.ca/> (Accessed May 27, 2014).",Non-OADS,/arxiv_data1/oa_pdf/1d/67/idmm-26-151.PMC4507841.pdf
Produced using a blank map found on Wikimedia Commons (http://commons.wikimedia.org/wiki/File:Chile_ location_map.svg).,Non-OADS,/arxiv_data1/oa_pdf/e0/06/idmm-26-157.PMC4507842.pdf
"<http://www.transfusionmedicine.ca/sites/transfusionmedicine/files/news/2010_Notice_CMAJ.pdf>   (Accessed October 20, 2013).",Non-OADS,/arxiv_data1/oa_pdf/e0/06/idmm-26-157.PMC4507842.pdf
"METHODS Study designThe first phase of the present longitudinal study was conducted at  the beginning of the mass vaccination campaign to assess the deter - minants of parents’ intention to have their child vaccinated with the  4CMenB vaccine (or adolescents’ intention to receive the 4CMenB original arTiCle This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/8f/dd/idmm-26-163.PMC4507843.pdf
2011 [http://edrv.endojournals.org/cgi/content/meeting_abstract/  32/03_MeetingAbstracts/P3-751].,OADS,/arxiv_data1/oa_pdf/27/31/WO-19-24896.PMC4507891.pdf
"Van Cutsem E, Köhne CH, Láng I, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/84/36/WO-19-24876.PMC4507892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/4d/hiv-7-215.PMC4508062.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS - Research and Palliative Care 2015:7 215–222HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  215ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S8200 0Predictors of HIV-test utilization in PMTCT  among antenatal care attendees in government  health centers: institution-based cross-sectional  study using health belief model in Addis Ababa,  ethiopia, 2013 Fikremariam Workagegn getachew Kiros lakew Abebe Health education and Behavioral  Sciences Department, Public and  Medical Sciences College, Jimma  University, Jimma, ethiopia Correspondence: getachew Kiros   Health education and Behavioral Sciences  Department, Public and Medical Sciences  College, Jimma University, Jimma,  ethiopia   email gechove@gmail.co mBackground:  Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome  (AIDS) is the most dramatic epidemic of the century that has claimed over two decades more  than 3 million deaths.",Non-OADS,/arxiv_data1/oa_pdf/38/4d/hiv-7-215.PMC4508062.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/38/4d/hiv-7-215.PMC4508062.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4d/hiv-7-215.PMC4508062.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/a8/ppa-9-961.PMC4508063.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 961–970Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  961OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8476 2The effect of carvedilol and propranolol on  portal hypertension in patients with cirrhosis:  a meta-analysis sheng chen1,* Jin-Jun Wang2,* Qin-Qin Wang1 Jun-Wei hu1 shuang Dong1 li-Juan hu1 Yi-cheng Jian1 Xin-Yan liu2 gen-Mei Yang2 Wu-Jun Xiong1 1Department of hepatology, Tongji  University school of Medicine,   shanghai east hospital, 2Department  of gerontology, shanghai Traditional  chinese Medicine University, shanghai  Putuo central hospital, shanghai,   People’s republic of china *These authors contributed equally  to this workPurpose:  Several randomized controlled clinical trials have been conducted to investigate the  role of carvedilol and propranolol on the effect of portal pressure in patients with cirrhosis,  leading to controversial results.",Non-OADS,/arxiv_data1/oa_pdf/e6/a8/ppa-9-961.PMC4508063.pdf
"Measurement of HVPG can accurately reflect the pressure in  patients with portal hypertension.4 It has been shown that the HVPG should increase  to above 12 mmHg for variceal bleeding.5 A good hemodynamic response is defined  as the reduction of HVPG to a value ,12 mmHg or by $20% from baseline, which  can significantly decrease the risk of bleeding or mortality, presenting a better outcome  than hemodynamic nonresponders.6,7correspondence: Wu-Jun Xiong Department of hepatology, Tongji   University school of Medicine, shanghai  east hospital, shanghai 200120, People’s  republic of china email xxxiongwj@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: The effect of carvedilol and propranolol on portal hypertension DOI: http://dx.doi.org/10.2147/PPA.S84762",Non-OADS,/arxiv_data1/oa_pdf/e6/a8/ppa-9-961.PMC4508063.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e6/a8/ppa-9-961.PMC4508063.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/02/02/opth-9-1291.PMC4508064.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1291–1298Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1291Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8788 7Clinical outcomes of wavefront-guided laser  in situ keratomileusis to treat moderate-to-high  astigmatism steven C schallhorn1,2 Jan a Venter2 stephen J hannan2 Keith a hettinger2 1University of California,  san Francisco, C a, Usa;  2Optical express, glasgow, UKPurpose:  The purpose of this study was to evaluate the refractive and visual outcomes of  wavefront-guided laser in situ keratomileusis (LASIK) in eyes with myopic astigmatism and  cylindrical component $2.0 diopter (D).",Non-OADS,/arxiv_data1/oa_pdf/02/02/opth-9-1291.PMC4508064.pdf
"In this study, we evaluated the results of wavefront-guided (WFG) laser in situ Correspondence: steven C schallhorn 11730 Caminito Prenticia, san Diego,   Ca 92131, Usa email scschallhorn@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Schallhorn et al Running head recto: Myopic astigmatism/wavefront-guided LASIK DOI: http://dx.doi.org/10.2147/OPTH.S87887",Non-OADS,/arxiv_data1/oa_pdf/02/02/opth-9-1291.PMC4508064.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/02/02/opth-9-1291.PMC4508064.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/02/opth-9-1291.PMC4508064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/46/ppa-9-1005.PMC4508065.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 1005–1016Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1005OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8220 3Older adults’ preferences for colorectal   cancer-screening test attributes and test choice christine e Kistler1–3 Thomas M hess4 Kirsten howard5,6 Michael P Pignone2,3,7 Trisha M crutchfield2,3,8 sarah T hawley9 Alison T Brenner2 Kimberly T Ward2 carmen l lewis10 1Department of Family Medicine,   school of Medicine, 2cecil g sheps   center for health services research,   3lineberger comprehensive cancer  center, University of north  carolina at chapel hill, chapel hill,   4Department of Psychology, north  carolina state University, raleigh,   nc, UsA; 5institute for choice,   University of south Australia, sydney,   nsW, Australia; 6school of Public  health, University of sydney, sydney,   nsW, Australia; 7Division of general  internal Medicine, school of Medicine,   8center for health Promotion and  Disease Prevention, University of  north carolina at chapel hill, chapel  hill, nc, 9Department of Medicine,   University of Michigan, Ann Arbor,   Mi, 10Division of general internal  Medicine, Department of Medicine,   University of colorado school of  Medicine, Aurora, cO, UsABackground:  Understanding which attributes of colorectal cancer (CRC) screening tests drive  older adults’ test preferences and choices may help improve decision making surrounding CRC  screening in older adults.",Non-OADS,/arxiv_data1/oa_pdf/9b/46/ppa-9-1005.PMC4508065.pdf
"However, the evidence  on how to improve patient–provider discussions about CRC screening is limited.6correspondence: christine e Kistler Department of Family Medicine,  University of north carolina at chapel  hill, 590 Manning Drive – cB 7595,  chapel hill, nc 27599, UsA Tel +1 919 395 8621 Fax +1 919 966 6126 email christine_kistler@med.unc.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kistler et al Running head recto: Older adult preferences for colorectal cancer screening DOI: http://dx.doi.org/10.2147/PPA.S82203",Non-OADS,/arxiv_data1/oa_pdf/9b/46/ppa-9-1005.PMC4508065.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9b/46/ppa-9-1005.PMC4508065.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/30/ijn-10-4479.PMC4508066.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4479–4490International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4479OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8493 0Magnetic resonance-guided regional gene delivery  strategy using a tumor stroma-permeable  nanocarrier for pancreatic cancer Qingbing Wang1,2 Jianfeng li3 sai an3 Yi chen1 chen Jiang3 Xiaolin Wang1,2 1Department of Interventional  radiology, Zhongshan hospital,   Fudan University, 2shanghai Institute  of Medical Imaging, 3Key laboratory  of smart Drug Delivery, Ministry  of  education, Department of  Pharmaceutics, school of Pharmacy,   Fudan University, shanghai, People’s  republic of chinaBackground:  Gene therapy is a very promising technology for treatment of pancreatic ductal  adenocarcinoma (PDAC).",Non-OADS,/arxiv_data1/oa_pdf/1d/30/ijn-10-4479.PMC4508066.pdf
"The continuous iden - tification of molecular changes that deregulate pivotal pathways in pancreatic tumor  cells has provided a large number of novel candidates for PDAC gene therapy.2 At  this point, development of a safe and effective gene delivery strategy is the major correspondence: Xiaolin Wang Department of Interventional radiology,  Zhongshan hospital, Fudan University,  180 Fenlin road, shanghai 200032,  People’s republic of china Tel/fax +86 21 6403 7258 email  wangdoctorzsh@yahoo.co m  chen Jiang Department of Pharmaceutics, school  of Pharmacy, Fudan University, 826  Zhangheng road, shanghai 201203,  People’s republic of china Tel/fax +86 21 5198 0079 email jiangchen@ shmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: MR-guided gene delivery using a nanocarrier for PDAC DOI: http://dx.doi.org/10.2147/IJN.S84930",Non-OADS,/arxiv_data1/oa_pdf/1d/30/ijn-10-4479.PMC4508066.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1d/30/ijn-10-4479.PMC4508066.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/30/ijn-10-4479.PMC4508066.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/79/vhrm-11-387.PMC4508067.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 387–395Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  387ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7022 9Supera self-expanding stents for endovascular  treatment of femoropopliteal disease: a review   of the clinical evidence Kalkidan Bishu1,2 ehrin J Armstrong1,2 1Division of Cardiology, University of  Colorado, Aurora,  2Denver VA Medical  Center, Denver, CO, USA Correspondence: ehrin J Armstrong   Denver VA Medical Center,   1055 Clermont Street, Denver,   CO 80220, USA   email e hrin.armstrong@gmail.co mAbstract:  Femoropopliteal lesions account for a significant proportion of endovascular inter - ventions for peripheral artery disease in patients with disabling claudication or chronic limb  ischemia.",Non-OADS,/arxiv_data1/oa_pdf/91/79/vhrm-11-387.PMC4508067.pdf
"Available  from: http://www.accessdata.fda.gov/cdrh_docs/pdf12/P120020b.pd f.  Accessed May 21, 2015.",OADS,/arxiv_data1/oa_pdf/91/79/vhrm-11-387.PMC4508067.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/91/79/vhrm-11-387.PMC4508067.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/79/vhrm-11-387.PMC4508067.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1695–1701Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1695OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8188 4Microribonucleic acid dysregulations in children  and adolescents with obsessive–compulsive  disorder hasan Kandemir1 Mehmet emin erdal2 salih selek3 Özlem İzci ay2 İbrahim Fatih Karababa4 Mustafa ertan ay2 Sultan Basmacı Kandemir5 Şenay Görücü Yılmaz2 suat ekinci6 Bahar Taşdelen7 Hüseyin Bayazit4 1Department of child and adolescent  Psychiatry, Faculty of Medicine,   Harran University, Şanlıurfa, T urkey;   2Department of Medical Biology and  genetics, Faculty of Medicine, Mersin  University, Mersin, T urkey; 3harris  county Psychiatric center, University  of T exas health science center at  Houston, TX, USA; 4Department  of Psychiatry, Faculty of Medicine,   Harran University, Şanlıurfa, T urkey;   5Department of Psychiatry, Balıklıgöl  State Hospital, Şanlıurfa, T urkey;   6Department of Psychiatry, Balıklı  Rum Hospital, Istanbul, T urkey;   7Department of Biostatistics, Faculty  of Medicine, Mersin University, Mersin,   T urkeyAim:  Obsessive–compulsive disorder (OCD) is a disorder characterized by the presence of  obsessions and/or compulsions.",Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
"More than 80% of patients diagnosed  with OCD report that related symptoms began before the age of 18 years.6 In terms of symptoms, OCD is heterogenous in its clinical appearance.7 Phenotypic  differences suggest that genetic, environmental, psychological, social, and biochemical  factors are involved in the etiology.8,9 Genetic factors have been thought of as impor - tant in the development of OCD.10 It is estimated that OCD symptom heritability is  between 45% and 65% in children, and between 27% and 47% in adults.11 Molecular  genetic studies of OCD have usually focused on the monoamine pathway genes.12–15 correspondence: hasan Kandemir Department of child and adolescent  Psychiatry, Faculty of Medicine, harran  University, Yemisehir, 63100 Şanliurfa,  Turkey Tel +90 414 318 3000 Fax +90 414 318 3190 email kandemirhsn@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kandemir et al Running head recto: miRNA dysregulations in youth with obsessive compulsive disorder DOI: http://dx.doi.org/10.2147/NDT.S81884",Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
"Available from: http://www3.appliedbiosystems.com/cms/groups/ mcb_marketing/documents/generaldocuments/cms_044972.pdf  Accessed August 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8d/cb/ndt-11-1695.PMC4508068.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/8e/ijn-10-4459.PMC4508069.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4459–4478International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4459OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8312 3Optimization, ex vivo permeation, and stability  study of lipid nanocarrier loaded gelatin capsules  for treatment of intermittent claudication Marwa ahmed sallam1 María T eresa Marín Boscá2 1Department of Industrial Pharmacy,   Faculty of Pharmacy, alexandria  University, alexandria, egypt;   2Department of Pharmacy and  Pharmaceutical Technology, Faculty  of Pharmacy, granada University,   granada, spainAbstract:  In this study, an optimized nanodispersible oral dosage form (containing a lactate  ester) was developed for cilostazol (CZL).",Non-OADS,/arxiv_data1/oa_pdf/26/8e/ijn-10-4459.PMC4508069.pdf
"The latter systems are isotropic mixtures correspondence: Marwa ahmed sallam Department of Industrial Pharmacy,  Faculty of Pharmacy, alexandria  University, PO Box 21521, 1 Midan  alkhartoom square, alazarita,  alexandria, egypt Tel +20 100 537 2143 Fax +20 3 4873 273 email dr_marwasallam@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sallam and Marín Boscá Running head recto: Optimization and stability of lipid nanocarrier for intermittent claudication DOI: http://dx.doi.org/10.2147/IJN.S83123",Non-OADS,/arxiv_data1/oa_pdf/26/8e/ijn-10-4459.PMC4508069.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/26/8e/ijn-10-4459.PMC4508069.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/8e/ijn-10-4459.PMC4508069.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1719–1720OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1719LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7908 9A tale of the two PeGylated liposomal  doxorubicins Correspondence: Jacqueline M Liu 16F-2, No.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
"Disclosure The authors report no conflicts of interest in this communication.Journal name: OncoTargets and Therapy Article Designation: Letter Y ear: 2015 Volume: 8 Running head verso: Chou et al Running head recto: PEGylated liposomal doxorubicins DOI: http://dx.doi.org/10.2147/OTT.S79089 Table 1  Clinical trials reporting single-agent liposomal doxorubicin therapy for refractory  ovarian cancer, with dosage, response, survival, and toxicity information Ovarian   cancerPatients   (n)Dose/   4 weeksORR PFS/OS   monthsGrade   3+4 toxicity Berger et al1Lipodox®recurrent 18 30 mg/m20 2.8/Nr Neutropenia  5.6% Lin et al6Lipo-Dox®CDDP-resistant   and paclitaxel- resistant18 40 mg/m227.8%, three   Cr, two Pr3.5/12 0 Chou et al4Lipo-Dox resistant/   refractory29 45 mg/m223%, one Cr,   five PR5.4/13.8 Neutropenia  12% Abbreviations:  Cr, complete response; Pr, partial response; Orr, overall response rate; PFS, progression-free  survival; OS, overall survival; Nr, not reached; CDDP, diamminedichloroplatinum(II).",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
"Available  from:  http://www.fda.gov/newsevents/newsroom/pressannouncements/ ucm337872.ht m. Accessed February 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/ott-8-1719.PMC4508070.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1735–1741OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1735Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8633 8single nucleotide polymorphisms of microrna  processing genes and outcome of non-hodgkin’s  lymphoma Yuhuan gao1 lanping Diao1 huan li1 Zhanjun guo2 1Department of hematology,   2Department of gastroenterology and  hepatology, The Fourth hospital of  hebei Medical University, shijiazhuang,   People’s republic of chinaObjective:  microRNA (miRNA)-related single nucleotide polymorphisms (miR-SNPs) in  miRNA-processing machinery genes can affect cancer risk, treatment efficacy, and patients’  prognosis by mediating the expression of targeted genes.",Non-OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
"They are also  responsible for regulating the expression of at least 30% of protein-coding genes.7–9  miRNA is implicated in a broad range of biological processes, such as embryonic  development, cellular differentiation, proliferation, apoptosis, cancer development, correspondence: Zhanjun guo Department of gastroenterology and  hepatology, The Fourth hospital of  hebei Medical University, 12 Jiankang  road, shijiazhuang 050011, People’s  republic of china Tel +86 311 8609 5342 email zjguo5886@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Gao et al Running head recto: rs197412 and NHL outcome DOI: http://dx.doi.org/10.2147/OTT.S86338",Non-OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
"genotyping of mir-snPs The miR-SNP of the miRNA processing genes including  XPO5  (rs11077), RAN  (rs14035), TNRC6B (rs9623117),  GEMIN3 (rs197412), and GEMIN4 (rs2740348) were  genotyped using the ligase detection reaction method,  using forward and reverse primers to amplify the DNA  fragments that flank the miR-SNPs based on the National  Center for Biotechnology Information (NCBI) SNP data - base ( http://www.ncbi.nlm.nih.gov/snp /).",OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/5d/ott-8-1735.PMC4508071.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/cf/ppa-9-989.PMC4508072.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 989–998Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  989OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8015 8Qualitative evaluation of adherence therapy in  Parkinson’s disease: a multidirectional model David James Daley1,2 Katherine helen O’ leary  Deane3 richard John gray4 rebekah hill3 Phyo Kyaw Myint5 1norwich Medical school, Faculty  of Medicine and health sciences,   University of east Anglia, norwich  research Park, 2norfolk and norwich  University hospital nhs Foundation  Trust, 3school of health sciences,   University of east Anglia, norwich  research Park, norwich, UK; 4hamad  Medical corporation, Doha, Qatar;   5epidemiology group, school of  Medicine and Dentistry, institute of  Applied health sciences, college of  life sciences and Medicine, University  of Aberdeen, Aberdeen, UKBackground:  Medication can control the symptoms of Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/f3/cf/ppa-9-989.PMC4508072.pdf
"Through a randomized controlled trial (RCT; ISRCTN07830951),5  we recently reported the efficacy of a novel intervention, ie, adherence therapy (AT), correspondence: David James Daley norwich Medical school, Faculty of  Medicine and health sciences, University  of east Anglia, norwich, nr4 7TJ, UK Tel +44 1603 286 143 email d.daley@uea.ac.u k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Daley et al Running head recto: Adherence therapy in PD: a multidirectional model DOI: http://dx.doi.org/10.2147/PPA.S80158",Non-OADS,/arxiv_data1/oa_pdf/f3/cf/ppa-9-989.PMC4508072.pdf
"Available from: http://www.academia.edu/2436503/Adherence_   therapy_manua l. Accessed June 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f3/cf/ppa-9-989.PMC4508072.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f3/cf/ppa-9-989.PMC4508072.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/fa/ndt-11-1685.PMC4508073.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1685–1693Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1685OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8528 8relationship between apathy and tumor location,  size, and brain edema in patients with intracranial  meningioma Yihua Peng1,* chunhong shao1,* Ye gong2 Xuehai Wu2 Weijun Tang3 shenxun shi1 1Psychiatry Department,   2Neurosurgery Department,   3radiology Department, huashan  hospital, Fudan University, People’s  republic of china *These authors contributed equally  to this workBackground:  The purpose of this study is to assess the relationship between apathy and tumor  location, size, and brain edema in patients with intracranial meningioma.",Non-OADS,/arxiv_data1/oa_pdf/c9/fa/ndt-11-1685.PMC4508073.pdf
"Keywords:  apathy, Apathy Evaluation Scale, meningioma, edema, location, size Introduction Apathy, defined by Marin as a neuropsychiatric syndrome due to lack of motivation,1  could present in several diseases, including schizophrenia, Alzheimer’s disease, correspondence: shenxun shi Psychiatry Department, huashan  hospital, 12 Wulumuqi road (Middle),  shanghai 200040, People’s republic of  china Tel +86 21 5288 8153 email drshishenxun@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Peng et al Running head recto: Apathy and frontal meningioma DOI: http://dx.doi.org/10.2147/NDT.S85288",Non-OADS,/arxiv_data1/oa_pdf/c9/fa/ndt-11-1685.PMC4508073.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c9/fa/ndt-11-1685.PMC4508073.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/fa/ndt-11-1685.PMC4508073.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/opth-9-1269.PMC4508074.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1269–1274Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1269Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8070 4evaluation of the effect of intravitreal ranibizumab  injections in patients with neovascular age related  macular degeneration on retinal nerve fiber layer  thickness using optical coherence tomography Mohamed F el-ashry1–3 gerassimos lascaratos1 Baljean Dhillon1,4 1Princess alexandra eye Pavilion,   edinburgh, UK; 2Ophthalmology  Department, Tanta University  hospital, Tanta, egypt; 3north Cumbria  University hospital, Carlisle, UK;   4Centre for Clinical Brain sciences,   school of Clinical sciences, University  of edinburgh, edinburgh, UKPurpose:  To evaluate the effect of repeated intravitreal ranibizumab injections for neovascular  age related macular degeneration (nAMD) on the retinal nerve fiber layer (RNFL) thickness  using optical coherence tomography.",Non-OADS,/arxiv_data1/oa_pdf/87/d2/opth-9-1269.PMC4508074.pdf
"Keywords:  optical coherence tomography, anti-VEGF, intraocular pressure, ranibizumab,  retinal nerve fiber layer Introduction Neovascular age related macular degeneration (nAMD), characterized by new forma - tion of choroidal vessels into the sub-retinal space,1 is responsible for nearly 90% of  severe vision loss among elderly people in the developed world.2 Vascular endothelial  growth factor (VEGF)-A is a key contributory factor in the pathophysiology underly - ing nAMD.3 Several studies have shown that the rise in ocular VEGF levels is linked  to the initiation of neovascularization, which is the first step in the pathogenesis of  nAMD in both humans3 and animals.4,5Correspondence: Mohamed F el-ashry Flat 6, 4 hill square, edinburgh,  eh8 9Dr, UK email elashrymohamed@yahoo.co.u kJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: El-Ashry et al Running head recto: Effect of ranibizumab on RNFL thickness DOI: http://dx.doi.org/10.2147/OPTH.S80704",Non-OADS,/arxiv_data1/oa_pdf/87/d2/opth-9-1269.PMC4508074.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/87/d2/opth-9-1269.PMC4508074.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/opth-9-1269.PMC4508074.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/40/tcrm-11-1047.PMC4508075.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 1047–1059Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1047ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8006 0Vasopressors in septic shock: a systematic review  and network meta-analysis Feihu Zhou1,* Zhi Mao1,* Xiantao Zeng2,* hongjun Kang1 hui liu1 liang Pan1 Peter C hou3 1Department of Critical Care  Medicine, Chinese People’s liberation  army general hospital, Beijing,   2Center for evidence-Based and  Translational Medicine, Zhongnan  hospital, Wuhan University,   Wuhan, People’s Republic of China;   3Department of emergency Medicine,   Brigham and Women’s hospital,   harvard Medical school, Boston, M a,   Usa *These authors contributed equally   to the paperObjective:  Vasopressor agents are often prescribed in septic shock.",Non-OADS,/arxiv_data1/oa_pdf/b5/40/tcrm-11-1047.PMC4508075.pdf
"However, vasopressor  agents are also critical to achieve and maintain adequate blood pressure and tissue  perfusion, and hence, should be used early.3 Sakr et al4 reported that the most fre - quently used vasopressor agent during septic shock was norepinephrine (NE, 80.2%),  Correspondence: Feihu Zhou Department of Critical Care Medicine,  Chinese People’s liberation army  general hospital, 28 Fu-Xing Road,  Beijing 100853, People’s Republic  of China Tel +86 10 6693 8148 Fax +86 10 8821 9862 email zhoufh301@126.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhou et al Running head recto: Vasopressors in septic shock DOI: http://dx.doi.org/10.2147/TCRM.S80060",Non-OADS,/arxiv_data1/oa_pdf/b5/40/tcrm-11-1047.PMC4508075.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b5/40/tcrm-11-1047.PMC4508075.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/40/tcrm-11-1047.PMC4508075.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/06/ott-8-1707.PMC4508076.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1707–1717OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1707Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8589 9The prognostic significance of protein tyrosine  phosphatase 4a2 in breast cancer Duanzheng Zhao1 libin guo2,* henrique neves3,* hiu-Fung Yuen4 shu-Dong Zhang5 cian M Mccrudden6 Qing Wen5 Jin Zhang2 Qi Zeng4 hang Fai Kwok3,5,6 Yao lin2 1College of Continuing Education,   Nanjing University of Aeronautics  and astronautics, nanjing, Jiangsu,   People’s Republic of China; 2college  of Life Sciences, Fujian Normal  University, Fuzhou, Fujian, People’s  Republic of China; 3Faculty of Health  Sciences, University of Macau, Avenida  de Universidade, Taipa, Macau special  administrative region, People’s  Republic of China; 4Institute of  Molecular and cell Biology, Biopolis  Drive, Proteos, Singapore; 5center  for Cancer Research and Cell  Biology, 6School of Pharmacy, Queen’s  University of Belfast, Belfast, UK *These authors have contributed  equally to this workAbstract:  Although PTP4A3  has been shown to be a very important factor in promoting cancer  progression, the role of its close family member PTP4A2  is still largely unknown.",Non-OADS,/arxiv_data1/oa_pdf/e3/06/ott-8-1707.PMC4508076.pdf
"These  contradictory findings on the role of PTP4A2  in breast cancer progression led us to  investigate the prognostic significance of PTP4A2  gene expression in five publicly correspondence: hang Fai Kwok Faculty of Health Sciences,  University of Macau, Avenida de  Universidade, Taipa, Macau special  administrative region email hfkwok@umac.m o  Yao lin College of Life Sciences, Fujian Normal  University, Fuzhou, Fujian 350117,  People’s Republic of China email yaolin@fjnu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao et al Running head recto: Protein tyrosine phosphatase 4A2 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S85899",Non-OADS,/arxiv_data1/oa_pdf/e3/06/ott-8-1707.PMC4508076.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/06/ott-8-1707.PMC4508076.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/06/ott-8-1707.PMC4508076.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/84/mder-8-297.PMC4508077.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 297–303Medical Devices: Evidence and Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/24/84/mder-8-297.PMC4508077.pdf
"Or use: http://youtu.be/xezrgccP54 oDove press submit your manuscript | www.dovepress.co m Dove press  297REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S4936 8Current perspectives in percutaneous atrial septal  defect closure devices N Bissessor1–4 1Department of Cardiology, The  Epworth Hospital, Melbourne, viC,  Australia;  2Division of interventional  Cardiology, The Alfred Hospital,  Melbourne, viC, Australia;   3Department of Clinical Science,  Charles Sturt University Albury  Campus, NSw, Australia ; 4Heart  Foundation, Griffith University, QLD,  Australia Correspondence: N Bissessor   Department of Cardiology, The Epworth  Hospital, 89 Bridge Rd, Richmond viC  3121, Australia   Tel +61 3 9426 6666  Fax +61 2 6021 5001  Email naylinbissessor@hotmail.co mAbstract:  In the last decade, percutaneous atrial septal defect (ASD) closure has become  the treatment of choice in most clinical presentations of ASD.",Non-OADS,/arxiv_data1/oa_pdf/24/84/mder-8-297.PMC4508077.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 303ASD closure: current perspectives active and cognitively intact elderly are offered ASD closure.,Non-OADS,/arxiv_data1/oa_pdf/24/84/mder-8-297.PMC4508077.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 1061–1075Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1061Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7913 5Adverse drug reactions and drug–drug  interactions with over-the-counter NSAiDs Nicholas Moore1 Charles Pollack2 Paul Butkerait2 1Department of Pharmacology,   Université de Bordeaux, Bordeaux,   France; 2Pfizer Consumer Healthcare,   Madison, NJ, USAAbstract:  Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen have a long  history of safe and effective use as both prescription and over-the-counter (OTC) analgesics/ antipyretics.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"In the process, Correspondence: Nicholas Moore Department of Pharmacology, U657,  Université de Bordeaux, 146 rue Leo  Saignat, F-33076, Bordeaux, France Tel +33 5 5757 1560 Fax +33 5 5757 4671 email nicholas.moore@pharmaco.u- bordeaux2.f rJournal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Moore et al Running head recto: Drug reactions and interactions with OTC NSAIDs DOI: http://dx.doi.org/10.2147/TCRM.S79135",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"Available from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials /Drugs/ArthritisAdvisoryCommittee/ UCM395527.pd f. Accessed September 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"Available from: http://medicine.iupui.edu/clinpharm/ddis/table.asp x.  Accessed March 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"Available from: http://www.fda.gov/Drugs/Drug - Safety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm125222.ht m. Accessed March 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/de/tcrm-11-1061.PMC4508078.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/6d/hmer-7-043.PMC4508079.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHepatic Medicine: Evidence and Research 2015:7 43–50Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  43REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S6246 3Management options in decompensated cirrhosis Neeral L Shah1 Yasmin Pourkazemi Banaei2 Kristen L Hojnowski2 Scott L Cornella3 1Division of Gastroenterology and  Hepatology, 2School of Medicine,   3Department of Medicine, University  of virginia, Charlottesville, vA, USA Correspondence: Neeral L Shah   Division of Gastroenterology and  Hepatology, University of virginia,  west Complex, 2nd Floor,   PO Box 800708, Charlottesville,   vA 22908, USA   Tel +1 434 924 2626   Fax +1 434 244 7586   Email neeral.shah@virginia.ed uAbstract:  Chronic injury to the liver from a variety of different sources can result in irreversible  scarring of the liver, known as cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/3f/6d/hmer-7-043.PMC4508079.pdf
"Available from: http://www.cdc.gov/vaccines/adults/rec­vac/ health­conditions/liver ­disease.htm l. Accessed March 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3f/6d/hmer-7-043.PMC4508079.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer ­ reviewed, open access journal covering all aspects of adult and pedi ­ atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/3f/6d/hmer-7-043.PMC4508079.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/6d/hmer-7-043.PMC4508079.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/opth-9-1299.PMC4508080.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1299–1305Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1299CASE SERIESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8370 1Detection of pigment epithelial detachment  vascularization in age-related macular degeneration  using phase-variance OCT angiography Scott M McClintic1 Dae Yu Kim2 Jeff Fingler3 Susan Garcia4 Robert J Zawadzki4 Lawrence S Morse4 Susanna S Park4 Scott E Fraser3 John S Werner4 Jason P Ruggiero5 Daniel M Schwartz6 1Department of Ophthalmology,   Casey Eye Institute, Oregon Health  and Science University, Portland,   OR, USA; 2Beckman Laser Institute  Korea and Department of Biomedical  Engineering, Dankook University,   Cheonan, South Korea; 3Translational  Imaging Center, University of  Southern California, Los Angeles,   CA, 4Department of Ophthalmology  and Vision Science, University of  California Davis, Sacramento, CA,   5Retina Associates, PC, Winchester,   VA, 6Department of Ophthalmology  and Vision Science, University  of California San Francisco, San  Francisco, CA, USAPurpose:  To demonstrate the use of phase-variance optical coherence tomography (PV -OCT)  angiography for detection of pigment epithelial detachment (PED) vascularization in age-related  macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/opth-9-1299.PMC4508080.pdf
"Correspondence: Daniel M. Schwartz,  Department of Ophthalmology and Vision  Science, University of California San  Francisco, 10 Koret Way, Room K219,  San Francisco, CA 94143-0730 USA  Tel +1 415 476 1152  Email dan.schwartz@ucsf.ed u Journal name: Clinical Ophthalmology Article Designation: CASE SERIES Y ear: 2015 Volume: 9 Running head verso: McClintic et al Running head recto: Detection of PED vascularization using phase-variance OCT angiography DOI: http://dx.doi.org/10.2147/OPTH.S83701",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/opth-9-1299.PMC4508080.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/opth-9-1299.PMC4508080.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/opth-9-1299.PMC4508080.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/42/vhrm-11-397.PMC4508081.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 397–401Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  397ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S8141 1Feasibility and safety of rehabilitation after venous  thromboembolism Frank noack1,2 Bernd schmidt1 Mroawan amoury2 Dietrich stoevesandt3 stephan gielen4 Birgit Pflaumbaum5 christiane girschick5 Heinz Völler6 axel schlitt5,7 1Department of Medicine i,   2Department of emergency Medicine,   3Department of Diagnostic Radiology,   4Department of Medicine iii,   University clinic Halle (saale), Halle,   germany; 5Department of cardiology  and Pulmology, Paracelsus-Harz- clinic Bad suderode, Quedlinburg,   germany; 6Klinik am see, Rüdersdorf,   germany; 7Medical Faculty, Martin  luther University Halle, Wittenberg,   germany correspondence: axel schlitt   Department of cardiology and  Pulmology, Paracelsus-Harz-clinic Bad  suderode, 06485 Quedlinburg, germany   Tel +49 394 859 9900   Fax +49 394 859 9812   email prof.dr.axel.schlitt@paracelsus- kliniken.d eBackground:  Venous thromboembolism is a life-threatening disease.",Non-OADS,/arxiv_data1/oa_pdf/46/42/vhrm-11-397.PMC4508081.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/46/42/vhrm-11-397.PMC4508081.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/42/vhrm-11-397.PMC4508081.pdf
Available from: http://www.awmf.org/leitlinien/detail/ll/065- 002.htm l.  14.,Non-OADS,/arxiv_data1/oa_pdf/46/42/vhrm-11-397.PMC4508081.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/dd/ndt-11-1703.PMC4508082.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1703–1711Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1703OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8554 0attitudes of psychiatrists toward obsessive– compulsive disorder patients Pichaya Kusalaruk ratana saipanish Thanita hiranyatheb Department of Psychiatry, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok, ThailandPurpose:  Negative attitudes from doctors and the resulting stigmatization have a strong impact  on psychiatric patients’ poor access to treatment.",Non-OADS,/arxiv_data1/oa_pdf/03/dd/ndt-11-1703.PMC4508082.pdf
"Only approximately one-third of OCD patients receive  appropriate pharmacotherapy, and fewer than 10% receive evidence-based psycho - therapy.1 As OCD patients often acknowledge the senseless nature of their intrusive,  recurrent thoughts and also the repetitive, unwanted behaviors, it may lead to shame,  and reluctance to seek help.2 People with this disorder have long delays in accessing  effective treatments; 17 years on average in one study.2 There is growing evidence  that stigmatization and negative attitudes toward mental disorders are important fac - tors that prevent these patients from seeking appropriate medical help.3–7 Aversion to  psychiatric treatment and ambivalence about mental health services because of the  fear of labeling and stigma have been found throughout the world.8correspondence: Pichaya Kusalaruk Department of Psychiatry, Faculty of  Medicine, ramathibodi hospital, Mahidol  University, 270 rama Vi road, Phayathai,  ratchathewi, Bangkok 10400, Thailand Tel +66 2 201 1929 Fax +66 2 354 7299 email pichaya.kus@mahidol.ed uJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kusalaruk et al Running head recto: Attitudes of psychiatrists toward OCD patients DOI: http://dx.doi.org/10.2147/NDT.S85540",Non-OADS,/arxiv_data1/oa_pdf/03/dd/ndt-11-1703.PMC4508082.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/03/dd/ndt-11-1703.PMC4508082.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/dd/ndt-11-1703.PMC4508082.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2015:8 63–73Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  63Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S70066early childhood wheezers: identifying asthma in  later life Anayansi Lasso-Pirot Silvia Delgado-villalta Adam J Spanier Department of Pediatrics, University  of Maryland School of Medicine,   Baltimore, MD, USA Correspondence: Adam J Spanier   University of Maryland Midtown Campus,  300 Armory Place, Suite 2B2042,  Baltimore, MD 21201, USA   Tel +1 410 856 3828   Fax +1 410 856 3897   email aspanier@peds.umaryland.ed uAbstract:  Wheeze in young children is common, and asthma is the most common non- communicable disease in children.",Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
"Available from: http://ebookoninternet.com/1814854/ quantification-effects-air-pollution-health-united-kingdom-committee- medical-effects-air-pollutants.htm l. Accessed March 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
Available from: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/53/jaa-8-063.PMC4508083.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/vhrm-11-403.PMC4508084.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 403–415Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  403ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S6479 8Preeclampsia: long-term consequences for  vascular health Lorena M Amaral Mark w Cunningham Jr Denise C Cornelius Babbette LaMarca Department of Pharmacology,   University of Mississippi Medical  Center, Jackson, MS, USA Correspondence: Babbette LaMarca   Division of Maternal Fetal Medicine,  Department of Pharmacology, Physiology,  Obstetrics and Gynecology, Center for  excellence in Renal and Cardiovascular  Research, University of Mississippi  Medical Center, 2500 North State Street,  Jackson MS, 39216, USA   Tel +1 601 815 1430   email bblamarca@umc.ed uAbstract:  Preeclampsia (PE) is a pregnancy-specific syndrome and one of the leading causes  of preterm birth, neonatal and maternal morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/vhrm-11-403.PMC4508084.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/vhrm-11-403.PMC4508084.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/vhrm-11-403.PMC4508084.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/32/ijn-10-4491.PMC4508085.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4491–4505International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4491OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8349 3respiratory syncytial virus-like nanoparticle  vaccination induces long-term protection without  pulmonary disease by modulating cytokines  and T -cells partially through alveolar macrophages Y oung-Tae lee1,*  eun-Ju Ko1,2,* hye suk hwang1,2 Jong seok lee1,3 Ki-hye Kim1 Y oung-Man Kwon1  sang-Moo Kang1,2 1center for Inflammation, Immunity  and Infection, Institute for Biomedical  sciences, 2Department of Biology,   georgia state University, atlanta, ga,   Usa; 3National Institute of Biological  resources, Incheon, south Korea *These authors contributed equally   to this workAbstract:  The mechanisms of protection against respiratory syncytial virus (RSV) are poorly  understood.",Non-OADS,/arxiv_data1/oa_pdf/9d/32/ijn-10-4491.PMC4508085.pdf
"Newcastle disease virus-based or  recombinant baculovirus-expressed VLPs containing RSV F and/or G glycoproteins, or  mixed RSV F and G VLPs (FG VLPs), were shown to elicit antigen-specific antibody correspondence: sang-Moo Kang Center for Inflammation, Immunity  and Infection, Institute for Biomedical  sciences, georgia state University, 100  Piedmont avenue, Psc718, atlanta,  ga 30303, Usa Tel +1 404 413 3588 Fax +1 404 413 3580 email skang24@gsu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lee et al Running head recto: The roles of alveolar macrophages in RSV disease DOI: http://dx.doi.org/10.2147/IJN.S83493",Non-OADS,/arxiv_data1/oa_pdf/9d/32/ijn-10-4491.PMC4508085.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9d/32/ijn-10-4491.PMC4508085.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/32/ijn-10-4491.PMC4508085.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jir-8-117.PMC4508086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2015:8 117–128Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  117ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S8226 1Implications of compromised zinc status   on bone loss associated with chronic   inflammation in c57Bl/6 mice Pitipa chongwatpol elizabeth Rendina-Ruedy Barbara J stoecker stephen l clarke edralin a lucas Brenda J smith Department of n utritional sciences,   Oklahoma state University, stillwater,   OK, Usa correspondence: Brenda J smith   Department of nutritional sciences,  Oklahoma state University, 420 human  science, stillwater, OK 74078, Usa   Tel +1 405 744 3866   Fax +1 405 744 1357   email bjsmith@okstate.ed uAbstract:  Compromised zinc status and chronic inflammation are independent factors that can  contribute to bone loss.",Non-OADS,/arxiv_data1/oa_pdf/c4/35/jir-8-117.PMC4508086.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/c4/35/jir-8-117.PMC4508086.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jir-8-117.PMC4508086.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1275–1284Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1275Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8585 1Prevalence of comorbid retinal disease in patients  with glaucoma at an academic medical center Joseph F griffith1 Jeffrey l goldberg2  1Cole eye institute, Cleveland Clinic  Foundation, Cleveland, Oh, 2shiley eye  Center, University of California san  Diego, la Jolla, C a, UsaBackground:  Patients with various retinal diseases and patients who have undergone retinal  procedures and surgeries have an increased risk of developing ocular hypertension and glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
"Correspondence: Joseph F Griffith Cole eye institute, 9500 euclid avenue,  i-13, Cleveland, Oh 44106, Usa Tel +1 202 365 5778 Fax +1 216 445 2226 email griffij2@ccf.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Griffith and Goldberg Running head recto: Prevalence of comorbid retinal disease in glaucoma patients DOI: http://dx.doi.org/10.2147/OPTH.S85851",Non-OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
Available from: http://quickfacts.census.gov/qfd/states/12/12086.html .,OADS,/arxiv_data1/oa_pdf/7b/2b/opth-9-1275.PMC4508087.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/cd/ott-8-1721.PMC4508088.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1721–1733OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1721Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8527 2B7-h3 silencing by rnai inhibits tumor  progression and enhances chemosensitivity  in U937 cells  Wei Zhang Jing Wang Yanfang Wang Fei Dong Mingxia Zhu Wenli Wan haishen li Feifei Wu Xinxing Yan Xiaoyan Ke Department of hematology and  lymphoma research center, Peking  University Third hospital, Beijing,   People’s republic of chinaBackground:  The role of B7-H3 in acute monocytic leukemia U937 cells has not been  thoroughly investigated.",Non-OADS,/arxiv_data1/oa_pdf/08/cd/ott-8-1721.PMC4508088.pdf
"Therefore, understanding the  molecular mechanisms of AML M5 pathogenesis and drug resistance will aid in the  development of efficient treatments for the disease.correspondence: Xiaoyan Ke Department of hematology and  lymphoma research center, Peking  University Third hospital, no 49 north  garden road, haidian District, Beijing  100191, People’s republic of china  Tel +86 10 8226 6780 Fax +86 10 8226 6780 email xykbysy@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: B7-H3 silencing by RNAi and tumor progression DOI: http://dx.doi.org/10.2147/OTT.S85272",Non-OADS,/arxiv_data1/oa_pdf/08/cd/ott-8-1721.PMC4508088.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/08/cd/ott-8-1721.PMC4508088.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/cd/ott-8-1721.PMC4508088.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/5a/opth-9-1285.PMC4508089.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1285–1290Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1285Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5635 0levels of thrombopoietin in aqueous humor of  patients with noninfectious acute anterior uveitis José-Juan Mondejar1,4  David salom1,3 salvador garcia-Delpech1,2  Manuel Diaz-llopis1 1Ophthalmology Department,  school of Medicine, University  of Valencia, 2Ophthalmology  Department, hospital Universitario  la Fe, 3Ophthalmology Department,  hospital de Manises, Valencia,  4Ophthalmology Department,  hospital general Universitario de  alicante, alicante, spainPurpose:  To measure thrombopoietin (TPO) levels in the serum and aqueous humors of patients  with noninfectious acute anterior uveitis.",Non-OADS,/arxiv_data1/oa_pdf/a7/5a/opth-9-1285.PMC4508089.pdf
"It is also a  positive vasculogenesis regulator,19-21 and its relationship with VEGF has been shown Correspondence: José-Juan Mondejar  Ophthalmology Department, school  of Medicine, University of Valencia,  Plaza Policia local 1-1-13, 46015 Valencia,  spain email josejuanmondejar@gmail.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Mondejar et al Running head recto: TPO in aqueous humor of uveitis patients  DOI: http://dx.doi.org/10.2147/OPTH.S56350",Non-OADS,/arxiv_data1/oa_pdf/a7/5a/opth-9-1285.PMC4508089.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a7/5a/opth-9-1285.PMC4508089.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2015:9submit your manuscript | www.dovepress.co m Dove press Dove press 1290Mondejar et al 48.,Non-OADS,/arxiv_data1/oa_pdf/a7/5a/opth-9-1285.PMC4508089.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jpr-8-399.PMC4508090.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 399–408Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  399Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5559 8The association between chronic pain and obesity Akiko Okifuji Bradford D Hare Pain Research and Management  Center, Department of  Anesthesiology, University of Utah,   Salt Lake City, UT, USA Correspondence: Akiko Okifuji   Pain Research and Management  Center, Department of Anesthesiology,  University of Utah, 615 Arapeen Drive,  Suite 200, Salt Lake City, UT 84108, USA   Tel +1 801 585 7690   Fax +1 801 585 7694   email akiko.okifuji@hsc.utah.ed uAbstract:  Obesity and pain present serious public health concerns in our society.",Non-OADS,/arxiv_data1/oa_pdf/e9/63/jpr-8-399.PMC4508090.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs311/en/ #.,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jpr-8-399.PMC4508090.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/e9/63/jpr-8-399.PMC4508090.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jpr-8-399.PMC4508090.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/ppa-9-999.PMC4508091.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 999–1004Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  999OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8429 7Beneficial effects of training at the anaerobic  threshold in addition to pharmacotherapy on  weight loss, body composition, and exercise  performance in women with obesity Oguz Ozcelik1 Yusuf Ozkan2 Sermin Algul1 Ramis Colak2,3 1Department of Physiology,   2Department of Endocrinology  and Metabolic Disease, Faculty of  Medicine, Fırat University, Elazig,   3Department of Endocrinology  and Metabolic Disease, Faculty of  Medicine, Ondokuz Mayis University,   Samsun, T urkeyObjective:  The aim of this study was to determine and compare the effects of weight loss  achieved through orlistat therapy alone or a combination of orlistat and an aerobic exercise  training program on aerobic fitness and body composition in obese females.",Non-OADS,/arxiv_data1/oa_pdf/56/4d/ppa-9-999.PMC4508091.pdf
"correspondence:  Oguz Ozcelik Department of Physiology, Faculty of  Medicine, Fırat University, Elazig, Turkey Tel +90 424 237 0000 ext 4623 Fax +90 424 237 9138 email oozcelik@excite.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ozcelik et al Running head recto: Beneficial effects of training at the anaerobic threshold DOI: http://dx.doi.org/10.2147/PPA.S84297",Non-OADS,/arxiv_data1/oa_pdf/56/4d/ppa-9-999.PMC4508091.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/56/4d/ppa-9-999.PMC4508091.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/4f/main.PMC4508246.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.05.008 2211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/be/4f/main.PMC4508246.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/4f/main.PMC4508246.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/be/4f/main.PMC4508246.pdf
"In recent years, HRSA-supported FQHCs have received funding to expand operations and provide clinical services to a greater num- ber of medically underserved patients ( http://bphc.hrsa.gov/about/ healthcenterfactsheet.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/be/4f/main.PMC4508246.pdf
"www.e-enm.org 117Endocrinol Metab 2015;30:117-123 http://dx.doi.org/10.3803/EnM.2015.30.2.117 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Mitochondrial Energy Metabolism and Thyroid Cancers Junguee Lee1, Joon Young Chang2, Yea Eun Kang2, Shinae Yi2, Min Hee Lee2, Kyong Hye Joung2, Kun Soon Kim2,  Minho Shong2 1Department of Pathology, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea; 2Research  Center for Endocrine and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine, Chungnam  National University School of Medicine, Daejeon, Korea Primary thyroid cancers including papillary, follicular, poorly differentiated, and anaplastic carcinomas show substantial differ - ences in biological and clinical behaviors.",Non-OADS,/arxiv_data1/oa_pdf/d0/6a/enm-30-117.PMC4508255.pdf
"They also  play central roles in apoptosis, cell proliferation, and cellular  Received:  10 October 2014, Revised:  13 October 2014,   Accepted:  21 December 2014 Corresponding author:  Minho Shong Research Center for Endocrine and Metabolic Diseases, Department of Internal  Medicine, Chungnam National University School of Medicine, 282 Munhwa-ro,  Jung-gu, Daejeon 301-721, Korea Tel: +82-42-280-7161, Fax:  +82-42-280-7995, E-mail:  minhos@cnu.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/6a/enm-30-117.PMC4508255.pdf
"124  www.e-enm.orgEndocrinol Metab 2015;30:124-141 http://dx.doi.org/10.3803/EnM.2015.30.2.124 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Comprehensive Review on Kisspeptin and Its Role in  Reproductive Disorders Holly Clarke, Waljit S. Dhillo, Channa N. Jayasena Department of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK Kisspeptin has recently emerged as a key regulator of the mammalian reproductive axis.",Non-OADS,/arxiv_data1/oa_pdf/95/a0/enm-30-124.PMC4508256.pdf
"Received:  2 December 2014,   Revised:  5 January 2015, Accepted:  12 January 2015 Corresponding author:  Channa N. Jayasena Department of Investigative Medicine, Hammersmith Hospital, Imperial College  London, 6th Floor, Commonwealth Building, Du Cane Road, London W12  ONN, UK Tel: +44-208-383-3242, Fax:  +44-208-383-3142,  E-mail:  c.jayasena@imperial.ac.ukCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/95/a0/enm-30-124.PMC4508256.pdf
Kisspeptin and Reproduction Copyright © 2015 Korean Endocrine Society www.e-enm.org 125Endocrinol Metab 2015;30:124-141 http://dx.doi.org/10.3803/EnM.2015.30.2.124 pISSN 2093-596X  ·  eISSN 2093-5978 DISCOVERY OF KISSPEPTIN Kisspeptin was first discovered in 1996 as a metastasis inhibi - tor in melanoma cell lines [1].,Non-OADS,/arxiv_data1/oa_pdf/95/a0/enm-30-124.PMC4508256.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/a0/enm-30-124.PMC4508256.pdf
"142  www.e-enm.orgEndocrinol Metab 2015;30:142-146 http://dx.doi.org/10.3803/EnM.2015.30.2.142 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Trends in the Diabetes Epidemic in Korea Kyoung Hwa Ha1,2, Dae Jung Kim1,2 1Department of Endocrinology and Metabolism, 2Cardiovascular and Metabolic Disease Etiology Research Center, Ajou  University School of Medicine, Suwon, Korea Diabetes mellitus is a leading cause of mortality and increased disability-adjusted life years worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a8/a3/enm-30-142.PMC4508257.pdf
"Studies have consistently reported an association between  Received:  17 March 2015, Revised:  20 March 2015,   Accepted:  25 March 2015 Corresponding author:  Dae Jung Kim Department of Endocrinology and Metabolism, Ajou University School of  Medicine, 164 World cup-ro, Yeongtong-gu, Suwon 443-380, Korea Tel: +82-31-219-5128, Fax:  +82-31-219-4497, E-mail:  djkim@ajou.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/a3/enm-30-142.PMC4508257.pdf
Diabetes Epidemic in Korea  Copyright © 2015 Korean Endocrine Society www.e-enm.org 143Endocrinol Metab 2015;30:142-146 http://dx.doi.org/10.3803/EnM.2015.30.2.142 pISSN 2093-596X  ·  eISSN 2093-5978 obesity and diabetes.,Non-OADS,/arxiv_data1/oa_pdf/a8/a3/enm-30-142.PMC4508257.pdf
Available from:  http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/a8/a3/enm-30-142.PMC4508257.pdf
"www.e-enm.org 147Endocrinol Metab 2015;30:147-158 http://dx.doi.org/10.3803/EnM.2015.30.2.147 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Genetic Studies on Diabetic Microvascular Complications:  Focusing on Genome-Wide Association Studies Soo Heon Kwak1, Kyong Soo Park1,2,3 1Department of Internal Medicine, Seoul National University Hospital; 2Depatment of Internal Medicine, Seoul National  University College of Medicine; 3Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of  Convergence Science and Technology, Seoul National University, Seoul, Korea Diabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage  renal disease and amputation.",Non-OADS,/arxiv_data1/oa_pdf/c8/25/enm-30-147.PMC4508258.pdf
"Prospective Diabetes Study, which  enrolled newly diagnosed type 2 diabetes mellitus (T2DM)  patients, participants randomized to intensive glucose control  (median hemoglobin A1c [HbA1c] 7.0%) had a 25% reduc - Received:  19 May 2015, Revised:  26 May 2015,   Accepted:  26 May 2015 Corresponding author:  Kyong Soo Park Department of Internal Medicine, Seoul National University Hospital, Seoul  National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul  110-744, Korea  Tel: +82-2-2072-2946, Fax:  +82-2-762-9662, E-mail:  kspark@snu.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/25/enm-30-147.PMC4508258.pdf
"www.e-enm.org 159Endocrinol Metab 2015;30:159-166 http://dx.doi.org/10.3803/EnM.2015.30.2.159 pISSN 2093-596X  ·  eISSN 2093-5978Review Article New Directions in Chronic Disease Management Hun-Sung Kim1,2, Jae-Hyoung Cho1,2, Kun-Ho Yoon1,2 Departments of 1Medical Informatics, 2Endocrinology and Metabolism, College of Medicine, The Catholic University of Korea,  Seoul, Korea A worldwide epidemic of chronic disease, and complications thereof, is underway, with no sign of abatement.",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/enm-30-159.PMC4508259.pdf
"Received:  19 May 2015, Revised:  26 May 2015,   Accepted:  29 May 2015 Corresponding author:  Kun-Ho Yoon Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital,  College of Medicine, The Catholic University of Korea, 222 Banpo-daero,  Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-8262, Fax:  +82-2-2258-8297, E-mail:  yoonk@catholic.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/enm-30-159.PMC4508259.pdf
Available from:  http://www.idf.org.,Non-OADS,/arxiv_data1/oa_pdf/7a/a5/enm-30-159.PMC4508259.pdf
"www.e-enm.org 167Endocrinol Metab 2015;30:167-174 http://dx.doi.org/10.3803/EnM.2015.30.2.167 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Clinical Implications of Glucose Variability: Chronic  Complications of Diabetes Hye Seung Jung Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Glucose variability has been identified as a potential risk factor for diabetic complications; oxidative stress is widely regarded as  the mechanism by which glycemic variability induces diabetic complications.",Non-OADS,/arxiv_data1/oa_pdf/ab/c0/enm-30-167.PMC4508260.pdf
"Similarly, the formula glucose excursion/ Received:  19 May 2015, Revised:  22 May 2015,   Accepted:  22 May 2015 Corresponding author:  Hye Seung Jung Department of Internal Medicine, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-0240, Fax:  +82-2-762-9662, E-mail:  junghs@snu.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/c0/enm-30-167.PMC4508260.pdf
"www.e-enm.org 175Endocrinol Metab 2015;30:175-176 http://dx.doi.org/10.3803/EnM.2015.30.2.175 pISSN 2093-596X  ·  eISSN 2093-5978Editorial Adipokine Profiles and Metabolic Health Seung-Hwan Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine,  The Catholic University of Korea, Seoul, Korea The epidemic of obesity is a major health problem that leads to  medical and socioeconomic burdens on society.",Non-OADS,/arxiv_data1/oa_pdf/72/f8/enm-30-175.PMC4508261.pdf
"Although some conflicting results for adipokine  levels also exist, current data support a close relationship to  Received:  6 May 2015, Revised:  11 May 2015,   Accepted:  12 May 2015 Corresponding author:  Seung-Hwan Lee Division of Endocrinology and Metabolism, Department of Internal Medicine,  Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-6069, Fax:  +82-2-595-2534, E-mail:  hwanx2@catholic.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/72/f8/enm-30-175.PMC4508261.pdf
"www.e-enm.org 177Endocrinol Metab 2015;30:177-184 http://dx.doi.org/10.3803/EnM.2015.30.2.177 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A  via Improvement of Palmitic Acid-Induced Endoplasmic  Reticulum Stress by AMPK Jinmi Lee1, Seok-Woo Hong1, Se Eun Park2, Eun-Jung Rhee2, Cheol-Young Park2, Ki-Won Oh2, Sung-Woo Park2,  Won-Young Lee2 1Institute of Medical Research, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk  Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Selenoprotein P (SEPP1) and fetuin-A, both circulating liver-derived glycoproteins, are novel biomarkers for insu - lin resistance and nonalcoholic fatty liver disease.",Non-OADS,/arxiv_data1/oa_pdf/76/50/enm-30-177.PMC4508262.pdf
"SEPP1 transcription is stimulated by interactions  Received:  8 May 2014, Revised : 30 May 2014,   Accepted:  24 June 2014 Corresponding author:  Won-Young Lee Division of Endocrinology and Metabolism, Department of Internal Medicine,  Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29  Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82-2-2001-2579, Fax:  +82-2-2001-1588, E-mail:  drlwy@hanmail.netCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/76/50/enm-30-177.PMC4508262.pdf
"www.e-enm.org 185Endocrinol Metab 2015;30:185-194 http://dx.doi.org/10.3803/EnM.2015.30.2.185 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Comparison of Serum Adipocytokine Levels according to  Metabolic Health and Obesity Status Tae Hoon Lee1,*, Won Seon Jeon1,*, Ki Joong Han1, Shin Yeoung Lee1, Nam Hee Kim1, Hyun Beom Chae1,   Choel Min Jang1, Kyung Mo Yoo1, Hae Jung Park1, Min Kyung Lee1, Se Eun Park1, Hyung Geun Oh2,   Cheol-Young Park1, Won-Young Lee1, Ki-Won Oh1, Sung-Woo Park1, Eun-Jung Rhee1 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, Seoul; 2Department of Neurology, Soonchunhyang University College of Medicine, Cheonan,  Korea Background:  Metabolic health is an emerging concept that is highly correlated with various metabolic complications, and adipo - cytokines have been causally linked to a wide range of metabolic diseases.",Non-OADS,/arxiv_data1/oa_pdf/1c/43/enm-30-185.PMC4508263.pdf
"Keywords:  Obesity; Metabolic health; Adipocytokine Received:  23 June 2014, Revised:  3 August 2014,   Accepted:  5 August 2014 Corresponding author:  Eun-Jung Rhee Division of Endocrinology and Metabolism, Department of Internal Medicine,  Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  29 Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82-2-2001-2485, Fax:  +82-2011-1588, E-mail:  hongsiri@hanmail.net *These authors contributed equally to this work.Copyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/43/enm-30-185.PMC4508263.pdf
Available from: http://www.ngsp.org/docs/ methods.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/43/enm-30-185.PMC4508263.pdf
"www.e-enm.org 195Endocrinol Metab 2015;30:195-200 http://dx.doi.org/10.3803/EnM.2015.30.2.195 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Anaplastic Thyroid Cancer: Experience of the Philippine  General Hospital Tom Edward Lo, Cecilia Alegado Jimeno, Elizabeth Paz-Pacheco Section of Endocrinology and Metabolism, Department of Medicine, University of the Philippines-Philippine General Hospital,  Manila, Philippine Background:  Anaplastic thyroid cancer (ATC) is a rare type of thyroid malignancy and one of the most aggressive solid tumors,  responsible for between 14% and 50% of the total annual mortality associated with thyroid cancer.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/enm-30-195.PMC4508264.pdf
"One-year and  Received:  24 June 2014, Revised:  9 July 2014,   Accepted:  7 August 2014 Corresponding author:  Tom Edward Lo Section of Endocrinology and Metabolism, Department of Medicine, University  of the Philippines-Philippine General Hospital, Taft Avenue, Ermita, Manila,  Philippine Tel: +63-2-829-7751, Fax:  +63-2-829-5510, E-mail:  tomedwardlo@yahoo.comCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/enm-30-195.PMC4508264.pdf
"www.e-enm.org 201Endocrinol Metab 2015;30:201-207 http://dx.doi.org/10.3803/EnM.2015.30.2.201 pISSN 2093-596X·eISSN 2093-5978Original Article Associations between Dietary Acid-Base Load and  Cardiometabolic Risk Factors in Adults: The Tehran Lipid  and Glucose Study Zahra Bahadoran1, Parvin Mirmiran2, Hadise Khosravi1, Fereidoun Azizi3 1Nutrition and Endocrine Research Center and Obesity Research Center, Research Institute for Endocrine Sciences, 2Department  of Nutrition and Clinical Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food  Technology Research Institute, 3Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti  University of Medical Sciences, Tehran, Iran Background:  In this study we investigated the associations of dietary acid-base load, identified by potential renal acid load  (PRAL) and protein to potassium (Pro:K) ratio, with cardiometabolic risk factors in Tehranian adults.",Non-OADS,/arxiv_data1/oa_pdf/67/36/enm-30-201.PMC4508265.pdf
"Tehran 19395-4741, Iran Tel: +98-21-223-57-484, Fax:  +98-21-224-16-264,  E-mail:  mirmiran@endocrine.ac.irCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/67/36/enm-30-201.PMC4508265.pdf
"208  www.e-enm.orgEndocrinol Metab 2015;30:208-215 http://dx.doi.org/10.3803/EnM.2015.30.2.208 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Apolipoprotein B Is Related to Metabolic Syndrome  Independently of Low Density Lipoprotein Cholesterol in  Patients with Type 2 Diabetes  Younghyup Lim1, Soyeon Yoo1, Sang Ah Lee1,2, Sang Ouk Chin1, Dahee Heo1, Jae Cheol Moon1, Shinhang Moon1,  Kiyoung Boo1, Seong Taeg Kim1, Hye Mi Seo1, Hyeyoung Jwa1, Gwanpyo Koh1,2 1Department of Internal Medicine, Jeju National University Hospital; 2Department of Internal Medicine, Jeju National  University School of Medicine, Jeju, Korea  Background:  Increased low density lipoprotein cholesterol (LDL-C) level and the presence of metabolic syndrome (MetS) are  important risk factors for cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/e6/06/enm-30-208.PMC4508266.pdf
"However, recently there are epide - Received:  21 January 2015, Revised:  9 March 2015,   Accepted:  23 April 2015 Corresponding author:  Gwanpyo Koh  Department of Internal Medicine, Jeju National University School of Medicine,  15 Aran 13-gil, Jeju 690-767, Korea Tel: +82-64-754-8163, Fax:  +82-64-717-1131, E-mail:  okdom@jejunu.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/06/enm-30-208.PMC4508266.pdf
"ApoB, LDL and Metabolic Syndrome Copyright © 2015 Korean Endocrine Society www.e-enm.org 209Endocrinol Metab 2015;30:208-215 http://dx.doi.org/10.3803/EnM.2015.30.2.208 pISSN 2093-596X  ·  eISSN 2093-5978 miological data reporting that apolipoprotein is more useful as  a risk factor of CVD than LDL-C or high density lipoprotein  cholesterol (HDL-C) [7,8].",Non-OADS,/arxiv_data1/oa_pdf/e6/06/enm-30-208.PMC4508266.pdf
"216  www.e-enm.orgEndocrinol Metab 2015;30:216-220 http://dx.doi.org/10.3803/EnM.2015.30.2.216 pISSN 2093-596X  ·  eISSN 2093-5978Brief  Report Glucagon-Like Peptide-1 Increases Mitochondrial  Biogenesis and Function in INS-1 Rat Insulinoma Cells  Mi Yeon Kang*, Tae Jung Oh, Young Min Cho Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that increases glucose-stimulated insulin secretion in pancre - atic β-cells.",Non-OADS,/arxiv_data1/oa_pdf/4b/fa/enm-30-216.PMC4508267.pdf
"In  this study, we examined the effect of GLP-1 and its analogue  Received:  14 July 2014, Revised : 27 August 2014,   Accepted:  29 August 2014 Corresponding author:  Young Min Cho Department of Internal Medicine, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-1965, Fax:  +82-2-762-9662, E-mail:  ymchomd@snu.ac.kr *Current affiliation: Department of Internal Medicine, St. Carollo Hospital,   221 Sunkwang-ro, Suncheon, KoreaCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/fa/enm-30-216.PMC4508267.pdf
GLP-1 and Mitochondrial Biogenesis Copyright © 2015 Korean Endocrine Society www.e-enm.org 217Endocrinol Metab 2015;30:216-220 http://dx.doi.org/10.3803/EnM.2015.30.2.216 pISSN 2093-596X  ·  eISSN 2093-5978 on mitochondrial biogenesis in pancreatic β-cells.,Non-OADS,/arxiv_data1/oa_pdf/4b/fa/enm-30-216.PMC4508267.pdf
"www.e-enm.org 221Endocrinol Metab 2015;30:221-225 http://dx.doi.org/10.3803/EnM.2015.30.2.221 pISSN 2093-596X  ·  eISSN 2093-5978Case Report A Calcitonin-Negative Neuroendocrine Tumor Derived  from Follicular Lesions of the Thyroid Ga Young Kim1, Chul Yun Park1, Chang Ho Cho2, June Sik Park3, Eui Dal Jung1, Eon Ju Jeon1 Departments of 1Internal Medicine, 2Pathology, 3Otolaryngology Head and Neck Surgery, Catholic University of Daegu School  of Medicine, Daegu, Korea Neuroendocrine lesions of the thyroid are rare.",Non-OADS,/arxiv_data1/oa_pdf/4b/4d/enm-30-221.PMC4508268.pdf
"Received:  25 July 2014, Revised:  26 August 2014,  Accepted:  2 September 2014 Corresponding author:  Eon Ju Jeon Department of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4026, Fax:  +82-53-651-4009, E-mail:  ejjeon@cu.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/4d/enm-30-221.PMC4508268.pdf
"226  www.e-enm.orgEndocrinol Metab 2015;30:226-230 http://dx.doi.org/10.3803/EnM.2015.30.2.226 pISSN 2093-596X  ·  eISSN 2093-5978Case Report Partial Androgen Insensitivity Syndrome Presenting with  Gynecomastia Sung Won Lee, Dong Shin Kwak, In Sub Jung, Joo Hee Kwak, Jung Hwan Park, Sang Mo Hong, Chang Bum Lee,  Yong Soo Park, Dong Sun Kim, Woong Hwan Choi, You Hern Ahn Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea Gynecomastia is a benign enlargement of the male breast caused by the proliferation of glandular breast tissue.",Non-OADS,/arxiv_data1/oa_pdf/ff/48/enm-30-226.PMC4508269.pdf
"Endocrine results were as follows: testosterone level of  Received:  4 August 2014, Revised:  1 September 2014,   Accepted:  3 September 2014 Corresponding author:  You Hern Ahn Department of Internal Medicine, Hanyang University College of Medicine,  222-1 Wangsimni-ro, Seongdong-gu, Seoul 133-792, Korea Tel: +82-2-2290-9556, Fax:  +82-2-2290-8231, E-mail:  ahnyh@hanyang.ac.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/48/enm-30-226.PMC4508269.pdf
"Partial AIS Presenting with Gynecomastia Copyright © 2015 Korean Endocrine Society www.e-enm.org 227Endocrinol Metab 2015;30:226-230 http://dx.doi.org/10.3803/EnM.2015.30.2.226 pISSN 2093-596X  ·  eISSN 2093-5978 50.83 nmol/L (normal range, 9.7 to 27.8), dihydroepiandros - terone (DHEA) level of 15.03 nmol/L (normal range, 6.2 to  43.3), and DHEA-sulfate (DHEA-S) level of 5,120 nmol/L  (normal range, 1,600 to 12,200), 17-hydroxyprogesterone level  of 6.61 nmol/L (normal range, 1.88 to 10.94), lutenizing hor - mone (LH) level of 11.5 IU/L (normal range, 1.7 to 8.6), follicle  stimulating hormone (FSH) level of 5.5 IU/L (normal range, 1.5  to 12.4), estradiol level of 0.191 mmol/L (normal range, 0.026  to 0.147), β-human chorionic gonadotropin  (β-hCG) level of  <0.1 IU/L (normal range, <2.6), prolactin of 21.7 pg/L (normal  range, 4.0 to 15.2), free T4 level of 18.9 pmol/L (normal range,  11.9 to 21.9), and thyroid stimulating hormone level of 2.43  mIU/L (normal range, 0.27 to 4.2).",Non-OADS,/arxiv_data1/oa_pdf/ff/48/enm-30-226.PMC4508269.pdf
"www.e-enm.org 231Endocrinol Metab 2015;30:231-232 http://dx.doi.org/10.3803/EnM.2015.30.2.231 pISSN 2093-596X  ·  eISSN 2093-5978Letter Expression of Glucagon-Like Peptide-1 Receptor in  Papillary Thyroid Carcinoma and Its Clinicopathologic  Significance   (Endocrinol Metab  2014;29:536-44, Min Jung Jung et al.)",Non-OADS,/arxiv_data1/oa_pdf/43/3c/enm-30-231.PMC4508270.pdf
"For - tunately, 18 of 56 cases in this study were sufficient to ascertain  Received:  11 February 2015, Revised:  16 February 2015,   Accepted:  23 February 2015 Corresponding author:  Eun Kyung Lee Center for Thyroid Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: +82-31-920-1743, Fax:  +82-31-920-0846, E-mail:  waterfol@ncc.re.krCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/43/3c/enm-30-231.PMC4508270.pdf
"www.e-enm.org 233Endocrinol Metab 2015;30:233-234 http://dx.doi.org/10.3803/EnM.2015.30.2.233 pISSN 2093-596X  ·  eISSN 2093-5978Response Expression of Glucagon-Like Peptide-1 Receptor in  Papillary Thyroid Carcinoma and Its Clinicopathologic  Significance   (Endocrinol Metab  2014;29:536-44, Min Jung Jung et al.)",Non-OADS,/arxiv_data1/oa_pdf/3f/6e/enm-30-233.PMC4508271.pdf
"Pathol - ogists evaluate the immunoreactive pattern (complete vs. in - complete circumferential membrane staining), intensity (none,  Received:  3 April 2015, Revised:  9 April 2015,   Accepted:  21 May 2015 Corresponding author:  Su Kyoung Kwon Division of Endocrinology and Metabolism, Department of Internal Medicine,  Kosin University Gospel Hospital, Kosin University College of Medicine, 262  Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6102, Fax:  +82-51-990-3077, E-mail:  mir316@naver.comCopyright © 2015 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/6e/enm-30-233.PMC4508271.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/31/main.PMC4508347.pdf
http://dx.doi.org/10.1016/j.cellsig.2015.04.014 0898-6568/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/31/main.PMC4508347.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/31/main.PMC4508347.pdf
"204 (2014) 265 –279, http://dx.doi.org/10.1083/jcb.201406135(2014) .",Non-OADS,/arxiv_data1/oa_pdf/33/31/main.PMC4508347.pdf
"Editor: M. J. Loeffelholz Address correspondence to Gregory A. Storch, storch_g@kids.wustl.edu.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JCM.00923-15 .",Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
These nucleotide sequences weremapped and visualized online using MUSCLE ( 19) at the National Insti- tute of Allergy and Infectious Diseases (NIAID) Virus Pathogen Databaseand Analysis Resource (ViPR) ( http://www.viprbrc.org ) website to pro- duce a multiple-sequence alignment (MSA).,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
The ongoing importance ofimproved diagnostic capability for EV-D68 is underscored by therecent decision by the Department of Health and Human Servicesto encourage the development of EV-D68 testing capability byauthorizing the emergency use of new in vitro diagnostics for EV-D68 detection ( http://www.gpo.gov/fdsys/pkg/FR-2015-02-2 7/html/2015-04121.htm ).,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1002/rmv.1820 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10 .1099/vir.0.043935-0 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
"Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc .gov/non-polio-enterovirus/outbreaks/EV-D68-outbreaks.html .",Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://www.cdc.gov/MMWR/preview /mmwrhtml/mm6336a4.htm?s_cid /H11005mm6336a4_w .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1099/vir.0.79925-0 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
Lancet Infect Dis 15:671– 682. http://dx.doi.org/10.1016/S1473 -3099(15)70093-9 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1371/journal.pone.0000966 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1542 /peds.2012-1391 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1089/gst.1995.1.9 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org /10.1093/bioinformatics/17.suppl_1.S132 .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
BMC Genomics 9:517. http://dx.doi.org/10.1186/1471-2164-9-517 .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
J Mol Biol 215:403– 410. http://dx.doi.org/10.1016 /S0022-2836(05)80360-2 .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
Bioinformatics 26:841– 842. http://dx.doi.org/10 .1093/bioinformatics/btq033 .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
J Clin Microbiol 44:2698 – 2704. http://dx.doi.org/10.1128/JCM.00542-06 .,OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi .org/10.1093/nar/gkh340 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1093/nar/gkn201 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1093/nar/gkt282 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1101/gr.987803 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1128 /JCM.40.10.3666-3670.2002 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1128 /JCM.03691-14 .,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
http://dx.doi.org/10.1016/j.jcv.2011.06.019 .Development and Evaluation of an EV-D68 RT-PCR Assay August 2015 Volume 53 Number 8 jcm.asm.org 2647 Journal of Clinical Microbiology,Non-OADS,/arxiv_data1/oa_pdf/6c/48/zjm2641.PMC4508392.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/7a/ehv177.PMC4508487.pdf
9.http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ ucm278646.htm (accessed 6 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/f4/7a/ehv177.PMC4508487.pdf
10.http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022406s009lbl.,Non-OADS,/arxiv_data1/oa_pdf/f4/7a/ehv177.PMC4508487.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/61/rjv088.PMC4508502.pdf
2011. http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/23/16/40119_2015_Article_44.PMC4508521.pdf
Available from: http://www.cdc.gov/HAI/surveillance/24.,OADS,/arxiv_data1/oa_pdf/3d/2b/idr-2015-2-5774.PMC4508534.pdf
"On March 21, the EU DG DEVCO funded European Mobile Lab (EMLab) Consortium(http://www.emlab.eu/), that include theNational Institute for Infectious Diseases L.Spallanzani (INMI), was alerted by WHO andwe were immediately obliged to revise all theproject plans of activity.",Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available at http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola.,OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from: http://apps.who.int/ebola/current-situation/ebola-situa-tion-report-25-march-2015 2.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://www.cidrap.umn.edu/news-perspec-tive/2014/12/commentary-when-next-shoe-drops-ebola-crisis-communication-lessons-october 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Availablefrom: http://www.standardmedia.co.ke/health/article/2000107329/mystery-hemorrhagic-fever-kills-23-in-guinea.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://www.msf.org/sites/msf.org/files/msf-whereiseveryone_-def-lr_-_july.pdf 6. WHO.,OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Availablefrom: http://who.int/mediacentre/news/sta-tements/2014/ebola-20140808/en 7.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/united-states-imported-case.html 10.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://www.thestar.com/news/world/2014/10/17/ebola_response_badly_fumbled_who_admits.htm 12.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://bigstory.ap.org/article/2489c78bff86463589b41f3faaea5ab2/emails-un-health-agency-resisted-declaring-ebola-emer-gency 13.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from:http://www.msf.org/article/ebola-pushed-limit-and-beyond 14.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
"June 29, 2010.Available from: http://www.psandman.com/col/WHO-credi-bility.htm16.",Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Decisions and list of resolutions.Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_DIV3-en.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
2008.Available from: http://www.oecd.org/dac/effectiveness/34428351.pdf  20.,Non-OADS,/arxiv_data1/oa_pdf/a7/93/idr-2015-2-5957.PMC4508539.pdf
Available from: http://www.who.int/medi- acentre/factsheets/fs310/en/  2.,OADS,/arxiv_data1/oa_pdf/56/e9/ni-2015-1-5840.PMC4508543.pdf
Available from: http://www.kinderkrebsinfo.de/health _professionals/clinical_trials/pohkinderkre bsinfotherapiestudien/hlh_2004/index_eng .html 8.,Non-OADS,/arxiv_data1/oa_pdf/78/c7/hr-2015-2-5841.PMC4508551.pdf
Available from: http://www.searo.who.int/indonesia/ documents/research-for-universal-health- coverage%289789240690837_eng%29.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/de/86/hr-2015-2-5843.PMC4508552.pdf
"Availability and requirements Project name: OrthoEvidence™TM Project home page: http://www.myorthoevi- dence.com/ Operating system: Linux Programming language: PHP, Database- MySQL version 5.5.4, Environment-Apache, PHP version-5.4 or higher Other requirements: Image Magick installed, Imagick PHP library installed  License: None.",Non-OADS,/arxiv_data1/oa_pdf/2f/23/or-2015-2-5762.PMC4508555.pdf
"38 Recently, Verdonk et al.described in VuMedi the Antwerp Monoloop procedure for the anatomical reconstruction of the ALL [https://www.vumedi.com/video/the-antwerp- monoloop-for-reconstruction-of-the-anterolat- eral-ligament-all/].",Non-OADS,/arxiv_data1/oa_pdf/11/5d/or-2015-2-5773.PMC4508556.pdf
"279© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 A Review of Inflammatory Processes of the Breast with a Focus   on Diagnosis in Core Biopsy Samples Timothy M. D’Alfonso  Paula S. Ginter · Sandra J. Shin  Department of Pathology and Laboratory   Medicine, Weill Cornell Medical College,  New York, NY, USAInflammatory and reactive lesions of the breast are relatively uncommon among benign breast le- sions and can be the source of an abnormality on imaging.",Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"Key Words:  Breast; Core biopsy; Inflammatory; MammogramReceived: June 2, 2015 Revised: June 10, 2015Accepted: June 11, 2015 Corresponding Author Timothy M. D’Alfonso, MDNew York-Presbyterian Hospital/Weill Cornell Medical College, 525 East 68th Street, Starr 1031E, New York, NY 10065, USA Tel: +1-212-746-2700Fax: +1-212-746-6484E-mail: tid9007@med.cornell.eduJournal of Pathology and Translational Medicine 2015; 49: 279-287 http://dx.doi.org/10.4132/jptm.2015.06.11▒ REVIEW ▒ Inflammatory and reactive conditions of the breast are rela- tively uncommon among benign breast lesions, and may present  with clinical and radiologic abnormalities akin to malignant  processes.",Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11280     •  D’Alfonso TM, et al.",OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11Inflammatory Processes of the Breast   •     281 with luminal histiocytes is seen (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11282     •  D’Alfonso TM, et al.",OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11Inflammatory Processes of the Breast   •     283 causes of granulomatous lobular inflammation.,Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11284     •  D’Alfonso TM, et al.",OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11Inflammatory Processes of the Breast   •     285 filtrates, unless the sample is quite limited.",Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11286     •  D’Alfonso TM, et al.",OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.11Inflammatory Processes of the Breast   •     287 Roberts O. Radiologic features of granulomatous mastitis.,Non-OADS,/arxiv_data1/oa_pdf/b8/b3/jptm-49-4-279.PMC4508565.pdf
"288pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the   Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group Chan Kwon Jung1 · Hye Sook Min2,3  Hyo Jin Park2 · Dong Eun Song4  Jang Hee Kim5 · So Yeon Park2  Hyunju Yoo6 · Mi Kyung Shin7  Korean Endocrine Pathology Thyroid  Core Needle Biopsy Study Group 1Department of Hospital Pathology, College  of Medicine, The Catholic University of Korea,  Seoul; 2Department of Pathology, Seoul National  University College of Medicine, Seoul;   3Department of Epidemiology and Preventive  Medicine, Graduate School of Public Health, Seoul National University, Seoul;  4Department  of Pathology, University of Ulsan College of Medi- cine, Seoul; 5Department of Pathology,   Ajou University School of Medicine, Suwon;  6Department of Pathology, Daerim Saint Mary’s  Hospital, Seoul; 7Department of Pathology,   Hallym University College of Medicine, Seoul, KoreaIn recent years throughout Korea, the use of ultrasound-guided core needle biopsy (CNB) has  become common for the preoperative diagnosis of thyroid nodules.",Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"Key Words:  Thyroid nodule; Guideline; Image-guided biopsy; Preoperative period; Diagnosis Received: April 16, 2015 Revised: June 2, 2015Accepted: June 3, 2015 Corresponding Authors Chan Kwon Jung, MD, PhD Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-1622 Fax: +82-2-2258-1627 E-mail: ckjung@catholic.ac.kr Mi Kyung Shin, MD, PhD  Department of Pathology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, 1 Singil-ro, Yeongdeungpo-gu, Seoul 150-950, Korea Tel: +82-2-829-5443Fax: +82-2-829-5268E-mail: smk0103@yahoo.co.krJournal of Pathology and Translational Medicine 2015; 49: 288-299 http://dx.doi.org/10.4132/jptm.2015.06.04▒ REVIEW ▒ Ultrasound-guided fine needle aspiration cytology (FNAC) is  the most accurate, effective and safe method for the preoperative  assessment of thyroid nodules.1 Since 2007, pathologists and cli - nicians have widely adopted the six-level diagnostic scheme of The Bethesda System for Reporting Thyroid Cytopathology (TB - SRTC).",Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     289 cians.2,3 However, a major limitation of FNAC for the diagnosis  of thyroid nodules, is the relatively high incidence of nondiag- nostic aspirates (10%–15%) and indeterminate aspirates (10%– 30%).4,5 Patients with thyroid nodules of nondiagnostic or in- determinate aspirates typically undergo repeated aspirations for  FNAC or diagnostic surgery.1  Ultrasound-guided core needle biopsy (CNB) has been suc- cessfully employed for the last decade as a complementary tool  for the evaluation of thyroid nodules.6-9 CNB reportedly reduces  the rate of nondiagnostic or indeterminate results.6 Therefore, CNB can be used when FNAC results are nondiagnostic or fail to correlate with clinical findings or results of ultrasound imag- ing studies.",Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04290     •  Jung CK, et al.",OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     291 terminology: (1) some clinicians and pathologists may under - stand the meaning of terms in a CNB pathology report differ - ently from the terms in an FNAC report; (2) the phrase “atypia  of undetermined significance” in TBSRTC is inappropriate ter - minology in the field of histopathology; (3) there is no consensus regarding specimen adequacy; and (4) the sample representativity  of the CNB may be different from that of the FNAC.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04292     •  Jung CK, et al.",OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     293 capsule because the tumor is not encapsulated although it has  invaded into the thyroid parenchyma and extrathyroidal tissue.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04294     •  Jung CK, et al.",OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     295 icance” in TBSRTC.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04296     •  Jung CK, et al.",OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     297 normofollicular proliferative lesions with fibrous capsules, solid  or trabecular follicular lesions with fibrous capsules, Hürthle cell  proliferative lesions with fibrous capsules, and follicular neo- plasms or samples suspicious for follicular neoplasms with focal nuclear atypia.",Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04298     •  Jung CK, et al.",OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.04Thyroid Core Needle Biopsy Diagnosis   •     299 15.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jptm-49-4-288.PMC4508566.pdf
"300pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer   for Molecular Diagnostic Testing Michael H. Roh Department of Pathology, University of Michigan  Health System, Ann Arbor, MI, USAIn this era of precision medicine, our understanding and knowledge of the molecular landscape  associated with lung cancer pathogenesis continues to evolve.",Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
"Key Words:  Lung neoplasms; Cytology; Biopsy, fine-needle; Molecular testing; Precision medicineReceived: May 6, 2015 Revised: June 10, 2015Accepted: June 16, 2015 Corresponding Author Michael H. Roh, MD, PhDDepartment of Pathology, University of Michigan Health System, 1500 E. Medical Center Drive,  Ann Arbor, MI 48109-5054, USA Tel: +1-734-936-6776Fax: +1-734-763-4095E-mail: mikro@med.umich.eduJournal of Pathology and Translational Medicine 2015; 49: 300-309 http://dx.doi.org/10.4132/jptm.2015.06.16▒ REVIEW ▒ During this current era of precision medicine, our current  knowledge regarding the molecular drivers underlying cancer  continues to evolve.",Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16Molecular Testing of Lung Cancer FNAs   •     301 FINE-NEEDLE ASPIRATION   SPECIMEN PROCESSING FNAs represent an advantageous, effective means to obtain di - agnostic cellular material as they can often sample a wide area of  the target lesion, acquire tumor cells with lower contamination  by background stromal connective tissue elements, and allow for immediate assessment during rapid on-site evaluation (ROSE).",Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16302     •  Roh MH tain more tumor cells for diagnosis and/or anticipated ancillary  studies while the patient is still accessible.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16Molecular Testing of Lung Cancer FNAs   •     303 boring EGFR mutations.11-16  EGFR mutation analysis is commonly performed via poly- merase chain reaction (PCR) and sequencing-based approaches;  advances in the development of testing modalities have afforded a multitude of methodologies.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16304     •  Roh MH satile; the consequence of this is that each type of cytologic ana- lyte platform needs to be carefully validated for any given mole- cular test.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16Molecular Testing of Lung Cancer FNAs   •     305 from ThinPrep slides.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16306     •  Roh MH The FDA has approved this dual breakapart probe set for use  on paraffin embedded tissue sections.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16Molecular Testing of Lung Cancer FNAs   •     307 monstrated that this can be accomplished using smears as well  as cell blocks.4 For example, Napsin-A and thyroid transcription  factor-1 are often positive in lung adenocarcinomas and can be  utilized for confirming this subtype of NSCLC.",Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16308     •  Roh MH EGFR mutation testing in lung cancer: a review of available methods  and their use for analysis of tumour tissue and cytology samples.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.16Molecular Testing of Lung Cancer FNAs   •     309 ogy specimens of lung adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/4b/08/jptm-49-4-300.PMC4508567.pdf
"310pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Analysis of Histologic Features Suspecting Anaplastic Lymphoma   Kinase (ALK)-Expressing Pulmonary Adenocarcinoma In Ho Choi · Dong Won Kim  Sang Yun Ha1 · Yoon-La Choi1  Hee Jeong Lee2 · Joungho Han1 Department of Pathology,   Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine,  Seoul;  1Department of Pathology, Samsung  Medical Center, Sungkyunkwan University  School of Medicine, Seoul; 2Department of  Pathology, Gwangmyeong Sungae Hospital, Gwangmyeong, KoreaBackground:  Since 2007 when anaplastic lymphoma kinase (ALK) rearrangements were discov- ered in non-small cell lung cancer, the ALK gene has received attention due to ALK-targeted  therapy, and a notable treatment advantage has been observed in patients harboring the EML4/ALK translocation.",Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
"Key Words:  Lung; Adenocarcinoma; Anaplastic large cell lymphoma kinase; Anaplastic lymphoma  kinase; In situ hybridization, fluorescenceReceived: March 3, 2015 Revised: May 10, 2015Accepted: May 12, 2015 Corresponding Author Joungho Han, MD, PhDDepartment of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-2800Fax: +82-2-3410-0025E-mail: hanjho@skku.eduJournal of Pathology and Translational Medicine 2015; 49: 310-317 http://dx.doi.org/10.4132/jptm.2015.05.13▒ ORIGINAL ARTICLE ▒ Two major genetic mutations in non-small cell lung carcino- mas (NSCLCs), epidermal growth factor receptor (EGFR) and  KRAS, have been well studied.",Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13Histological Features of ALK-Positive Pulmonary Adenocarcinoma   •     311 features of ALK-positive pulmonary adenocarcinoma, in order to  identify important histologic findings in small biopsied speci- mens whose architecture is difficult to assess and to evaluate  whether the combination of these morphologic features and IHC results can overcome the shortcomings of FISH.",Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13312     •  Choi IH et al.,OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13Histological Features of ALK-Positive Pulmonary Adenocarcinoma   •     313 tive (0 or 1+) or failed ALK-IHC and positive ALK-FISH.,Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13314     •  Choi IH et al.,OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13Histological Features of ALK-Positive Pulmonary Adenocarcinoma   •     315 ative group.,Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13316     •  Choi IH et al.,OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.13Histological Features of ALK-Positive Pulmonary Adenocarcinoma   •     317 time-consuming process, dependency on many conditions, in- cluding skill of interpretation, and preparation of material such as  quantity and quality of tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/de/d6/jptm-49-4-310.PMC4508568.pdf
"318pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancers with Higher Density of Tumor-Associated Macrophages   Were Associated with Poor Survival Rates Kyong Yeun Jung1,2 · Sun Wook Cho1,3  Young A Kim4 · Daein Kim3  Byung-Chul Oh5 · Do Joon Park1  Young Joo Park1 1Department of Internal Medicine, Seoul National  University College of Medicine, Seoul;   2Department of Internal Medicine,   Eulji University School of Medicine, Seoul;  3Department of Internal Medicine,   National Medical Center, Seoul; 4Department of  Pathology, SMG-SNU Boramae Medical Center,  Seoul; 5Lee Gil Ya Cancer and Diabetes Institute,  Gachon University Graduate School of Medicine, Incheon, KoreaBackground:  Macrophages are a component of a tumor’s microenvironment and have various  roles in tumor progression and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"Key Words:  Tumor-associated macrophage; Prognosis; NeoplasmsReceived: May 21, 2015 Accepted: June 1 2015 Corresponding Author Young Joo Park, MD, PhD Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-2072-4183Fax: +82-2-764-2199E-mail: yjparkmd@snu.ac.krJournal of Pathology and Translational Medicine 2015; 49: 318-324 http://dx.doi.org/10.4132/jptm.2015.06.01▒ ORIGINAL ARTICLE ▒ The tumor microenvironment includes cancer cells and vari- ous stromal cells, including immune cells, fibroblasts, and vas- cular endothelial cells.1 Tumor-associated macrophages (TAMs)  are also present in the tumor microenvironment and are impor - tant in tumor progression and metastasis.2 TAMs can induce  neoplastic cell transformation, elicit tumor destructive reactions,  and have either negative or positive effects on tumor growth.3  Several reports have suggested that TAMs are associated with tumor growth, disease progression, and poor prognosis in some  human cancers.",Non-OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01Tumor-Associated Macrophages and Prognosis   •     319 vided the clinical information associated with each section, in- cluding age at surgery; gender; pathologic diagnosis; TNM  staging for cancers; survival/death follow-up result for lung and  breast cancers; and estrogen receptor (ER), progesterone receptor (PR), p53, and C-erbB2 expression for breast cancers.",Non-OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01320     •  Jung KY, et al.",OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01Tumor-Associated Macrophages and Prognosis   •     321 aluated by assessing adenocarcinoma and squamous cell carcino - ma of lung cancer, infiltrating ductal carcinoma of breast cancer,  and PTC.",Non-OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01322     •  Jung KY, et al.",OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01Tumor-Associated Macrophages and Prognosis   •     323 phocytic and macrophage infiltration, microvessel density and sur - vival in patients with primary operable breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.06.01324     •  Jung KY, et al.",OADS,/arxiv_data1/oa_pdf/8a/bf/jptm-49-4-318.PMC4508569.pdf
"325© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy   for an Otherwise Commonly Misinterpreted Neoplasm Paola A. Escalante Abril   Miguel Fdo.",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
"Tel: +52-55-01-55-2789-2000E-mail: k7nigricans@hotmail.comJournal of Pathology and Translational Medicine 2015; 49: 325-330 http://dx.doi.org/10.4132/jptm.2015.05.20▒ CASE STUDY ▒ Analogous to the mixed epithelial/mesenchymal tumours seen  in Müllerian derivatives, some glial neoplasms can display a bi- morphic appearance due to an accompanying mesodermal com- ponent.",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.20326     •  Escalante Abril  PA, et al.",OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.20WHO Grade IV Gliofibroma   •     327 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.20328     •  Escalante Abril  PA, et al.",OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.20WHO Grade IV Gliofibroma   •     329 in less than 5% of the overall tumour.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.20330     •  Escalante Abril  PA, et al.",OADS,/arxiv_data1/oa_pdf/d0/7a/jptm-49-4-325.PMC4508570.pdf
"331© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 A Rare Case of Primary Tubular Adenocarcinoma of the Thymus,   Enteric Immunophenotype: A Case Study and Review of the Literature Hae Yoen Jung · Hyundeuk Cho   Jin-Haeng Chung1 · Sang Byoung Bae2   Ji-Hye Lee · Hyun Ju Lee Si-Hyong Jang · Mee-Hye Oh Department of Pathology, Soonchunhyang  University Cheonan Hospital, Cheonan;   1Department of Pathology and Respiratory  Center, Seoul National University Bundang  Hospital, Seongnam; 2Division of Hematology  and Oncology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, KoreaThymic carcinomas are uncommon malignant tumors, and thymic adenocarcinomas are ex - tremely rare.",Non-OADS,/arxiv_data1/oa_pdf/8a/fe/jptm-49-4-331.PMC4508571.pdf
"Key Words:  Thymus gland; Adenocarcinoma; Keratin-20; Caudal type homeobox 2Received: March 10, 2015 Revised: April 8, 2015Accepted: April 16, 2015 Corresponding Author Mee-Hye Oh, MD, PhDDepartment of Pathology, Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-3580Fax: +82-41-570-3580E-mail: mhoh0212@schmc.ac.krJournal of Pathology and Translational Medicine 2015; 49: 331-334 http://dx.doi.org/10.4132/jptm.2015.04.16▒ CASE STUDY ▒ Thymic carcinomas are uncommon malignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/8a/fe/jptm-49-4-331.PMC4508571.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.16332     •  Jung HY, et al.",OADS,/arxiv_data1/oa_pdf/8a/fe/jptm-49-4-331.PMC4508571.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.16Primary Thymic Adenocarcinoma   •     333 lar adenocarcinomas (7.7%).,Non-OADS,/arxiv_data1/oa_pdf/8a/fe/jptm-49-4-331.PMC4508571.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.16334     •  Jung HY, et al.",OADS,/arxiv_data1/oa_pdf/8a/fe/jptm-49-4-331.PMC4508571.pdf
"335© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Sclerosing Extramedullary Hematopoietic Tumor   Mimicking Intra-abdominal Sarcoma Serap Karaarslan · Nalan Nese1 · Guray Oncel2 · Nazan Ozsan3 · Taner Akalin3   Hasan Kaplan4 · Filiz Buyukkececi5 · Mine Hekimgil3 Department of Pathology, Sifa University Faculty of Medicine, Izmir; 1Department of Pathology, Celal Bayar University Faculty of Medicine, Izmir;   2Department of Radiology, Sifa University Faculty of Medicine, Izmir; 3Department of Pathology, Ege University Faculty of Medicine, Izmir;   4Department of General Surgery, Sifa University Faculty of Medicine, Izmir; 5Department of Hematology, Kent Hospital, Izmir, TurkeyJournal of Pathology and Translational Medicine 2015; 49: 335-338 http://dx.doi.org/10.4132/jptm.2015.04.22▒ BRIEF CASE REPORT ▒ Sclerosing extramedullary hematopoietic tumor (SEMHT) is  a rare tumor that occurs in patients with chronic myeloprolifer - ative disorders (CMPDs).",Non-OADS,/arxiv_data1/oa_pdf/96/5c/jptm-49-4-335.PMC4508572.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.22336     •  Karaarslan S et al.,OADS,/arxiv_data1/oa_pdf/96/5c/jptm-49-4-335.PMC4508572.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.22Hematopoietic Tumor Mimicking Sarcoma   •     337 lated to SEMHT.,Non-OADS,/arxiv_data1/oa_pdf/96/5c/jptm-49-4-335.PMC4508572.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.22338     •  Karaarslan S et al.,OADS,/arxiv_data1/oa_pdf/96/5c/jptm-49-4-335.PMC4508572.pdf
"339© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Ureteral Marginal Zone Lymphoma of Mucosa-Associated Lymphoid   Tissue, Chronic Inflammation, and Renal Artery Atherosclerosis  Hojung Lee · Jong Eun Joo · Young Ok Hong · Won Mi Lee   Eun Kyung Kim · Jeong Joo Woo1 · Soo Jung Gong2 · Jooryung Huh3 Departments of Pathology, 1Radiology, and 2Internal Medicine, Eulji General Hospital, Eulji University College of Medicine, Seoul;   3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2015; 49: 339-342 http://dx.doi.org/10.4132/jptm.2015.04.28▒ BRIEF CASE REPORT ▒ Malignant lymphoma of the upper urinary tract including the  renal pelvis and ureter is extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/8b/fc/jptm-49-4-339.PMC4508573.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.28340     •  Lee H, et al.",OADS,/arxiv_data1/oa_pdf/8b/fc/jptm-49-4-339.PMC4508573.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.28Ureteral MALT Lymphoma and Inflammation   •     341 manifest as ureteral MALT lymphoma and renal artery athero - sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/8b/fc/jptm-49-4-339.PMC4508573.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.28342     •  Lee H, et al.",OADS,/arxiv_data1/oa_pdf/8b/fc/jptm-49-4-339.PMC4508573.pdf
"343© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Late Bone Metastasis of Histologically Bland Struma Ovarii:   The Unpredictability of Its Biologic Behavior Sun-Ju Oh · Minjung Jung · Young-Ok Kim Department of Pathology, Kosin University Gospel Hospital, Busan, KoreaJournal of Pathology and Translational Medicine 2015; 49: 343-345 http://dx.doi.org/10.4132/jptm.2015.04.27▒ BRIEF CASE REPORT ▒ Struma ovarii (SO) is a subtype of ovarian teratoma that con- tains mostly thyroid tissue comprising more than 50% of the tu- mor volume.1 It is the most common type of monodermal tera- toma of the ovary, accounting for approximately 2.7% of all te-ratomas.",Non-OADS,/arxiv_data1/oa_pdf/35/dd/jptm-49-4-343.PMC4508574.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.27344     •  Oh S-J, et al.",OADS,/arxiv_data1/oa_pdf/35/dd/jptm-49-4-343.PMC4508574.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.27Malignant Struma Ovarii   •     345 plastic thyroid tissue is sometimes associated with recurrence or  extra-ovarian metastasis, which have previously been designated  as peritoneal strumosis, malignant SO, metastatic SO, or related  terms.3 Roth and Karseladze2 described three cases of SO with  extra-ovarian dissemination having an innocuous appearance  resembling that of a colloid or nodular goiter.",Non-OADS,/arxiv_data1/oa_pdf/35/dd/jptm-49-4-343.PMC4508574.pdf
"346pISSN 2383-7837 eISSN 2383-7845 © 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Necrotizing Sarcoid Granulomatosis: Possibly Veiled Disease in   Endemic Area of Mycobacterial Infection Yosep Chong · Eun Jung Lee · Chang Suk Kang · Tae-Jung Kim · Jung Sup Song1 · Hyosup Shim2 Departments of Hospital Pathology and 1Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul;   2Department of Pathology, Yonsei University College of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2015; 49: 346-350 http://dx.doi.org/10.4132/jptm.2015.04.17▒ BRIEF CASE REPORT ▒ Corresponding Author Tae-Jung Kim, MD, PhD Department of Hospital Pathology, Yeouido St. Mary’s Hospital, 10 63-ro,   Yeongdeungpo-gu, Seoul 150-713, Korea  Tel: +82-2-3779-2157, Fax: +82-2-783-6648, E-mail: kimecho@catholic.ac.kr Received:  February 2, 2015  Revised:  April 2, 2015 Accepted:  April 16, 2015Necrotizing sarcoid granulomatosis (NSG) is a rare granulo - matous disease that primarily affects the lung and presents as  nodular masses of confluent sarcoid-like granulomas with ex - tensive necrosis and vasculitis.1 Proper diagnosis and treatment  are challenging for clinicians, radiologists, and pathologists be - cause of the rarity and diagnostic difficulty of this disease.2-4  Since it was first described by Liebow,1 only 135 cases have been  reported.2,4,5 In addition to its rarity, the similarity of the clinical, radiolog - ical, and pathological features of NSG to other granulomatous  diseases, such as granulomatous infection, nodular sarcoidosis,  and Wegener’s granulomatosis (WG), is the largest obstacle in  its proper diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/bc/09/jptm-49-4-346.PMC4508575.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.17Necrotizing Sarcoid Granulomatosis   •     347 lymphohistiocytes.,Non-OADS,/arxiv_data1/oa_pdf/bc/09/jptm-49-4-346.PMC4508575.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.17348     •  Chong Y, et al.",OADS,/arxiv_data1/oa_pdf/bc/09/jptm-49-4-346.PMC4508575.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.17Necrotizing Sarcoid Granulomatosis   •     349 findings include multiple lung nodules without hilar lymphade - nopathy.,Non-OADS,/arxiv_data1/oa_pdf/bc/09/jptm-49-4-346.PMC4508575.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.04.17350     •  Chong Y, et al.",OADS,/arxiv_data1/oa_pdf/bc/09/jptm-49-4-346.PMC4508575.pdf
"351© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Salivary Gland Hyalinizing Clear Cell Carcinoma Jung-Chia Lin1 · Jia-Bin Liao1,2 · Hsiao-Ting Fu1 · Ting-Shou Chang2,3,4 · Jyh-Seng Wang1,2,5 1Department of Pathology and Lab Medicine, Kaohsiung Veterans General Hospital, Kaohsiung; 2National Defense Medical Center, Taipei;   3Department of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung; 4Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan;  5Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.Journal of Pathology and Translational Medicine 2015; 49: 351-353 http://dx.doi.org/10.4132/jptm.2015.05.06▒ BRIEF CASE REPORT ▒ Hyalinizing clear cell carcinoma (HCCC) is a rare malignant  salivary gland tumor that was characterized as a distinct entity  by Milchgrub et al.",Non-OADS,/arxiv_data1/oa_pdf/12/40/jptm-49-4-351.PMC4508576.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.06352     •  Lin J-C, et al.",OADS,/arxiv_data1/oa_pdf/12/40/jptm-49-4-351.PMC4508576.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.05.06Salivary Gland Hyalinizing Clear Cell Carcinoma   •     353 presence of EWSR1 rearrangement.,Non-OADS,/arxiv_data1/oa_pdf/12/40/jptm-49-4-351.PMC4508576.pdf
11. http://www.sofar.ro/sisteme-diagnosticare/cal-detect.html 12.,Non-OADS,/arxiv_data1/oa_pdf/61/d6/cm8703p163.PMC4508585.pdf
Available from:  http://www.who.int/worldblooddonorday/campaignkit/WBDD_ GlobalNeed_English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/cm8703p159.PMC4508586.pdf
Available from: http://www.ginasthma.org  9.,Non-OADS,/arxiv_data1/oa_pdf/5e/be/cm8703p171.PMC4508587.pdf
75. http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/68/c9/cm8703p135.PMC4508592.pdf
Available from: http://www.reference.,Non-OADS,/arxiv_data1/oa_pdf/e2/55/cm8703p182.PMC4508596.pdf
Aviable from: http://www.guideline.gov/content.,Non-OADS,/arxiv_data1/oa_pdf/e2/55/cm8703p182.PMC4508596.pdf
Available from:  http://posters.webges.com/e-Poster/poster.php?id=1057&step=2 .,Non-OADS,/arxiv_data1/oa_pdf/11/ff/cm8801p50.PMC4508601.pdf
Available from:http://www.artsennet.nl/nieuws/nieuws- onderzoeken/nieuwsartikel/32136/richtlijn-liesbreuken- ontwikkeld-via-internet.htm .,Non-OADS,/arxiv_data1/oa_pdf/29/f4/cm8801p58.PMC4508607.pdf
Available from: http://www.sciencedirect.com/ science/book/9780123850959 .,Non-OADS,/arxiv_data1/oa_pdf/89/c9/cm8801p3.PMC4508609.pdf
"Original image, selected by a pannel of reviewers from  the internet: http://renatabeautyandelegance.blogspot.ro/2012/03/ becca-cosmetics.htm",Non-OADS,/arxiv_data1/oa_pdf/0d/80/cm8801p73.PMC4508613.pdf
Availabile from: http://nvbdcp.gov.in/Doc/Diagnosis- Treatment-Malaria-2013.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/20/c7/pr-2015-2-5859.PMC4508623.pdf
Available from: http://www.who.int/mentalhealth/manage- ment/depression/definition/en.,Non-OADS,/arxiv_data1/oa_pdf/7a/f2/pr-2015-2-5872.PMC4508624.pdf
Available from: http://www.who.int/whr/2008/whr08_en.pdf 72.,OADS,/arxiv_data1/oa_pdf/7a/f2/pr-2015-2-5872.PMC4508624.pdf
Available from:  http://www.ncbi.nlm.nih.gov/clinvar /5359551/.,Non-OADS,/arxiv_data1/oa_pdf/fa/9a/pr-2015-2-5955.PMC4508625.pdf
Available from: https://hrdag.org/wp-content/uploads/ 2013/08/kosovo-politicalkillings-2000- cc.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
Available from: http://www.proasyl.de/fileadmin/ proasyl/fm_redakteure/Newsletter_Anhaenge/122/Longtime.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
Available from: http://edukimi.uni- pr.edu/getattachment/Personeli/Personeli- akademik/Xhafer-Ismajli/Syllabusi- PSIKOLOGJI--E-PERGJITHSHME.pdf.aspx 10.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
Available from http://www.ptsd.va.gov/professional/newsletters/research-quarterly/v22n2.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
Available from: http://digitalcollections.sit.edu/cgi/view- content.cgi?article=1228&context=isp_co llection 16.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
Available from: http://www.gift- fromwithin.org/pdf/culture.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/mi-2015-1-5609.PMC4508626.pdf
"In: Luck G, Brabant O, eds.Proceedings of the 3rd InternationalConference on Music & Emotion (ICME3).Jyväskylä: University of Jyväskylä,Department of Music (http://urn.fi/URN:NBN:fi:jyu-201305291829), 2013.",Non-OADS,/arxiv_data1/oa_pdf/77/85/mi-2015-1-5784.PMC4508630.pdf
Available from: pdf-file:http://www.wfmt.info/Musictherapyworld/modules/mmmagazine/issues/20080108093144/20080108100520/MTT8_3_Gebhardt_Georgi.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/77/85/mi-2015-1-5784.PMC4508630.pdf
"Key Words:  Orbital shear stress, Endothelial cells, Akt phosphorylation, Nitric oxide                    synthase Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/57/vsi-31-33.PMC4508651.pdf
Vasc Spec Int 2015;31(2):33-40  • http://dx.doi.org/10.5758/vsi.2015.31.2.33,Non-OADS,/arxiv_data1/oa_pdf/76/57/vsi-31-33.PMC4508651.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.33 Different Effects of Orbital Shear Stress on Vascular Endothelial Cells 3510-0 prolene (Microsurgery Instrument Inc., Bellaire, TX,  USA).",OADS,/arxiv_data1/oa_pdf/76/57/vsi-31-33.PMC4508651.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.33 Different Effects of Orbital Shear Stress on Vascular Endothelial Cells 37with the Student's t-test, post hoc test and ANOVA test and  then judged as statistically significant when the P-value  was less than 0.05.",Non-OADS,/arxiv_data1/oa_pdf/76/57/vsi-31-33.PMC4508651.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.33 Different Effects of Orbital Shear Stress on Vascular Endothelial Cells 39stress difference was calculated by the modified Hagen- Poiseuille equation ( τ = 4ηQ/πr³;η is blood viscosity, Q is flow  rate in milliliters per second, and r is radius in centimeters)  after 6 weeks of applied conditions.",OADS,/arxiv_data1/oa_pdf/76/57/vsi-31-33.PMC4508651.pdf
"Key Words:  Abdominal aortic aneurysm, Kidney/abnormalities, Renal artery Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/12/vsi-31-54.PMC4508652.pdf
Vasc Spec Int 2015;31(2):54-57  • http://dx.doi.org/10.5758/vsi.2015.31.2.54,Non-OADS,/arxiv_data1/oa_pdf/f4/12/vsi-31-54.PMC4508652.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.54 Open Surgical Repair of AAA Coexisting with Horseshoe Kidney 55serum creatinine level of 0.90 mg/dL.,Non-OADS,/arxiv_data1/oa_pdf/f4/12/vsi-31-54.PMC4508652.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.54 Open Surgical Repair of AAA Coexisting with Horseshoe Kidney 577) O'Hara PJ, Hakaim AG, Hertzer NR,  Krajewski LP, Cox GS, Beven EG.",Non-OADS,/arxiv_data1/oa_pdf/f4/12/vsi-31-54.PMC4508652.pdf
"Key Words:  Acute iliofemoral deep vein thrombosis, Iliac vein stenting, Post-          thrombotic syndrome, Villalta scale Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/ba/vsi-31-47.PMC4508653.pdf
Vasc Spec Int 2015;31(2):47-53  • http://dx.doi.org/10.5758/vsi.2015.31.2.47,Non-OADS,/arxiv_data1/oa_pdf/db/ba/vsi-31-47.PMC4508653.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.47 Catheter Directed Thrombolysis and Stenting in Ilio-femoral Vein Thrombosis 492) Treatment procedures For patients with lower leg edema, several basic labo - ratory tests were checked such as D-dimer, albumin, BUN  and creatinine.",Non-OADS,/arxiv_data1/oa_pdf/db/ba/vsi-31-47.PMC4508653.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.47 Catheter Directed Thrombolysis and Stenting in Ilio-femoral Vein Thrombosis 51nificant difference between the two groups (P=0.97; Fig.,Non-OADS,/arxiv_data1/oa_pdf/db/ba/vsi-31-47.PMC4508653.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.47 Catheter Directed Thrombolysis and Stenting in Ilio-femoral Vein Thrombosis 533) Ashrani AA, Heit JA.",Non-OADS,/arxiv_data1/oa_pdf/db/ba/vsi-31-47.PMC4508653.pdf
"Key Words:  Spontaneous rupture, Iliac vein, Hemoperitoneum Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/d9/vsi-31-62.PMC4508654.pdf
Vasc Spec Int 2015;31(2):62-65  • http://dx.doi.org/10.5758/vsi.2015.31.2.62,Non-OADS,/arxiv_data1/oa_pdf/8d/d9/vsi-31-62.PMC4508654.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.62 Spontaneous Iliac Vein Rupture 63arteries ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/d9/vsi-31-62.PMC4508654.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.62 Spontaneous Iliac Vein Rupture 65term decreased mobility owing to spinal stenosis.,Non-OADS,/arxiv_data1/oa_pdf/8d/d9/vsi-31-62.PMC4508654.pdf
"Key Words:  Aortic diseases, Polycystic kidney diseases, Endovascular procedures Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/8d/vsi-31-58.PMC4508655.pdf
Vasc Spec Int 2015;31(2):58-61  • http://dx.doi.org/10.5758/vsi.2015.31.2.58,Non-OADS,/arxiv_data1/oa_pdf/34/8d/vsi-31-58.PMC4508655.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.58 Endovascular Procedure for Aortic Dissection 5914.3 mm) and minimal amount of pericardial effusion with  a left ventricular ejection fraction of 56%.,Non-OADS,/arxiv_data1/oa_pdf/34/8d/vsi-31-58.PMC4508655.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.58 Endovascular Procedure for Aortic Dissection 61intervention.,Non-OADS,/arxiv_data1/oa_pdf/34/8d/vsi-31-58.PMC4508655.pdf
"Key Words:  Infected aneurysm, Operation, Endovascular procedure, Bypass,  Mycobacterium Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/58/vsi-31-41.PMC4508656.pdf
Vasc Spec Int 2015;31(2):41-46  • http://dx.doi.org/10.5758/vsi.2015.31.2.41,Non-OADS,/arxiv_data1/oa_pdf/a6/58/vsi-31-41.PMC4508656.pdf
http://dx.doi.org/10.5758/vsi.2015.31.2.41 Surgical Treatment of Infected Aortoiliac Aneurysm 43urysm after stent insertion for iliac stenosis.,Non-OADS,/arxiv_data1/oa_pdf/a6/58/vsi-31-41.PMC4508656.pdf
"http://dx.doi.org/10.5758/vsi.2015.31.2.41 Surgical Treatment of Infected Aortoiliac Aneurysm 45bridement of the infected field [2,4,6,15].",Non-OADS,/arxiv_data1/oa_pdf/a6/58/vsi-31-41.PMC4508656.pdf
"DTI-TBSS of INPH603 Neurol Med Chir (Tokyo) 53, September, 2013 of the tract.32) To keep the procedures simple,  the default settings recommended in the TBSS  manual (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS) were used.",Non-OADS,/arxiv_data1/oa_pdf/ae/9a/nmc-53-601.PMC4508678.pdf
"Statistical analyses were performed using the R version 2.15.1 software package (R Core Team, 2012; Foundation for Statistical Computing, Vienna, Austria; ISBN 3-900051-07-0; URL: http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/cd/f0/nmc-54-40.PMC4508694.pdf
medical information about the patients was anonymized and retrospectively regis - tered via a website (https://jr-net.tri-kobe.net/jr-net/).,Non-OADS,/arxiv_data1/oa_pdf/82/8c/nmc-54-1.PMC4508695.pdf
"data were collected at the Translational research  informatics center (Tri, http://www.tri-kobe.org/).",OADS,/arxiv_data1/oa_pdf/82/8c/nmc-54-1.PMC4508695.pdf
"The study protocol, which is summarized briefly here, is available on line with the full text of this article (https://jr-net.tri-kobe.net/jr-net/).",Non-OADS,/arxiv_data1/oa_pdf/82/8c/nmc-54-1.PMC4508695.pdf
"Waltham, Upt oDate: http://www.uptodate.com/contents/ moyamoya-disease-etiology-clinical-features-and-diagnosis  3) takahashi JC, Miyamoto S: Moyamoya disease: recent progress  and outlook.",Non-OADS,/arxiv_data1/oa_pdf/34/cc/nmc-54-133.PMC4508707.pdf
"Waltham, Upt oDate:   http://www.uptodate.com/contents/moyamoya-disease- treatment-and-prognosis  5) Kuriyama S, Kusaka Y, Fujimura M, Wakai K, t amakoshi a,  Hashimoto S, t suji i, inaba Y, Yoshimoto t : Prevalence and  clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.",OADS,/arxiv_data1/oa_pdf/34/cc/nmc-54-133.PMC4508707.pdf
"Available at http://www.asahq.org/Home/For- members/Clinical- information/ ASA-Physical-Status-Classification-System, 2011.",Non-OADS,/arxiv_data1/oa_pdf/3d/62/nmc-53-870.PMC4508737.pdf
Available at http://www.spine.org/Documents/ Lumbar Stenosis11.pdf pp 63–64 2011.,Non-OADS,/arxiv_data1/oa_pdf/3d/62/nmc-53-870.PMC4508737.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*K.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
The online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201503039/DC1.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"11:832– 838. http://dx.doi.org/10.1038/ncb1890Chang, P., M. Coughlin, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1038/ncb1322 Chang, W., J.N.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"391:177– 184. http://dx.doi.org/10.1042/BJ20050885 Chang, P., M.  Coughlin, and T.J.  Mitchison.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1083/jcb.120.4.947 Cooper, E.M., C.  Cutcliffe, T.Z.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1038/emboj.2009.27 Cooper, E.M., J.D.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1074/ jbc.M109.059667 DeLuca, J.G., B. Moree, J.M.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/S1097-2765(03)00424-6 Fant, X., A. Merdes, and L. Haren.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/ S0074-7696(04)38001-0 Fededa, J.P., and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1038/ncb2482 Feng, L., J. Huang, and J. Chen.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1101/gad.1770609 Feng, L., J. Wang, and J. Chen.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1177/1947601912473477 Gadde, S., and R.  Heald.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/j.cub.2004.09.02115380094 Gruss, O.J., and I.  Vernos.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"2:64. http://dx.doi.org/10.1186/1756-0500-2-64 Holland, A.J., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1172/JCI66420 Hu, X., J.A.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1074/jbc.M110.200857 Hua, S., Z. Wang, K. Jiang, Y .",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"127:539– 552. http://dx.doi.org/10.1016/j.cell.2006.08.053 Khodjakov, A., L. Copenagle, M.B.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1083/jcb.200208143 Kisurina-Evgenieva, O., G.  Mack, Q.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.org/10.1242/ jcs.01568,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1146/annurev-biochem-060310-170328 Komander, D., M.J. Clague, and S. Urbé.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"10:550– 563. http://dx.doi.org/10.1038/nrm2731 Manning, A.L., and D.A.Compton.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/j.cub.2006.11.071 Merdes, A., K. Ramyar, J.D.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81365-3 Merdes, A., R.  Heald, K.  Samejima, W.C.  Earnshaw, and D.W.  Cleveland.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1083/ jcb.149.4.851 Meunier, S., and I. Vernos.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1038/ncb2372 Radulescu, A.E., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1007/BF00293368 Rieder, C.L. 2005.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1042/ BC20080218 Saredi, A., L.  Howard, and D.A.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1101/gad.1739609 Silk, A.D., A.J.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1083/jcb.200810091 Silljé, H.H., S.  Nagel, R.  Körner, and E.A.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/j.cub.2006.02.070 Skoufias, D.A., S. DeBonis, Y .",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1074/jbc.M511735200 Sobhian, B., G.  Shao, D.R.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"316:1198– 1202. http://dx.doi.org/10.1126/science.1139516 Stegmeier, F., M.  Rape, V .M.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1038/nature05694 Stegmeier, F., M.E.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1101/ gad.1770309 Wiese, C., A. Wilde, M.S.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1126/ science.1057661 Wittmann, T., M. Wilm, E. Karsenti, and I. Vernos.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1083/jcb.149.7.1405 Wong, R.W., G. Blobel, and E. Coutavas.",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1074/jbc.C300249200 Yang, Z., U.S. Tulu, P. Wadsworth, and C.L. Rieder.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1016/j.cub.2007.04.056 Yang, Y ., M. Liu, D. Li, J.",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"http://dx.doi.org/10.1073/ pnas.1319341111 Zhang, J., M. Cao, J. Dong, C. Li, W. Xu, Y .",OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"5:5059. http://dx.doi.org/10.1038/ncomms6059 Zheng, H., V .",Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/85/JCB_201503039.PMC4508884.pdf
"Two-color imaging of tethered vesicles with  Myo2p, the GEF Sec2p, and several exocyst components allowed us to document a timeline for yeast exocytosis in which  Myo2p leaves 4 s before fusion, whereas Sec2p and all the components of the exocyst disperse coincident with fusion.Tracking individual secretory vesicles during  exocytosis reveals an ordered and regulated process Kirk W. Donovan and Anthony Bretscher Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853 © 2015 Donovan and Bretscher This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Anthony Bretscher: apb5@cornell.edu Abbreviations used in this paper: FLIP, fluorescence loss in photobleaching;  GAP, GTPase activating protein.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201501118/DC1.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.200408124 Brennwald, P., and G.  Rossi.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.febslet.2007.03.043 Carr, C.M., E. Grote, M. Munson, F.M.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/jcb.146.2.333 D’Adamo, P., A. Menegon, C. Lo Nigro, M. Grasso, M. Gulisano, F. Tamanini,  T. Bienvenu, A.K.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1038/487 Donovan, K.W., and A. Bretscher.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.09.001 Donovan, K.W., and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"4:260–269) http://dx.doi.org/10.1038/ncb718 Gao, X.-D., S. Albert, S.E.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/jcb.200302038 Gietz, R.D., R.H. Schiestl, A.R.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1002/yea.320110408 Grosshans, B.L., A. Andreeva, A. Gangar, S. Niessen, J.R. Yates III, P. Brennwald,  and P. Novick.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1093/emboj/18.4.1071 Guo, W., F.  Tamanoi, and P.  Novick.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80493-6 Jin, Y ., A. Sultana, P. Gandhi, E. Franklin, S. Hamamoto, A.R.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.10.009 Johnston, G.C., J.A.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.113.3.539 Lamping, E., K. Tanabe, M. Niimi, Y .",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.gene.2005.07.014 Lehman, K., G. Rossi, J.E.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"146:125– 140. http://dx.doi.org/10.1083/jcb.146.1.125 Lillie, S.H., and S.S. Brown.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.org/10.1083/jcb.125.4.825,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/0092-8674(89)90961-6 Longtine, M.S., A.  McKenzie III, D.J.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U Luo, G., J. Zhang, and W. Guo.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1091/mbc.E14-04-0907 Mizuno-Yamasaki, E., M.  Medkova, J.  Coleman, and P.  Novick.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.03.016 Morgera, F., M.R.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/0092-8674(80)90128-2 Ortiz, D., M. Medkova, C. Walch-Solimena, and P. Novick.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/jcb.200201003 Rivera-Molina, F., and D. Toomre.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/jcb.201212103 Robinson, N.G., L. Guo, J. Imai, A. Toh-E, Y .",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1091/mbc.E10-07-0570 Salminen, A., and P.J.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/0092-8674(87)90455-7 Santiago-Tirado, F.H., A.  Legesse-Miller, D.  Schott, and A.  Bretscher.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.11.006 Schott, D., J. Ho, D. Pruyne, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.147.4.791 Schott, D.H., R.N.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/jcb.200110086 Scott, B.L., J.S.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.200405018 Sherman, F. 2002.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1021/bi048008z Stalder, D., E.  Mizuno-Yamasaki, M.  Ghassemian, and P.J.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.130.2.299 Togneri, J., Y .-S.  Cheng, M.  Munson, F.M.",OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
"http://dx.doi.org/10.1083/ jcb.137.7.1495 Walworth, N.C., P.  Brennwald, A.K.",Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
http://dx.doi.org/10.1016/S0092-8674(01)00363-4,OADS,/arxiv_data1/oa_pdf/18/3e/JCB_201501118.PMC4508886.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*M-T.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201501018/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/ncb2262 Astin, J.W., J. Batson, S. Kadir, J. Charlet, R.A. Persad, D. Gillatt, J.D.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/ncb2122 Batlle, E., and D.G. Wilkinson.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)01015-2 Bement, W.M., and M.S. Mooseker.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1002/ cm.970310202 Charras, G.T., C.K.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/ng.2007.11 Diz-Muñoz, A., M.  Krieg, M.  Bergert, I.  Ibarlucea-Benitez, D.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1371/journal.pbio.1000544 Evans, I.R., T. Renne, F.B.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1242/jcs.03333 Fagotto, F., N. Rohani, A.S. Touret, and R. Li.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1016/j.cell.2009.08.048 Gliksman, N.R., G.  Santoyo, K.D.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1074/jbc.M008319200 Groeger, G., and C.D. Nobes.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1042/BJ20070146 Irie, F., and Y .",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/nn964 Kayser, M.S., M.J. Nolt, and M.B. Dalva.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.05.007 Klein, R.  2012.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1242/dev.074997 Komaba, S., and L.M. Coluccio.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"285:27686– 27693. http://dx.doi.org/10.1074/jbc.M109.087270 Marston, D.J., S.  Dickinson, and C.D.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/ncb1044 Martin, R., A.  Jäger, M.  Böhl, S.  Richter, R.  Fedorov, D.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/21907 Moeller, M.L., Y .",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1074/jbc.M511756200 Mohamed, A.M., J.R.  Boudreau, F.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.org/10.1007/s00018-009-0254-5,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1128/EC.1.2.213-228.2002 Poliakov, A., M.L.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1083/ jcb.200807151 Raposo, G., M.N.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81560-3 Riedl, J.A., D.T.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1042/ BJ20050048 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1242/jcs.02607 Schaupp, A., O. Sabet, I. Dudanova, M. Ponserre, P. Bastiaens, and R. Klein.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1083/jcb.201305037Sheetz, M.P. 2001.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/35073095 Tang, N., and E.M.  Ostap.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1016/ S0960-9822(01)00320-7 Tolias, K.F., J.B. Bikoff, C.G.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.4161/cib.3.1.10141 Vignjevic, D., M.  Schoumacher, N.  Gavert, K.P.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-07-0929 Wybenga-Groot, L.E., B. Baskin, S.H.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"106:745– 757. http://dx.doi.org/10.1016/S0092-8674(01)00496-2 Xu, Q., G. Mellitzer, V .",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.1038/20452 Yamada, A., A.  Mamane, J.  Lee-Tin-Wah, J.",OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"http://dx.doi.org/10.4161/ cam.5.5.16971 Zimmer, M., A. Palmer, J. Köhler, and R. Klein.",Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
http://dx.doi.org/10.1038/ncb1045,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/JCB_201501018.PMC4508888.pdf
"They demon - strate that resolution of G4 structures on the G-rich tem - plate strand of the telomere requires some overlapping  functions of BLM and WRN helicase for leading strand  synthesis.Beginning at the end: DNA replication within the  telomere Susan A. Gerbi Division of Biology and Medicine, Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912 © 2015 Gerbi This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1038/nchem.1548 Cesare, A.J., N. Quinney, S. Willcox, D. Subramanian, and J.D. Griffith.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1046/j.1365-313X.2003.01882.x Crabbe, L., R.E.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1126/science.1103619 Doksani, Y ., J.Y .",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1016/j.cell.2013.09.048 Drosopoulos, W.C., S.T.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1083/jcb.201112083 Drosopoulos, W.C., S.T.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1083/jcb.201410061 Erliandri, I., H.  Fu, M.  Nakano, J.H.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1093/nar/ gku835 Fry, M., and L.A.  Loeb.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1074/ jbc.274.18.12797 Greider, C.W., and E.H.  Blackburn.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80760-6 Ivessa, A.S., J.Q.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1101/gad.982902 Kurth, I., and J.  Gautier.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1093/nar/gkp929 Lopes, J., A.  Piazza, R.  Bermejo, B.  Kriegsman, A.  Colosio, M.P.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1128/ MCB.24.9.4019-4031.2004 McClintock, B. 1939.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1093/ nar/29.13.2843 Muller, H. J. 1938.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1016/j.cell.2011.04.015 Paeschke, K., M.L.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1038/nature12149 Sfeir, A., S.T.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.021 Soudet, J., P. Jolivet, and M.T. Teixeira.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"http://dx.doi.org/10.1016/j.molcel.2014.02.030 Watson, J.D. 1972.",OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
"239:197– 201. http://dx.doi.org/10.1038/newbio239197a0 Zakian, V .A. 1976.",Non-OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
http://dx.doi.org/10.1016/S0022-2836(76)80123-4,OADS,/arxiv_data1/oa_pdf/98/05/JCB_201506078.PMC4508890.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to William C. Drosopoulos: drosopou@aecom.yu.edu; or Carl  L. Schildkraut: schildkr@aecom.yu.edu Abbreviations used in this paper: CldU, chlorodeoxyuridine; G4, G-quadruplex;  IdU, iododeoxyuridine; IF, immunofluorescence; SMARD, single molecule anal - ysis of replicated DNA.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201410061/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.org/10.1093/nar/ gks407,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/nchem.1548 Biffi, G., M.  Di Antonio, D.  Tannahill, and S.  Balasubramanian.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"34:5402– 5415. http://dx.doi.org/10.1093/nar/gkl655 Byun, T.S., M.  Pacek, M.C.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1101/gad.1301205 Chan, K.L., P.S.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601777 Chavez, A., A.M.  Tsou, and F.B.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.bbadis.2009.02.008 Chung, W.J., B. Heddi, F. Hamon, M.P.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1002/anie.201308063 Conti, C., B. Saccà, J. Herrick, C. Lalou, Y .",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1091/mbc.E06-08-0689 Courbet, S., S.  Gay, N.  Arnoult, G.  Wronka, M.  Anglana, O.  Brison, and  M.  Debatisse.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/nature07233 Crabbe, L., R.E.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1126/science.1103619 Croteau, D.L., V .",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1146/annurev-biochem-060713-035428 De Cian, A., G.  Cristofari, P.  Reichenbach, E.  De Lemos, D.  Monchaud,  M.P.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.cell.2008.11.045 de Lange, T. 2005.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1101/ gad.1346005 Doksani, Y ., J.Y .",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.cell.2013.09.048 Drosopoulos, W.C., S.T.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1083/jcb.201112083 Du, X., J.  Shen, N.  Kugan, E.E.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1128/ MCB.24.19.8437-8446.2004 Fry, M., and L.A.  Loeb.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1074/ jbc.274.18.12797 Gilson, E., and V .",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/nrm2259 Griffith, J.D., L. Comeau, S. Rosenfield, R.M.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80760-6 Guan, Z., C.M.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1083/jcb.200905144 Hand, R., and J. German.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/nar/gkt957 Johnson, J.E., K. Cao, P. Ryvkin, L.S.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/nar/gkp1103 Kuzminov, A.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1002/bies.201200128 Levenson, V ., and J.L. Hamlin.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/nar/21.17.3997 Lillard-Wetherell, K., A. Machwe, G.T.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1128/ MCB.20.9.3286-3291.2000 London, T.B., L.J.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/82548 Machwe, A., L. Xiao, J. Groden, and D.K. Orren.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1021/bi0615487 Machwe, A., R. Karale, X. Xu, Y .",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1021/bi2001054 Maizels, N., and L.T. Gray.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1371/journal.pgen.1003468 Martin, C.D., G. Rojas, J.N.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"6:46. http://dx.doi.org/10.1186/1472-6750-6-46 McDaniel, L.D., N.  Chester, M.  Watson, A.D.  Borowsky, P.  Leder, and  R.A. Schultz.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"2:1387– 1404. http://dx.doi.org/10.1016/j.dnarep.2003.08.006 Mohaghegh, P., J.K. Karow, R.M.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/ nar/29.13.2843 Monchaud, D., C.  Allain, H.  Bertrand, N.  Smargiasso, F.  Rosu, V .",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.biochi.2008.02.019 Nguyen, G.H., W.  Tang, A.I.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.org/10.1126/science.1064603,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"129:79– 90. http://dx.doi.org/10.1016/j.mad.2007.10.007 Opresko, P.L., C. von Kobbe, J.P. Laine, J. Harrigan, I.D.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1074/jbc.M505211200 Pacek, M., A.V .",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/nar/gkq136 Ralf, C., I.D.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1074/jbc.M604268200 Rao, V .A., C. Conti, J. Guirouilh-Barbat, A. Nakamura, Z.H.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.org/10.1158/1541-7786.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1093/nar/gkr868 Schofield, D.J., A.R.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1186/ gb-2007-8-11-r254 Sfeir, A., S.T.",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.021 Singh, D.K., A.K.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1016/j.mrfmmm.2011.06.002 Snow, B.E., M. Mateyak, J. Paderova, A. Wakeham, C. Iorio, V .",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1128/MCB.01866-06 Suhasini, A.N., N.A.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
"http://dx.doi.org/10.1038/emboj.2010.362 Wu, Y ., K.  Shin-ya, and R.M.",OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JCB_201410061.PMC4508891.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*M.J.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201411001/DC1.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.semcdb.2012.01.008Belenkaya, T.Y ., Y .",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.12.003 Bray, S.J. 2006.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nrm2009 Brou, C. 2009.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.yexcr.2008.09.010 Bulgakova, N.A., I. Grigoriev, A.S. Yap, A. Akhmanova, and N.H. Brown.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/jcb.201211159 Burd, C., and P.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"6:6. http://dx.doi.org/10.1101/cshperspect.a016774 Chang, H.C., M. Hull, and I. Mellman.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/jcb.200311084 Childress, J.L., M. Acar, C. Tao, and G. Halder.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.cub.2006.09.031 Cohen, M., M. Georgiou, N.L.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.06.006 Cornell, M., D.A.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nature07854 Couturier, L., N.  V odovar, and F.  Schweisguth.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nature05954 Dornier, E., F.  Coumailleau, J.F.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/ jcb.201201133 Fabrowski, P., A.S. Necakov, S. Mumbauer, E. Loeser, A. Reversi, S. Streichan,  J.A.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"4:2244. http://dx.doi.org/10.1038/ncomms3244 Fehon, R.G., P.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ncb1678 Freeman, C.L., G. Hesketh, and M.N.J. Seaman.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1247/csf.07045 Gallagher, C.M., and J.A. Knoblich.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.09.014 Girard, M., and P.S. McPherson.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1074/jbc.M505036200 Grant, B.D., and J.G.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nrm2755 Gustafsson, M.G., L.  Shao, P.M.  Carlton, C.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1529/ biophysj.107.120345 Hanyaloglu, A.C., E.  McCullagh, and M.  von Zastrow.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ sj.emboj.7600688 Harterink, M., F.  Port, M.J.  Lorenowicz, I.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ ncb2281 Henne, W.M., N.J. Buchkovich, and S.D. Emr.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.05.015 Hori, K., M.  Fostier, M.  Ito, T.J.  Fuwa, M.J.  Go, H.  Okano, M.  Baron, and  K. Matsuno.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/dev.01448 Hori, K., A.  Sen, T.  Kirchhausen, and S.  Artavanis-Tsakonas.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/ jcb.201104146 Housden, B.E., K. Millen, and S.J. Bray.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/onc.2012.554 Koumandou, V .L., C. Boehm, K.A.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1128/ EC.00273-12 Le Borgne, R., and F. Schweisguth.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00187-4 Le Bras, S., C. Rondanino, G. Kriegel-Taki, A. Dussert, and R. Le Borgne.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/ jcs.110171Li, H., H.-F. Li, R.A. Felder, A. Periasamy, and P.A. Jose.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"13:031206. http://dx.doi.org/10.1117/1.2943286 Lloyd, T.E., R.  Atkinson, M.N.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1084/jem.20111855 Lu, H., and D. Bilder.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2007.00686.x Matsuno, K., M. Ito, K. Hori, F. Miyashita, S. Suzuki, N. Kishi, S. Artavanis- Tsakonas, and H.  Okano.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2011.01201.x McGough, I.J., F. Steinberg, D. Jia, P.A.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.cub.2014.06.024 Millman, E.E., H.  Zhang, H.  Zhang, V .",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2008.00813.x Miura, E., T.  Hasegawa, M.  Konno, M.  Suzuki, N.  Sugeno, N.  Fujikake,  S. Geisler, M. Tabuchi, R. Oshima, A. Kikuchi, et al.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.nbd.2014.07.014 Moberg, K.H., S. Schelble, S.K.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.09.018 Montagne, C., and M. González-Gaitan.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/dev.104240 Morrison, H.A., H. Dionne, T.E.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/0925-4773(95)00397-J Ni, J.Q., R. Zhou, B. Czech, L.P. Liu, L. Holderbaum, D. Yang-Zhou, H.S.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nmeth.1592 Nolo, R., L.A.  Abbott, and H.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)00040-4 Pan, C.L., P.D.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.12.001 Piddini, E., F.  Marshall, L.  Dubois, E.  Hirst, and J.P.  Vincent.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/ dev.02145 Pocha, S.M., T.  Wassmer, C.  Niehage, B.  Hoflack, and E.  Knust.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ ncb1687 Rives, A.F., K.M.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/jcs.103440 Seaman, M.N.J., A. Gautreau, and D.D. Billadeau.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.tcb.2013.04.010 Shi, A., L.  Sun, R.  Banerjee, M.  Tobin, Y .",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/emboj.2009.272 Sisson, J.C., C. Field, R. Ventura, A. Royou, and W. Sullivan.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/ jcb.151.4.905 Sönnichsen, B., S.  De Renzis, E.  Nielsen, J.  Rietdorf, and M.  Zerial.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/jcb.149.4.901 Sprinzak, D., A. Lakhanpal, L. Lebon, L.A. Santat, M.E.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/nature08959 Steinberg, F., M.  Gallon, M.  Winfield, E.C.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ncb2721 Tanaka, T., and A. Nakamura.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/dev.017293 Temkin, P., B.  Lauffer, S.  Jäger, P.  Cimermancic, N.J.  Krogan, and M.  von  Zastrow.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/ncb2252 Thompson, B.J., J. Mathieu, H.-H.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1371/ journal.pone.0093987 Troost, T., S. Jaeckel, N. Ohlenhard, and T. Klein.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/jcs.097261 Vaccari, T., and D. Bilder.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.09.019 Vaccari, T., H. Lu, R. Kanwar, M.E.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1083/jcb.200708127 Vaccari, T., T.E.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/jcs.046391van den Heuvel, M., R.  Nusse, P.  Johnston, and P.A.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.ajhg.2011.06.001 Vilariño-Güell, C., A. Rajput, A.J.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1371/ journal.pbio.1001847 Wilkin, M.B., A.-M. Carbery, M. Fostier, H. Aslam, S.L.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.09.002 Wucherpfennig, T., M. Wilsch-Bräuninger, and M. González-Gaitán.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1111/j.1365-2443.2011.01488.x Yan, Q., W.  Sun, P.  Kujala, Y .",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.12.004 Yousefian, J., T.  Troost, F.  Grawe, T.  Sasamura, M.  Fortini, and T.  Klein.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1242/ jcs.114934 Zavodszky, E., M.N.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"5:3828. http://dx.doi.org/10.1038/ncomms4828 Zhang, Y ., B.",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1091/mbc.12.7.2011 Zhang, P., Y .",OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
"http://dx.doi.org/10.1038/cr.2011.167 Zimprich, A., A.  Benet-Pagès, W.  Struhal, E.  Graf, S.H.",Non-OADS,/arxiv_data1/oa_pdf/62/57/JCB_201411001.PMC4508892.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*A.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
Online supplemental material is avail-able at http://www.jcb.org/cgi/content/full/jcb.201412047/DC1.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"http://dx.doi.org/10.1371/journal.pcbi.1003619 Bean, G.J., S.T.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"http://dx.doi.org/10.1021/bi900014d Carballido-López, R., A.  Formstone, Y .",Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.07.017 Charest, P.G., and R.A. Firtel.",OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"http://dx.doi.org/10.1016/j.jmb.2015.01.025 Domínguez-Escobar, J., A. Chastanet, A.H. Crevenna, V .",OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
"http://dx.doi.org/10.1126/science.1203466 Ducret, A., O. Théodoly, and T. Mignot.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/JCB_201412047.PMC4508894.pdf
